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Resumen
La Para´lisis Cerebral (PC) es un conjunto de alteraciones neurolo´gicas debidas a una
lesio´n cerebral surgida en la infancia, que afectan de forma permanente al movimiento
de la persona y a su coordinacio´n motora. En algunos casos, estas limitaciones pueden ir
acompan˜adas de problemas sensoriales o intelectuales, dependiendo de la severidad de la
lesio´n. Es la discapacidad f´ısica ma´s comu´n en pacientes pedia´tricos, con una prevalencia
de 2.11 casos por 1000 nacimientos. Los tratamientos convencionales de la PC pueden
dividirse en tres pilares principales (fisioterapia, terapia ocupacional y logopedia), los
cuales deben progresar cada d´ıa en busca de ofrecer mejores resultados a los pacientes.
Como parte de la mejora de estos tratamientos convencionales, la terapia por asistencia
robo´tica de la marcha es un concepto que ha surgido en los u´ltimos an˜os para comple-
mentar la terapia f´ısica convencional de personas con problemas motores, como aquellos
derivados de la PC. Sin embargo, el uso de entrenadores robo´ticos esta´ au´n limitado en la
pra´ctica cl´ınica: los cl´ınicos y familiares demandan ma´s investigaciones que confirmen la
efectividad de la terapia robo´tica, as´ı como estudios que determinen si la rehabilitacio´n
robo´tica realmente merece la pena.
El objetivo principal de esta tesis doctoral es ofrecer una novedosa solucio´n robo´tica para
la rehabilitacio´n de la marcha de pacientes pedia´tricos con PC y deso´rdenes similares.
El enfoque que se pretende dar con el dispositivo robo´tico propuesto en la tesis es
distinto al que existe hasta el momento, aportando nuevas ideas no so´lo sobre el disen˜o
y el control del dispositivo, sino tambie´n sobre los protocolos de intervencio´n cl´ınica.
La metodolog´ıa utilizada para alcanzar este objetivo se baso´ en un estudio detallado
sobre la aplicacio´n de entrenadores robo´ticos de rehabilitacio´n elaborados en los u´ltimos
an˜os. Con esta investigacio´n se identificaron las principales limitaciones y desaf´ıos de
las terapias robo´ticas actuales, los cuales sirvieron para sentar las bases del disen˜o y
desarrollo de una nueva plataforma robo´tica englobada en el marco de trabajo de esta
tesis: CPWalker.
CPWalker esta´ compuesto por dos partes principales: un andador inteligente y un ex-
oesqueleto con 6 grados de libertad. A trave´s de ellas, es posible proporcionar soporte
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parcial de peso del usuario al mismo tiempo que se realiza un movimiento guiado de las
articulaciones con desplazamiento en entornos reales.
El entrenador robo´tico CPWalker promueve la progresio´n de pacientes con PC dentro del
tratamiento de rehabilitacio´n, incrementando el nivel de intensidad y frecuencia de los
ejercicios, al mismo tiempo que aumenta la motivacio´n del usuario y adapta la terapia a
las posibilidades de cada paciente. Para ello, utiliza estrategias de control innovadoras,
las cuales pueden ser seleccionadas de forma individual para cada articulacio´n, dando
as´ı una alta versatilidad en la definicio´n de los tratamientos.
La plataforma robo´tica desarrollada fue evaluada tanto te´cnica como cl´ınicamente con
pacientes pedia´tricos. Los resultados muestran el potencial del dispositivo como her-
ramienta de rehabilitacio´n, proporcionando tambie´n soporte preliminar para futuras
implementaciones cl´ınicas, no solo en CPWalker, sino tambie´n en otros dispositivos
robo´ticos de la marcha.
El trabajo desarrollado en esta tesis ha sido llevado a cabo con la ayuda financiera del
Ministerio de Economı´a y Competitividad espan˜ol y la Secretar´ıa de Estado de Inves-
tigacio´n, Desarrollo e Innovacio´n, bajo el contrato BES-2013-064225/DPI2012-39133-
C03-01.
Abstract
Cerebral Palsy (CP) is a set of neurological disorders derived from a brain lesion oc-
curred in infancy or early childhood, which permanently a↵ect body movement and
muscle coordination. In some cases, these limitations go together with sensory or intel-
lectual problems, which depend on the severity of the disease. CP is the most common
physical disability in childhood, presenting a prevalence of 2.11 cases per 1000 births.
Conventional treatments for CP could be divided in three main pillars (physiotherapy,
occupational therapy and speech therapy), which must be continuously improved looking
for better results for the patients.
As part of the enrichment of these conventional treatments, robot-assisted gait therapy
is a promising tool that has appeared in the last years to complement conventional
physical therapy of people with gait disorders as those derived from CP. However, the
use of robotic trainers in pediatric clinical practice is still limited: clinicians and families
demand further research that confirms the e↵ectiveness of robotic therapy, and clarifies
if robotic rehabilitation is worthwhile for their children.
The main objective of this doctoral thesis is to provide a novel robotic solution for gait
rehabilitation of pediatric population with CP and related disorders. The approach
that the proposed robotic device expects to o↵er is di↵erent from those existing so far,
providing new ideas not only about the design and control of the device, but also about
clinical intervention protocols. The methodology used to reach this objective was based
on a detailed study about the application of robotic trainers developed in the last years
for CP rehabilitation. This research identified the main limitations and challenges of
current robotic therapies, which served as the base to design and develop a novel robotic
platform in the framework of this thesis: CPWalker.
CPWalker is composed by two main parts: a smart walker and an exoskeleton with 6
degrees of freedom. Through them, it is possible to provide user’s partial body weight
support in parallel with guided joint motion and over-ground displacement.
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CPWalker trainer promotes the progression of patients with CP into the rehabilitation
treatment, increasing the level of intensity and frequency of the exercises as well as
enhancing the motivation and tailoring the therapy to each user. To do so, innovative
control strategies were used, which may be individually selected per joint giving a high
versatility for the treatment’s design.
The developed robotic platform was evaluated both technically and in clinical envi-
ronments with pediatric patients. The results show the potential of the novel robotic
platform to serve as a rehabilitation tool, also providing preliminary support for future
clinical implementations not only in CPWalker, but also in other existing robotic gait
trainers.
The work developed in this dissertation has been carried out with the financial support
from the Ministerio de Economı´a y Competitividad of Spain and the Secretar´ıa de Estado
de Investigacio´n, Desarrollo e Innovacio´n, under Contract BES-2013-064225/DPI2012-
39133-C03-01.
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Objectives, Motivation and
Organization of Work
All of us were born with limitations, which we are continuously overcoming by the
acquisition of capabilities during childhood, adolescence and adulthood. The faculty to
obtain these capabilities depends on each person, being very often related to the person’s
attitude towards challenges of life. People with disabilities have major challenges to face
during their development, however, the term “disability” is referred to the di culty to
carry out particular or specific activities, but it never means a total incapacity. People
with disabilities are also full of skills and possibilities for the future, which in most of
the cases will get better with e↵ort.
Cerebral Palsy (CP) is the most frequent disability in childhood [1, 2]. It is caused by
abnormal development or damage to parts of the brain, which very often are responsible
of control movement, balance or posture, and to a lesser grade, they a↵ect sensory or
cognitive mechanisms. CP in childhood is associated with heavy demands on health,
educational and social services, as well as on families and children themselves.
Early and ongoing rehabilitation treatments look for the improvement of capabilities of
people with CP. The main therapies are [3]: i) physical and occupational therapy, which
is focused on walking, standing, stretching exercises, and flexibility; ii) oral medication,
which is generalized to spasticity treatment; iii) orthoses, which are normally used in chil-
dren with CP to try to prevent deformities, contractures, and pain; iv) botulinum toxin
to treat localized spasticity; v) ferule and plaster to avoid moderate contractures; vi)
multilevel orthopedic surgery, which consists in two or more soft-tissue or bony surgical
procedures, at two or more anatomical levels during one unique operative procedure [4];
vii) partial body weight-supported treadmill training and constraint-induced movement
therapy, which are based on motor learning theories and promote the standardization of
gait pattern by involving sensory information and reflection components of gait; and viii)
Robot-Assisted Gait Training (RAGT), which may be an e↵ective tool to compensate
or rehabilitate the functional skills of people with CP [5].
1
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In particular, rehabilitation robotics has been an emerging research field in the last
years [6]. RAGT shows some promising advantages compared to conventional therapy
[7], however, it should be further improved to increase its e↵ectiveness, enhance motor
learning and enrich recovery [7, 8]. The improvements of RAGT begin with the integra-
tion not only of Peripheral Nervous System (PNS) but also of Central Nervous System
(CNS) into the human-robot loop. The parallel integration of both systems maximizes
the therapeutic e↵ects arising from the brain plasticity, which may be understood as
the ability of the brain to change and thereby adapt the nervous system to physiologic
changes and experiences [9]. Although this approach has been previously studied in
other populations (e.g. Spinal Cord Injury (SCI) [10]), nowadays there is a lack of stud-
ies in CP [6]. On the other hand, recent studies suggest that RAGT should also include
user’s motivation and cognitive aspects as the attention as essential points to achieve a
higher impact in physical abilities. In that sense, techniques that involve cooperative
tasks (virtual reality (VR), training in real-life scenario or exercises with challenges for
the patients) are being used, but still under development [7].
The main purpose of this work is to design, develop and evaluate a new robotic platform
to improve the gait function of children with CP. Moreover, the author defines di↵erent
strategies to implement into the robotic platform to be part of rehabilitation clinical
protocols with children with CP. It is important to highlight that the target patients of
this thesis (young children) have greater brain plasticity than adults [11], and are more
likely to have a change in motor patterns following an intervention. According to this
fact, it is essential to propose them physical exercises that increase their attention and
motivation, delivering direct and causal feedback throughout the therapy. In order to
fulfil the previous requirements and to provide a better solution for children with CP,
various objectives are given below, which pursue two main goals: first, to design a new
robotic platform that manages to improve the traditional gait rehabilitation; and second,
to introduce new concepts and guidelines to allow novel therapies into the rehabilitation
field. In a nutshell, the proposed objectives are:
• To develop a new robotic platform to support new therapies for gait rehabilitation
of children with CP.
• To elaborate novel rehabilitation therapies based on the robotic platform in order
to improve the traditional rehabilitation, tailoring the therapy to the patient’s
needs.
• To provide means for an objective evaluation of the robot-based rehabilitation
therapies, based on the evaluation of the gait kinematic patterns, functional as-
sessment and synergies generated.
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• To validate the functional and usability benefits of the proposed robotic concept
with final users (clinicians and patients).
• To evaluate the practical feasibility of the new system in clinical practice.
• To compare patients treated with traditional therapies with the ones treated with
the therapies developed with this novel device.
Four hypotheses support these previous objectives:
• The rehabilitation with the proposed device will engage the users throughout ther-
apy sessions. Patients will enhance their interest and motivation if the exercises
are challenging, and thereby, the treatment outcomes will become better. With
this goal, the device will use di↵erent technologies through which the CNS and
PNS will be introduced in the rehabilitation.
• The ambulation treatment in real rehabilitation environments is a more challeng-
ing exercise than the rehabilitation on treadmill. If the patient’s motivation is
higher, the intensity and frequency of the therapy will increase. Moreover, chil-
dren might create new brain connections and develop cognitive skills by exploring
the world around them. This means that spatial cognition, problem solving and
depth perception will be upgraded, which implies improvements in the outcomes
of the treatment.
• The inclusion of novel algorithms to correct the child’s posture and to enable the
definition of tailored therapies for each patient will promote user’s participation
and may impact on brain reorganization.
• The early use of assistive technology in children with CP is considered a parameter
of paramount importance to the results of the therapy. It is during these ages
when brain plasticity is at its highest level, leading to the maximum capability for
physical and cognitive rehabilitation.
Organization of work
The proposed methodology to achieve the objectives described in the previous section is
based on an in-depth bibliographical study related to di↵erent fields of CP, in particular,
technology used for gait rehabilitation. The work is divided into five chapters that
partially overlap with the principal publications derived from the thesis [3, 12–14]. The
chapters are organized as follow:
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First chapter presents a general review of the state-of-the-art of CP rehabilitation. It
starts describing the CP term and analysing the possible classification groups depending
on di↵erent approaches. Subsequently, the chapter exposes an extensive review of the
current treatments for patients with CP, with special emphasis on robotic rehabilitation
[3]. The state-of-the-art of robotic devices for rehabilitation in CP is presented at the
end of chapter 1. The rest of the dissertation is based on this preliminary research.
Although several existing robotic devices attempt to improve the gait training of chil-
dren with CP and similar neurological and motor disorders, new challenges in robotic
rehabilitation are needed in order to ratify its e↵ectiveness and enrich current training
protocols [7, 8, 15]. In this regard, chapter 2 establishes the main requirements for the
development of a novel robotic platform for gait rehabilitation in CP. Both the me-
chanical design and control architecture of the platform are described in this chapter,
going into detail about the di↵erent incorporated systems and their interaction [12]. The
conclusions of chapter 2 will serve as the base to develop new algorithms and control
strategies to implement innovative robot-based therapies.
The third chapter is focused on the definition and technical evaluation of elemental
control strategies for robotic gait training in pediatric population. These strategies
are based on a Multimodal Human-Robot Interface (MHRI) that makes the interaction
between the patient and the robotic device. The control strategies are defined and
evaluated using the gait trainer of this thesis, but they could also be applied to other
rehabilitation platforms. Indeed, at the end of chapter 3, the author exposes how a
controller developed within the framework of this dissertation, has been transferred
to other domains. A preliminary validation of the control strategies on real patients
provided important outcomes to define a robot-based gait training proposal [13].
Chapter 4 covers the goal settings and detailed guidelines of an accurate robot-based
program for gait rehabilitation of pediatric population with CP [14]. This rehabilitation
program tries to improve patients’ capabilities related to diverse functional domains of
the International Classification of Functioning, Disability and Health framework, Chil-
dren and Youth version (ICF-CY) [16]. Two gait training phases (strength phase and
power phase) are considered, which are validated in four children with CP as prelimi-
nary support for future clinical implementations. At the end of the chapter, the author
presents a discussion of the obtained results.
Chapter 5 summarizes the main conclusions and identifies major contributions of this
work. Furthermore, it presents the future work derived from the outcomes of this dis-
sertation.
Bibliography is exposed at the end of the thesis.
Chapter 1
Introduction to Cerebral Palsy
and Gait Rehabilitation
In the last decades, studies about rehabilitation in Cerebral Palsy have increased, plac-
ing emphasis on promoting active therapies with high intensity and repetitive and task-
specific training in order to enhance neuroplasticity. Robot-based treatment for gait re-
habilitation is a novel approach, currently under development, which drives the patient’s
gait in special conditions enhancing the progress of the therapy.
This chapter presents an overview of the Cerebral Palsy pathology, its main risk factors
and classification scales. The chapter highlights the principal therapies carried out in re-
habilitation of Cerebral Palsy, and focuses on emerged robotic technologies reviewing the
current devices used with this aim. Finally, the chapter also identifies the main short-
comings on current robotic trainers in order to define a new device for gait rehabilitation
in Cerebral Palsy and related disorders.
1.1 Cerebral Palsy
CP term could be defined, according to the National Institute of Neurological Disorders
and Stroke (NINDS), as “any one of a number of neurological disorders that appear in
infancy or early childhood and permanently a↵ect body movement and muscle coordi-
nation but do not worsen over time”. These disorders can disturb other higher functions
and infer in the CNS. Nevertheless, the definition of CP remains a controversial issue at
the present time. The universal acceptance of one definition of CP does not exist, but it
is often associated with sensory deficits, cognition impairments, communication and mo-
tor disabilities, behaviour issues, seizure disorder, pain, and secondary musculoskeletal
5
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problems [17]. Movement and posture disorders derived from CP are generally charac-
terized by loss of muscle strength, improper muscle activation and loss of coordination
[18].
This disease is more common in males, and the main causes and risk factors are: multiple
birth, extreme prematurity, birth asphyxia, feeding issues, prolonged hospitalization, or
postnatal infection [19]. So far, CP has been diagnosed between 12 and 24 months of
age, but nowadays, it is possible an early diagnosis at 12 weeks of age for roughly half
the a↵ected population, via the evaluation of risk factors previously given [19].
The overall rate of CP for the period of 1980 to 1990 was 2.08/1000 live births (95%
CI 2.02 to 2.14) [20, 21]. One in five children with CP (20.2%) had a severe intellectual
deficit and was unable to walk. Among babies that weighed less than 1500 g at birth,
the rate of CP was more than 70 times higher than those weighing 2500 g or more at
birth. The rate of CP rose during the 1970s but remained constant during the late
1980s [21]. It was also maintained about constant from 1980s to through 2002, rather
than increasing as might be expected [2]. The rate of multiple births in the population
increased from 1.9% in 1980 to 2.4% in 1990, and the proportion of multiples among
infants with CP increased from 4.6% in 1976 to 10% in 1990. Multiples have a four-fold
higher rate of CP than singletons overall [20, 22]. Recent studies a rm that the current
prevalence of CP is 2.11/1000 births (95% CI 1.98-2,25) [1, 2].
In the last years, the improvements in care during pregnancy and after birth have pre-
vented cases of CP with severe intellectual disability (prevalence for these cases decreased
about 2.6% each year from 1985 to 2002, [2]).
1.2 Classification of Cerebral Palsy
The CP term covers a quite heterogeneous groups of disorders, and therefore, it is
di cult to classify the type of CP su↵ered by a patient. In accordance with the Spanish
confederation for the care of people with CP [23], individuals with CP are normally
categorized into classes or groups, though most people with CP have a combination or
two or more types. From a topographic point of view, depending on how many structures
are involved (see Figure 1.1), people with CP could be classified as having Hemiplegia,
Paraplegia, Tetraplegia, Diplegia, or Monoplegia [23]:
• Hemiplegia: Only one side of the body a↵ected, including arm, leg and trunk.
• Paraplegia: Lower limbs a↵ected.
• Tetraplegia: Lower limbs and upper limbs a↵ected.
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• Diplegia: The most a↵ected limbs are the lower limbs.
• Monoplegia: Only one limb is a↵ected, usually an arm.
This classification, used in combination with the type of movement disorder (Spastic-
ity, Dyskinesia/Athetoid, Ataxia, or Mixed), o↵ers an interesting approach for clinical
practice. Table 1.1 shows the description of each movement disorder in CP according to
“Surveillance of Cerebral Palsy in Europe” (SCPE) [24].
On the other hand, functional classification procedures are recommended when a clinical
decision is required. In order to categorize the degree of involvement, the most used
scale is the “Gross Motor Function Classification System” (GMFCS) from Palisano et
al. in 1997 [25], which was revised in 2007. It defines five levels of CP depending on
functional limitations (Figure 1.2), the need for hand-held mobility devices (such as
walkers, crutches or canes) or wheeled mobility, and to a much lesser extent, quality of
movement. This bibliography also recognizes that the levels of GMFCS are based on
age (groups under two years old, between two and four years old, between four and six
years old, between six and 12 years old and between 12 and 18 years old):
• Level I: Walks without limitations.
• Level II: Walks with limitations in long distances and balancing. They may need
a hand-held mobility device to learn to walk for the first time. They require some
support to walk up and down stairs.
• Level III: Walks using a hand-held mobility device.
• Level IV: Self-mobility with limitations. They may use powered mobility.
• Level V: Has severe limitations in head and trunk control. They are transported
in a manual wheelchair, and self-mobility is only achieved if the child is able to
learn how to operate a powered wheelchair.
Figure 1.1: Types of CP depending on structures involved.
1. Introduction to Cerebral Palsy and Gait Rehabilitation 8
Table 1.1: Types of movement disorders in CP according to Surveillance of Cerebral
Palsy in Europe (SCPE)
Spastic CP
- Abnormal pattern of posture and/or movement.
- Increased tone.
- Pathological reflexes.
- Spastic CP may be either bilateral or unilateral:
· It is bilateral if limbs on both sides of the body are involved.
· It is unilateral if limbs on one side of the body are involved.
Dyskinetic
or Athetoid
CP
- Involuntary, uncontrolled, recurring, occasionally stereotyped
movements.
- Abnormal pattern of posture and/or movement.
- Spastic CP may be either dystonic or choreo-athetotic:
· Dystonic CP is dominated by both hypokinesia and hypertonia.
· Choreo-athetotic CP is dominated by both hyperkinesia and
hypotonia.
Ataxic CP
- Abnormal pattern of posture and/or movement.
- Loss of orderly muscular coordination used to perform movements
with abnormal force, rhythm and accuracy.
Mixed CP - Combined several types of CP.
Another evaluative method is the “Functional Mobility Scale” (FMS) [26], which is uti-
lized to measure functional mobility over three distinct distances (5 m, 50 m and 500 m),
specifying the assistive device that the child needs to use. In line with the GMFCS and
the FMS, severity is also used for classification purposes (Moderate, Moderately severe,
or Severe CP).
Finally, taking into account the measure on fine motor function, the “Manual Ability
Classification System” (MACS) [27] classifies the use of hands in users with CP to
perform activities of daily life. Other scales as “Modified Ashworth Scale” (MAS) or
“Tardieu Scale” have the purpose of measuring spasticity in patients with CP. They are
a quick and easy form that can assist a clinician’s assessment of spasticity during passive
soft-tissue stretching.
However, in spite of all these metrics, in most cases it is di cult to classify a patient
due to the wide variety of alterations and levels of severity.
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Figure 1.2: Levels of Gross Motor Function Classification System (GMFCS).
1.3 Current therapies for patients with CP
A complete cure for CP is not currently available, because this means repair of the
underlying brain damage. Therefore, rehabilitation is commonly used with the princi-
pal aim of improving patient’s independence in daily life [6] and preventing secondary
complications. If secondary musculoskeletal disorders appear and they are persistent,
some factors emerge such as gait impairments, abnormal muscle tone, fatigue, weakness,
communication impairments and loss of function.
Therapies for CP and their mode of application depend on the specific patient’s disorders
and severity, and they range from physical therapy to medication and surgery. However,
under all conditions, rehabilitation needs to be implemented during the early stages of
child’s development, because it is at this phase when fundamental abilities and skills
are developed [28]. These abilities include activities of daily living as playing, self-
care activities and fine motor tasks (writing, reading or drawing). The success rate of
rehabilitation also increases in accordance with the intensity of therapy, repetition, and
patient’s motivation, the latest specially in children [6]. As a result, it is essential to
give children with CP the opportunity to interact with the environment looking for an
integral development (physical and cognitive).
The estimated cost to care for an individual with CP is a real problem for families and
caregivers, and it is around $1 million. The combined estimated lifetime costs for all
people with CP who were born in 2000 will total $11.5 billion in direct and indirect costs
[22].
Next subsections summarize the main therapies carried out so far for rehabilitation of
people with CP [3].
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1.3.1 Physical and occupational therapy
Physical therapy is a part of rehabilitation that tries to restore, maintain and promote
patient’s optimal movement and physical function. The main goal of the physical therapy
is to maximize functional control of the body, or increase gross motor function. There
are a wide variety of exercises that are carried out in physical therapy for CP [29], but
in general, they are focused on walking, standing, stretching exercises, and flexibility.
Physical therapy should be always guided by a physiotherapist, who can benefit from
di↵erent instruments as bars, treadmill and other adaptive equipment designed to achieve
mobility, but also could involve robotic devices to implement the exercises. In the last
case, it is called “robotic physical therapy”.
1.3.2 Oral medication and botulinum toxin
Some drugs could be indicated in CP cases in which the distribution of muscle overactiv-
ity is di↵use. In particular, the main current approved agents to treat spasticity in CP
are baclofen and diazepam. From the end of 20th century, botulinum toxin type-A has
been used to complement the existing oral medication for treating spasticity, mainly fo-
cused on motor problems of children with CP [30]. The principal di↵erence between both
oral medication and botulinum toxin is that the e↵ects of the latest could be localized
for a specific region of the body.
1.3.3 Orthoses and technical supports
Technical support is defined as any product developed with the aim of preventing, com-
pensating or neutralizing activities limitations or restrictions in the participation. De-
vices for gait technical support in CP are primarily designed to allow autonomous dis-
placement to the patient, improving functional independence and social integration. In
a second way, they try to prevent deformities, contractures, and pain. As a consequence,
user’s quality of life is changed for the better.
The whole of technical aids in children with CP is extremely diverse, and it may range
from orthoses (Figure 1.3) to canes, crutches and walkers (Figure 1.4):
• Orthoses: They are external supports that can be adapted individually for each
patient. Their aim is to modify the structural or functional conditions of the neu-
romusculoskeletal human system. In CP, orthoses are normally used to reinforce
and protect a surgical procedure during a rehabilitation period. With them, the
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Figure 1.3: Types of orthoses for children with movement disorders. (a) Foot orthoses
(FO); (b) Ankle Foot orthoses (AFO); (c) Knee Ankle Foot orthoses (KAFO); (d) Hip
Knee Ankle Foot orthoses (HKAFO).
development of growth abnormalities are limited and the gait is improved [31].
There are some types of orthoses depending on the body segment that is utilised:
– Foot orthoses (FO): Normally used as insoles, Figure 1.3 (a).
– Ankle Foot orthoses (AFO): The most applied in CP to prevent equinus foot,
Figure 1.3 (b).
– Knee Ankle Foot orthoses (KAFO): They are not very common in CP treat-
ments, Figure 1.3 (c).
– Hip Knee Ankle Foot orthoses (HKAFO): They are rarely used today in chil-
dren with CP. They control lateral movements and spasticity, Figure 1.3 (d).
• Walkers: They are useful devices to assist people in walking actions. For its
use, it is necessary the presence of motor control as the patient’s capacity of head
control and weight discharge in lower limbs [32]. There are some types of walkers,
but the most used are anterior walkers (positioned in front and moved forward
by the user, Figure 1.4 (a)) and posterior walkers (the person pulls from behind,
Figure 1.4 (b)). Some studies in the bibliography a rm that posterior walkers
have more advantages in terms of upright positioning and energy conservation
than anterior walkers [33]. Moreover, posterior walkers could be more favourables
since the person’s center of mass is within the base of support of the walker.
1.3.4 Orthopaedic surgery
Most of current basic treatments applied with the aim of improving the mobility in
patients with CP, are not e↵ective at some specific age (observe Figure 1.5) [34]. With the
child’s growth, deformities in bones increase, and muscles on hip, knee and ankle work in
a worse way contributing to the development of crouch gait (Figure 1.6). The progress
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Figure 1.4: Types of walkers for children with movement disorders. (a) Anterior
walker; (b) Posterior walker.
of crouch gait linked to a pubertal growth spurt, generates knee pain, a decrement of
endurance, and the necessity of using gait assistive devices [4].
To address the limitation of progressive musculoskeletal disorders, orthopaedic proce-
dures have been designed. One of the most important concepts in this field is the “Single
Event Multilevel Surgery” (SEMLS), adopted by Nene et al. in 1993 [35]. It may be
understood as a type of surgery in which multiple levels of musculoskeletal pathology in
both lower limbs are addressed by two surgical teams during only one operative proce-
dure. It requires only one hospitalization and one rehabilitation period [4, 34, 36]. The
Figure 1.5: Treatment applied during the growth of children with CP. Frequency
peak for SEMLS is achieved in puberty stage.
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Figure 1.6: Sti↵ knee flexo in a patient with CP.
most common gait pattern treated with SEMLS corresponds with crouch gait combined
with knee flexion, hip flexion and ankle dorsi-flexion [32].
SEMLS technique has demonstrated important benefits in musculoskeletal problems of
children with CP, reducing walking e↵ort [35], improving the “Gross Motor Function
Measure” (GMFM) [37, 38] and kinematic parameters [39], gait speed [40] and the
Gillette Gait Index (GGI) [41]. However, it should be only applied if conservative
treatments were not enough to stop the progressive deterioration of patient’s ambulation.
Current conventional rehabilitation techniques after a surgical procedure in CP are
mainly carried out in four stages, which following chronological order in rehabilitation
period, they are: i) in first phases after surgical process we found early mobilization,
cryotherapy, active and resisted kinesiotherapy of non-operated limb and isometric con-
traction of operated limb; ii) analytical and resisted kinesiotherapy of operated limb,
stretching exercises and trunk and postural control exercises; iii) in more advanced re-
habilitation stages we found dissociation of limbs, weight transfer exercises and changing
between sitting and standing position; and iv) muscle strengthening machine, balance
exercises, squats, stairs and parallel bars.
1.3.5 Robotic physical therapy
Recently, several technological advancements have been introduced into the field of re-
habilitation to complement conventional therapeutic interventions. In the light of this,
robot-assisted therapy appears as an alternative and complementary treatment [6]. It
could be defined as a form of physical therapy that uses a non-invasive robotic device to
help a person with an impaired functional ability to recover their function [42]. Robot-
assisted training increases the therapy compliance by proposing goal-directed tasks that
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encourage the patients. This approach has interesting advantages compared to tradi-
tional therapy, because it suggests functional exercises with accurate and assembled
movements, instead of repetitive movements without goals. Moreover, robotic trainers
reduce the physical load and cost of conventional therapies, integrating at the same time
novel systems to objectively measure the progression of the exercise. As a result, the
number of sessions, frequency, intensity, and finally the positive impact of the treatment
are typically increased.
Robotic devices may sometimes be combined with new and advanced methods of feed-
back, as the application of virtual scenarios, where the users can interact with a virtual
object in real-time and feel that they are part of a virtual environment during the ther-
apy [6, 43]. In that sense, there is widespread interest in using VR in the rehabilitation of
children with CP to address upper [44, 45] and lower extremity motor functions [46, 47].
On the other hand, robot-assisted gait therapy is also often combined with partial body
weight support (PBWS) [48–50], providing beneficial results specially in patients with
low ambulatory status. This feature allows repetitive execution of gait movements in a
controlled and safe way, with an adjustable support of body weight, which is sometimes in
high demand by the therapists. Generally, training protocols include a gradual increase
of di culty level by decreasing the amount of PBWS provided during walking.
Nevertheless, although some features of using robot-based therapies have demonstrated
positive results compared to traditional training in di↵erent pathologies, there is a weak
evidence regarding the use of RAGT in case of children with gait disorders [8, 51].
With the main aim of addressing this fact, this thesis proposes a novel solution based on
robotic rehabilitation as part of the gait training for patients with CP. In order to better
understand the robotic field, and to know the existing alternatives, next section gives
an (incomplete) overview of robotic devices that are currently used for rehabilitation of
children with CP, both upper and lower limbs. This will serve to discuss the challenges
that are needed to fulfil, and it will provide the background for a new proposal of robotic
gait trainer.
1.4 State-of-the-art of robotic devices for rehabilitation in
CP
Robotic rehabilitation has been a growing research field in the last years. Most of the
robotic devices were initially designed for spinal cord injury or stroke patients, and they
are being recently adapted for people with CP. Within CP, pediatric population with CP
is one of the last groups in which these technologies are being applied. In this case, there
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is still no standardization about clinical conditions, time or outcome measures used. For
this reason, it is di cult to describe and precisely quantify the benefits of robot-based
therapy in children su↵ering of CP. Additionally, a more detailed description of user’s
profile is required, specially in case of users with CP, whose motor particularities are
very heterogeneous.
This section gives a general overview of the current robotic devices to implement reha-
bilitation in CP. According to that, both cases upper and lower limbs are necessary to
be reviewed to understand the last advances in robot-assisted rehabilitation for CP. The
review provides a framework to finally identify the lacks in devices for lower limbs in
order to look for a better robotic solution for gait rehabilitation of children with CP.
1.4.1 Robot-assisted rehabilitation for upper limbs
There are currently a limited number of robotic systems targeting the upper extremity
that have been applied to children with CP [52]. These devices work via goal-directed
tasks and reaching movements to rehabilitate hand and arm function.
The InMotion2 (Figure 1.7 (a)), also called the shoulder-elbow robot, is an end-e↵ector
robot, a commercial version of MIT-MANUS (Interactive Motion Technologies, United
States) [53], which is capable of continuously adapting to and challenging each pa-
tient’s ability. This device aims to improve the patient’s range of motion, coordination,
strength, movement speed, and smoothness. 117 subjects that had previous strokes were
trained with InMotion2, and during the training patients were able to execute shoulder
and elbow joint movements with significantly greater independence. At the end of the
experiment, the subjects were better able to draw circles [54]. In most cases, studies
conducted with stroke patients have encouraged new experiments with people with CP,
as in another experiment where 12 children aged 5-12 years with CP and upper-limb
hemiplegia received robotic therapy twice a week for 8 weeks. The children showed sig-
nificant improvement in their total Quality of Upper Extremity Skills Test (QUEST) and
Fugl-Meyer Assessment scores [53]. Following the distal approach, Interactive Motion
Technologies developed the MIT-Manus InMotion3, which works with flexion, exten-
sion, pronation, and supination of the a↵ected wrist. The results are similar to those of
InMotion2, but in this case, InMotion3 can operate both as a standalone device and as
an InMotion2 module; InMotion3 has not yet been used in studies that include children
with CP.
Another robotic system for the upper limbs is the New Jersey Institute of Technology’s
Robot-Assisted Virtual Rehabilitation System. It is comprised of a HapicMaster and a
custom-made ring gimbal (represented in Figure 1.7 (b)). This system has 6 Degrees
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Figure 1.7: Robots for upper limbs rehabilitation. (a) InMotion (Interactive Motion
Technologies); (b) HapicMaster; (c) Armeo (Hocoma AG); (d) YouGrabber (YouRe-
hab); (e) REAPlan.
of Freedom (DOF) and is a force-controlled haptic interface [6]; it provides the user
with a realistic haptic sensation and the power to closely simulate the weight and force
found in a wide variety of human tasks. The programmable robot arm utilizes the
admittance control paradigm, giving the device unique haptic specifications, and was
used in combination with virtual scenarios to improve shoulder and elbow movements
[55]. In a study that tested 9 patients with CP, who performed 9 sessions (60 minutes
each) of 3-timed upper extremity tasks and several measurements of reaching kinematics,
the patients improved in measures of motor activity in the Melbourne Assessment (MA)
after treatment [6].
The ARMEO (Hocoma AG) system (based on the T-WREX system) proposes a rehabil-
itative exercise that allows early rehabilitation of motor abilities and provides adaptive
arm support in a 3D workspace (Figure 1.7 (c)). The ARMEO system is focused on
patients that lack su cient strength to move their arm and hand against gravity [56].
Some springs can support the weight of the upper and lower arm [6], and the system
may be adapted for each child. Unfortunately, no clinical trials have been found with
this system and people with CP.
The YouGrabber System (Figure 1.7 (d)), developed by YouRehab Company, Switzer-
land, is a virtual rehabilitation system based on video games that uses a pair of data
gloves and an infrared camera to capture the fingers flexion. This system allows mirror
movement training, and a particular advantage of YouGrabber is its ability to provide
both unilateral and bilateral training [57]. The games are based on reach, grip, and
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transport tasks [6]. In the first study, 5 children with motor deficits in upper limbs were
tested with YouGrabber. The experiment was developed in 9 sessions of 45 minutes each,
and the tasks involved hand grasping and releasing, wrist pronation and supination, and
arm reaching. Results were satisfactory: 4 out of 5 patients showed improvements in all
measures in the MA [58].
Gilliaux et al. [59, 60] assessed another robot-assisted therapy (REAPlan, see Figure 1.7
(e)) through a single-blind randomized trial. The REAPlan is a distal e↵ector robot that
allows for displacements of upper limb in horizontal plane. 16 children with CP were
randomized into two groups: a control group of 8 users conducting 5 conventional therapy
sessions per week over 8 weeks and a robotic group of 8 users conducting 3 conventional
therapy sessions and 2 robot-assisted sessions per week over 8 weeks. Outcome measures,
such as QUEST and PEDI (Pediatric Evaluation of Disability Inventory) were analysed.
According to the author, there was evidence that the robotic therapy was e↵ective since
the outcome measures improved significantly more in the robotic group than in the
control group; the authors also suggested studying the long-term e↵ects of the therapy.
A classification of the most used devices for CP focused on upper limbs is shown in
Table 1.2.
1.4.2 Robot-assisted rehabilitation for lower limbs
One of the main goals of neuromotor rehabilitation is the recovery of locomotion ability,
because it allows patients to improve their independence and quality of life. In this
framework, robotics is emerging as a leading technology for motor rehabilitation of
subjects with neurological impairments and, in particular, the recovery of walking. As
was previously exposed, RAGT has some promising advantages over traditional training,
because it is intensive, controlled, repetitive, and provided with goal-oriented tasks,
which is known to be related to cortical organization and motor learning processes [61].
This aspect is particularly important for pediatric population, who could obtain better
results thanks to their higher neuroplasticity.
In general, there are basically two groups of assistive robotic devices to help people
with mobility problems: alternative devices and empowering (or augmentative) ones.
These solutions are selected based on the degree of the user’s disability. In case of
total incapacity of mobility (including both bipedestation and locomotion), alternative
solutions are used, such as wheelchairs or special vehicles. On the other hand, people who
have reduced mobility, commonly use augmentative devices that utilize their residual
capabilities, e.g. walkers and exoskeleton robots are augmentative devices that assist in
standing, balance, and locomotion [62]:
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• Robotic walkers: Walkers are intended to help users’ navigation providing bal-
ance support. They take advantage of the user’s remaining locomotion capability,
and also help to avoid the early and deteriorative use of alternative devices, most
commonly wheelchairs. “Smart walkers” are robotic devices based on walkers
that are optimized to improve the human-machine interaction and, as a result, to
improve the acceptance and functionality of these systems in rehabilitation.
• Exoskeletons: Exoskeletons are mechatronic devices whose segments and joints
correspond to some extent to those of the human body and the system is externally
coupled to the person. In rehabilitation applications, exoskeletons should be able
to replicate, with a patient, the movements performed with a therapist during the
treatment. In the case of functional compensation, exoskeletons are designed to
support the execution of activities of daily living by assisting the user in the basic
motor functions. The exoskeletons were intended to provide either joint support
by means of brakes or clutches [63–66] or actively add power to the joints, thus
providing a means to control and complete joint movements [67–70]. In addition,
sensors attached to exoskeletons can assess patient’s forces and movements, which
would give the therapist quantitative feedback regarding the patient’s recovery
and rehabilitation process. Therefore, exoskeletons could act as a tool for the
measurement of the performance and evolution of the treatment [71].
The number of robotic devices (comprehending walkers and exoskeletons) that have
been developed or adapted for gait rehabilitation of CP is growing from the last years.
The most important ones could be summarized as: i) NF-Walker [72]; ii) Innowalk-Pro
[73]; iii) Lokomat [74]; iv) GT1RehaStim [75]; v) Walkbot [76]; vi) Autoambulator;
and vii) Multi-robot [77], (all of them represented in Figure 1.8). Their analysis (given
below) present some outcomes obtained in relevant studies carried out with each device.
The advantages and disadvantages of the current robotic gait trainers when are used in
pediatric population with CP, will be also examined.
The NF-Walker is a commercially available device that illustrates the use of robotics for
the assistance of people with CP (Figure 1.8 (a)). It is a hybrid assistive device that
gives dynamic support to standing position and gait. The user’s weight is discharged
by the wheels of the device [72]. This platform provides motor stimulation for users
and gives them a sense of accomplishment. It can be individually adapted to the user,
who is supported in an upright and corrected position with both hands free. The NF-
Walker was developed by Made for Movement, Norway. To evaluate the applicability
of this robotic walking aid in non-ambulatory children with CP, Smania et al. [78]
conducted an experiment with an 11-year-old boy (GMFCS IV) that was unable to
walk independently due to spastic tetraparesis. The outcomes measures were: 2-minute
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Figure 1.8: Robotic-assisted gait trainers in CP. (a) NF-Walker; (b) Innowalk-Pro;
(c)Lokomat; (d) GT1RehaStim; (e) Walkbot; (f) Autoambulator; (g) Multi-robot.
walking test, 10-meter walking test, respiratory and heart parameters, and energy cost
of locomotion. The results were satisfactory in most of the tests, suggesting that the
NF-Walker may allow children su↵ering from CP with severe gait impairment to move
around in their environment. This device may potentially stimulate the development of
gait in children with neurological gait impairment.
Other devices developed by Made for Movement are Innowalk and Innowalk-Pro (Fig-
ure 1.8 (b)). Both Innowalk and Innowalk-Pro are robots intended for rehabilitation
programs with PBWS that can induce healthy gait patterns in their users. Innowalk
gives disabled people (including CP) the opportunity to experience assisted, guided,
and repetitive movement, which is very beneficial for rehabilitation after surgery, and
provides steady and corrected leg movement in sitting and/or standing positions [73].
With the Innowalk-Pro, the upper limbs, lower limbs and Innowalk movements are co-
ordinated as part of the therapy [79]. The Innowalk and Innowalk-Pro are static devices
because the patient does not move through the room. In [80], 5 children with GM-
FCS scores between III and V were chosen for an experiment where they had to use
the Innowalk for 4 weeks (5 times per week, 30 minutes per day). At the end of the
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study, 4 of 5 children had increased muscle mass, 3 of 5 improved their joint deflection,
and all of them improved their posture control. Moreover, 72.2% of patients’ caregivers
stated that the child enjoyed using Innowalk, while 85.1% stated that Innowalk helped
to maintain the child’s function [73].
Lokomat (Figure 1.8 (c)) is a robotic platform designed by Hocoma AG, Switzerland
[74] for the treatment of RAGT in adults and children a↵ected by di↵erent pathologies
as stroke or CP. This device is the most widely used hospital rehabilitation robotic
platform worldwide. Pediatric Lokomat is adapted to the individual patient’s anatomy.
Its concept is similar to the Innowalk in that it practices rehabilitation therapies using
repetitive movements. The Lokomat consists of a 2-leg exoskeleton with motor drives,
a PBWS, and a synchronized treadmill. Several studies have been conducted with
Lokomat, e.g. a study developed with 16 users that had previous strokes demonstrated
that after treatment all patients had improved gait performance and motor function;
although 5 patients were initially unable to walk in the Lokomat for 30 minutes, they
succeeded in doing so within 1 to 3 days [81]. In another study that included patients
with CP, 33 patients (nine females and 24 males, all around 7 years of age; all GMFCS
III initially) underwent 40 Lokomat sessions; after the 40 sessions of 20 minutes each, 8
users (24%) could walk without assistance and achieved GMFCS II, and 15.3% of the
remaining patients showed improvements in their gait pattern [82]. Borggraefe et al.
[83] showed positive e↵ects after 12 training sessions with the Lokomat and described
improvements in standing and walking ability (dimensions D and E of the GMFM,
respectively) in 20 children with bilateral CP, which were maintained after a period of
6 months. The authors also reported the intervention’s e cacy was dose-dependent, as
the improvements in the task (walking) measured in dimension E of the GMFM were
positively correlated with higher distance and time walked.
Another system for robotic-assisted gait training available in the market for the rehabil-
itation of children with CP is the Gait Trainer GT-1 RehaStim (Figure 1.8 (d)), which
aims to improve the patient’s ability to walk through repetitive training. The weight
of the user is relieved and children are positioned on two footplates that simulate the
stance and swing phases of gait [75]. A recent study checked the e↵ectiveness of this
device compared to conventional training in 18 children with diplegia or tetraplegia.
The GT-1 group received 30 minutes of robot training plus 10 minutes of stretching
exercises, while the control group received 40 minutes of conventional physiotherapy; all
the subjects underwent 10 sessions over a 2-week period. The results were satisfactory
for the experimental group, showing improvements on the 10-meter walk test, 6-minute
walk test, hip kinematics, speed, and step length, which was maintained 1 month after
the treatment had finished [75].
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Finally, other novel rehabilitation devices for CP are Autoambulator (HealthSouth,
United States), Walkbot (Walkbot, South Korea) and Multi-robot (Harvard University,
[77]), Figure 1.8 (e), (f), (g), respectively.
Table 1.3 summarizes the described studies for the most relevant robotic devices for gait
rehabilitation in CP.
Based on this, author concludes that robotic gait trainers is one of the best solutions for
rehabilitation in CP. However, most of therapies performed with the current robotic
gait trainers are peripherally driven and are based on motor control reorganization
triggered by peripheral physical therapy. There is evidence that CP a↵ects primarily
brain structures, so this suggests that for a proper rehabilitation, both PNS and CNS
should be integrated in a physical and cognitive therapy. Moreover, although all of the
current technological devices allow more intense sessions, the exercises proposed are not
complete at all. The robotic training should be further optimized to fit better into motor
learning and recovery, as well as neural plasticity. To do so, the training has to be made
more task specific, encouraging the patients to an active participation and facilitating
functional improvement [84].
Table 1.4 gives a general vision the main characteristics, advantages and weaknesses of
the presented robotic devices, with the main aim of clarifying the challenges in this field.
These challenges will be used as a background to develop the new proposal for robotic
gait training, which is the principal objective of this doctoral thesis.
1.5 Conclusions
This chapter presented a general introduction about CP disability, its classification and
therapies carried out for the rehabilitation of patients, particularly when they are chil-
dren. The definition adopted for CP encompasses several disorders of posture and move-
ment due to a defect or lesion in the immature brain [17]. Although there are some
classification procedures to categorize CP into di↵erent levels, it is a challenge not met
in full.
CP a↵ects many di↵erent body functionalities (e.g. cognitive disabilities, epilepsy, vision
or speech impairments...), but particularly, the number of patients with CP su↵ering
from pathological gait patterns is very high. Gait disorders in CP are enhanced when
the children grow up and they increase their weight. To treat it, there are some types
of therapies that look for a better quality of life. From a physical rehabilitation point
of view, the therapies have been classified as conventional physical rehabilitation or
robot-based therapies, depending on the resources employed in each case.
1. Introduction to Cerebral Palsy and Gait Rehabilitation 23
T
a
b
le
1
.3
:
T
h
e
m
os
t
re
le
va
nt
ro
b
ot
ic
p
la
tf
or
m
s
fo
r
lo
w
er
li
m
b
s
in
C
P
D
ev
ic
e
N
u
m
b
er
of
T
h
er
ap
ie
s
an
d
m
ea
su
re
m
en
ts
R
es
u
lt
s
p
at
ie
nt
s
N
F
-W
al
ke
r
[7
2]
1
-
2
m
in
w
al
ki
n
g
te
st
Im
p
ro
ve
m
en
ts
in
al
l
te
st
.
U
se
of
N
F
-W
al
ke
r
m
ay
h
el
p
ch
il
d
re
n
w
it
h
se
ve
re
im
p
ai
rm
en
t
of
ga
it
as
a
re
su
lt
of
C
P
-
10
m
w
al
ki
n
g
te
st
-
R
es
p
ir
at
or
y
an
d
h
ea
rt
p
ar
am
et
er
s
-
E
n
er
gy
co
st
of
lo
co
m
ot
io
n
In
n
ow
al
k
[8
0]
5
S
es
si
on
tr
ai
n
in
g:
30
m
in
/d
ay
;
5
d
ay
s/
w
ee
k;
4
w
ee
ks
4
of
5
ch
il
d
re
n
in
cr
ea
se
d
m
u
sc
le
m
as
ss
,
3
of
5
im
p
ro
ve
d
th
ei
r
jo
in
t
d
efl
ec
ti
on
,
an
d
al
l
of
th
em
im
p
ro
ve
d
th
ei
r
p
os
tu
re
co
nt
ro
l
L
ok
om
at
[8
2,
83
]
33
40
se
ss
io
n
s
of
20
m
in
u
te
s
ea
ch
8
u
se
rs
co
u
ld
w
al
k
w
it
h
ou
t
as
si
st
an
ce
an
d
th
e
15
.3
%
of
th
e
re
st
of
th
e
p
at
ie
nt
s
h
ad
an
im
p
ro
ve
m
en
t
in
th
ei
r
ga
it
p
at
te
rn
G
T
1
R
eh
aS
ti
m
[7
5]
18
-
30
m
in
of
ro
b
ot
tr
ai
n
in
g
+
10
m
in
of
st
re
tc
h
in
g
ex
er
ci
se
s
T
h
e
re
su
lt
s
w
er
e
sa
ti
sf
ac
to
ry
in
al
l
th
e
ex
p
er
im
en
ts
an
d
m
ai
nt
ai
n
ed
1
m
on
th
af
te
r
th
e
tr
ea
tm
en
t
h
ad
fi
n
is
h
ed
-
10
m
w
al
k
te
st
-
6
m
in
w
al
k
te
st
-
H
ip
ki
n
em
at
ic
s,
sp
ee
d
an
d
st
ep
le
n
gt
h
1. Introduction to Cerebral Palsy and Gait Rehabilitation 24
Table 1.4: Main characteristics and shortcomings in current robotic devices for gait
rehabilitation of children with CP. The gait exercises can be implemented through over-
ground walking (OW), treadmill training (TT) or foot plates (FP), depending on the
device
Device Type Characteristics Challenges
NF-Walker Assistance OW
- Guided movement
- PBWS
- Active postural control
- Task specific training
Innowalk-Pro Rehabilitation FP
- CNS inclusion
- PBWS
- Active postural control
- Task specific training
- Over-ground experience
Lokomat Rehabilitation TT
- CNS inclusion
- Active postural control
- Task specific training
- Over-ground experience
- Arm movement
GT-1 RehaStim Rehabilitation FP
- CNS inclusion
- Active postural control
- Task specific training
- Over-ground experience
- Arm movement
Autoambulator Rehabilitation TT
- CNS inclusion
- Active postural control
- Task specific training
- Over-ground experience
- Arm movement
Walkbot Rehabilitation TT
- CNS inclusion
- Active postural control
- Task specific training
- Over-ground experience
- Arm movement
Multi-robot Rehabilitation TT
- Guided movement
- Active postural control
- Task specific training
- Over-ground experience
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The main disadvantages founded for conventional therapies were the limitation due to
therapist’s physical e↵ort and the lack of durability of the sessions (specially in lower
limbs rehabilitation). Moreover, guided movements of the user’s joints do not perform
an exact pattern because the human intervention into the treatment is very high. For
this reason, robotic therapy appeared. Robotic devices for rehabilitation in patients
with CP reduce the therapists’ workload compared to traditional training, and they
continuously guide the patient’s lower or upper limbs following physiological patterns,
with high repetition accuracy and prolonged training duration.
Clinical experience of gait rehabilitation suggests that gait training in children could
be conducted even more e↵ectively using robot-based therapy rather than conventional
strategies [42]. The most important robotic devices for gait assistance and rehabilitation
in CP were presented, highlighting their principal studies, advantages and weaknesses.
As a brief recapitulation, most of the current devices use PBWS at a time that provide
guided and repetitive movement of the lower limbs. Nevertheless, the majority of these
available gait trainers do not integrate the CNS into the therapy and the exercises are
not tailored for the specific patient’s needs. Evaluations with the most common available
devices for rehabilitation have been mostly carried out following position control mode
instead of training with “assist as needed” strategy [85]. Moreover, they avoid to correct
the posture during walking and do not allow free movement in real environment. A new
device with the goal of including all the advantages of current treatments in only one
equipment is necessary. This novel system should incorporate new strategies that address
the presented limitations, providing facilities to tailor the therapies to the patients. In
that form, a better and complete rehabilitation will be achieved.
On the other hand, there is a lack of published recommendations regarding the most
e cient rehabilitation program [37], which should specify the treatment duration and
provide guidelines to introduce the robot-based rehabilitation into the clinical practice.
It is necessary a new proposal for gait rehabilitation in users with CP and similar motor
disorders. New strategies are needed to help to promote, maintain, and rehabilitate the
functional capacity, and thereby diminish the dedication and assistance required and the
economical demands that CP represents for the patients, the families and the caregivers.

Chapter 2
Design of a Robot-Assisted Gait
Trainer for Children with
Cerebral Palsy: CPWalker
Although several impairments interfere with the quality of life of children with CP (seizure
disorders, hearing and visual problems, cognitive and attentional deficits...), mobility im-
pairment is the hallmark of this disease [17]. Mobility impairments have special influence
on the child’s development, characterizing gait by reduced speed and endurance or short-
ened step length [86]. In last decades, robotic strategies for gait rehabilitation in CP have
complemented conventional therapies, demonstrating improvements in kinematics, gait
speed and endurance of these patients [61, 75, 87–90]. Several robotic devices appeared
in the market to treat CP, nevertheless so far there is no study that provides a depth
and complete assessment of robot-based therapies in the treatment of children with CP.
Further research is crucial both in device design and clinical interventions in order to
validate e↵ectiveness and clarify training protocols [7, 8, 15, 51].
This chapter presents a new robotic platform to support novel therapies for gait reha-
bilitation in CP: “CPWalker”. CPWalker represents a new approach for gait training
in children, which overcomes the challenges exposed for the current robotic devices. The
specific patients’ necessities after a surgical procedure will be determined to present the
conceptual design of the system. These requirements will be incorporated in the mechan-
ical design, which in conjunction with novel control strategies, are expected to make the
robot an optimal solution for rehabilitation.
27
2. Design of a Robot-Assisted Gait Trainer: CPWalker 28
Figure 2.1: Main purposes for the rehabilitation improvement with the proposed
novel robotic platform.
The principal aim of this dissertation is centered on developing a new robotic solution
that helps to improve current gait rehabilitation in children with neurological or motor
disorders as those derived from CP. Limitations of current RAGTs came from both low
versatility o↵ered by the robotic device and scarce definition of training protocols. In
order to fulfil these limitations it is fundamental the understanding of four key ideas
that will help to guide the process of development of the new robotic trainer covered in
the framework of this thesis (see Figure 2.1):
• Diagnosis: The first step for the development of the new robotic device should be
to understand the problem. An exhaustive study of the CP disease, risk factors,
current limitations and patients’ necessities for an appropriate recovery lay the
foundations for the proposal of a new solution.
• Research: Once the principal requirements are detected, next step is focused on
the research of new possibilities for improvement. The design of the robotic device
(mechanical configuration and control strategies) will be based on the importance
given to diverse selected features, also thinking in possible future therapies to be
implemented with the rehabilitation platform.
• Therapy: After the prototype assembly, the definition of novel training proto-
cols and its implementation in patients with CP should lead next stage to assess
e↵ectiveness with objective results.
• Information: Finally, these results should be returned to the people involved,
specially clinicians and patients. Their judgement and concerns will serve to re-
design activities carried out in previous points.
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The ideas proposed in Figure 2.1 not only support the line followed in the thesis, but
could also help to improve the assessments of current rehabilitation of patients with CP
[43].
2.1 Users’ requirements and layout
The requirements for the new robotic device must be obtained involving users through-
out the whole design process. This philosophy of user-centered design was introduced
in 1986 by Norman and Draper, and it requires the extraction of users’ needs for a pos-
terior validation of the designed product to the collected needs. The definition of the
target population in this research was undertaken based on the conclusions of an expert
panel discussion. Three di↵erent types of professionals comprised the expert panel: i)
therapists, surgeons and other clinicians from the “Nin˜o Jesu´s Hospital” (HNJ); ii) re-
searchers from the “Biomechanical Institute of Valencia” (IBV); and iii) researchers and
engineers from the “Neural and Cognitive Engineering group” (gNEC) of the “Spanish
National Research Council” (CSIC).
The expert panel reached a consensus on defining a target population, which mainly
comprised children with CP after a surgical process in their lower limbs. These rep-
resentative users were selected because they were optimal candidates to test the new
robotic platform, since they finished the critical growth phase and passed a surgical
procedure that restored their lower limbs ameliorating musculoskeletal problems. 22 pa-
tients under this characteristic were studied in order to stablish the main rehabilitation
requirements for pediatric population with CP. The mean age of the chosen population
was 13.5±1.4 years-old and the mean weight 43.8±3.51 kg. All these patients had the
necessity of correcting the sti↵ knee flexo through extensor bilateral osteotomies of distal
femur. The gait pattern associated with these users was crouch gait, which is common in
diplegic children with ambulation capability and individuals with tetraplegia who spend
too much time in wheelchairs. The principal problems found after surgical processes in
these children were:
• Limitation in motor control and associated spasticity.
• Muscular weakness.
• Increased energy consumption.
• A large period of rehabilitation up to 2 years.
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Table 2.1: Descriptive parameters of the sample for interview
Sample composition
Gender
- 9 females
- 14 males
Age
- Users with CP aged 11 and 16 years-old
- Relatives and professionals between 25
and 55 years-old
Classification
- 4 children with CP
- 10 relatives
- 4 doctors
- 5 physiotherapists
Sessions description
Duration
- Interviews: 1h
- Discussion groups: 2h
Place
- Nin˜o Jesu´s Hospital (Madrid)
- AVAPACE Valencia
- Biomechanical Institute of Valencia
The definition of the requirements for the new robotic trainer was based on the popu-
lation problems exposed above, and the process included interviews not only with the
expert panel groups, but also with users with CP and their families.
2.1.1 Discussion group and interviews
With the aim of collecting the principal requirements to incorporate in the new robotic
platform, a discussion group was selected, which was composed by children with CP,
their relatives and professionals as doctors or physiotherapists (see Table 2.1).
A discussion group is a group of individuals with similar interest who gather either
formally or informally to bring up ideas, solve problems or give comments. It consists
on a carefully planned conversation to obtain information about a specific field, in a
permissive environment.
The election of the discussion group was complemented with interviews. An interview is
a conversation between two or more people where questions are asked by the interviewer
to elicit facts or statements from the interviewee. Interviews are a standard part of
qualitative research, and seek to describe the meanings of central themes in the subject’s
life. It was considered as a method that helped to understand the experiences of others.
The goal of these discussion groups and interviews was to obtain exhaustive information
about the necessities, interests and concerns of the target group with CP. Table 2.1
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summarizes some descriptive parameters of the sample that composed the discussion
group. The discussion group and interviews took into account the evaluation of current
commercial walkers and their traditional rehabilitation. The participants in the sympo-
sium discussed about their own experiences with di↵erent models of walkers (posterior
walker, anterior walker, walker with integrated seat...) and the physical rehabilitation
carried out with their physiotherapists. Some requirements for the new robotic device
were discussed based on their concerns.
2.1.2 Design requirements
The evaluation of the results derived from the discussion group and interviews provided
some requirements, features and functionalities that should be integrated in the novel
device. Focusing on the demands to cover by the new robotic platform, this section
distinguishes di↵erent points that are separated in several fields: i) the correction of
problems related to gait function; ii) posture and balance, iii) clinical aspects that the
robotic device needs to fulfil; and iv) other important general characteristics. Figure 2.2
represents in a schematic way all the selected features grouped in the four fields and the
relative importance provided by the users of the discussion group.
The most voted desire was to change the patient’s previous gait pattern (Figure 2.2).
It means to improve the traditional rehabilitation through the new robotic device in
order to relearn to walk. Covered by this first requirement, there were other three
characteristics that also received high importance, and they looked for rehabilitation
from over-ground walking, relearning from verticality and including also the upper body
(trunk posture).
Other requirement with great significance for the clinicians was the “Assist-As-Needed”
(AAN) strategy, which allows individual and selective support for all the joints. In
the same level of importance was the PBWS, which has to be highlighted because the
existing over-ground gait trainers do not o↵er this possibility. Also the safety of the
device, which should be understood as the prevention of falling.
After these principal concerns, some other requirements took more or less the same im-
portance. They were mainly related to ease of use, comfort, versatility and how the new
device could reduce the therapists’ e↵ort in the exercises. The remaining requirements
were in most cases covered by the ones afore indicated or had lesser relevance.
These conclusions served as the base to design the concept of the new rehabilitation
device. To address the proposed requirements, next section covers the introduction to
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Figure 2.2: Requirements for the new concept of robotic gait trainer and their relative
importance given by the people involved in the discussion group.
the conceptual design of the novel robotic platform for gait rehabilitation and training
in patients with CP and analogous disorders. This platform is named CPWalker.
2.2 Robotic platform for gait rehabilitation and training
in children with CP
This section is oriented to give an analysis of human gait linked to the preliminary
conceptual design of the new robotic platform for gait rehabilitation: CPWalker. The
ambition with the new device is to provide novel robot-based therapies to enhance
walking function in children with CP.
2. Design of a Robot-Assisted Gait Trainer: CPWalker 33
2.2.1 Biomechanics of human walking
To specify the structure of the new device and prior to start with the the mechanical
design of the rehabilitation equipment, it was necessary to understand the biomechanics
of human walking as an essential part for developing such robotic device. The analysis of
normal gait will served to define the DOFs in which CPWalker robotic platform should
provide assistance.
The process of human walking starts with an impulse in the CNS and concludes with
the emergence of reaction forces on the ground. A gait cycle is the period of time
between a first foot ground contact and the next ground contact by the same foot. Each
gait cycle is commonly classified in two main phases: stance phase and swing phase,
both represented in Figure 2.3. Focusing the attention on right leg (blue shadow leg on
Figure 2.3), the stance phase comprehends the period in which right foot is in contact
with the ground (around 60% of the whole cycle), being the swing phase the time in
which the right foot is elevated preparing the next heel strike.
Foot prepositioning is the first subtask in the gait cycle (Figure 2.3) [91]. It means
preparing the knee extension and hip flexion to support a good weight acceptance.
Once the contralateral foot is lifted of the ground, all the weight is supported by a single
limb, so it is necessary to maintain the stability during this stance phase. The shift from
stance to swing is preceded by the push o↵ subtask, where the ipsilateral foot takes o↵
the ground. In this moment is very important to keep enough distance from the floor
executing a proper step height (foot clearance in Figure 2.3). The swing phase ends
ensuring that the step length is adequate to start again a new gait cycle.
The sagittal plane is the dominant plane of motion during human walking. The move-
ments referred to this plane are flexion (the limb approaches the body) and extension
Figure 2.3: Gait cycle diagram and gait subtasks (grey blocks) focused on right stride.
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Table 2.2: Estimated power for human flexion-extension movements during normal
walking
Joint Flexion Power [W/kg] Extension Power [W/kg]
Hip 0.93 -0.57
Knee 0.73 -1.12
Ankle 3.21 -0.42
(the limb is away from the body) for all the joints of the lower limbs. Table 2.2 shows
the estimated power of each joint for human walking in sagittal plane [92].
2.2.2 Conceptual design of CPWalker
The conceptual design of CPWalker aims to solve the limitations found on the current
commercial rehabilitation robots. Concretely, CPWalker will integrate in only one plat-
form all the advantages collected from commercial rehabilitation equipments for CP,
introducing improvements to address the challenges proposed for these robotic devices
(see Table 2.3).
To justify the di↵erent fields of Table 2.3, there are some studies [42, 61, 87, 88] that
demonstrate promising results of robotic strategies for gait rehabilitation related to
improvements on patients’ kinematics, speed and ambulation endurance. On the other
hand, the provision of PBWS in robot-based therapies is beneficial in case of children
Table 2.3: Main aspects and principal advantages of current robotic devices for gait
rehabilitation in CP
Actuated Central Peripheral Active Task
and Guided PBWS Over-ground Nervous Nervous Postural Specific
Movement Training System System Control Training
Innowalk * *
Innowalk-Pro * *
NF-Walker * * *
Lokomat * * *
GT-1 RehaStim * * *
Walkbot * * *
Autoambulator * * *
Multi-robot * *
CPWalker * * * * * * *
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with a severe level of disability (GMFCS III, IV and V) [49, 50, 93, 94]. Nevertheless,
these new therapies should not replace over-ground treatments [95]. The possibility
of free over-ground displacement in real rehabilitation environments and the inclusion
of CNS and PNS into the treatment, encourage more challenging exercises with an
important motivating condition and, as a consequence, a proper physical rehabilitation.
At the same time, to maintain a correct posture during walking is a very relevant aspect
in case of children with CP [96, 97]. The inclusion of di↵erent sensors to improve
postural control during robot-based therapy is expected to lead to better treatment
results. Finally, the option of implementing strategies focused on specific and selected
subtasks of walking has been demonstrated to be a crucial factor in facilitating functional
improvements [84, 98].
Figure 2.4 shows an overview of the preliminary concept of the CPWalker robotic plat-
form. This concept looks for improving the users’ physical and cognitive skills by involv-
ing the requirements of Table 2.3. The device is composed by two main parts: a walker to
provide balance and support to the patients during over-ground walking training, and
an exoskeleton to guide the joints of their lower limbs allowing flexion and extension
movements in sagittal plane. Several sensors were distributed throughout the platform
constituting the MHRI for the interaction between the patient and the robot. These
sensors were the foundation for the inclusion of CNS and the implementation of task
specific training through AAN strategies. The concept of CPWalker (Figure 2.4) intro-
duced a new change on the rehabilitation treatments, which was focused on four main
pillars: first, the possibility of free over-ground movement with PBWS (not restricted to
treadmill training) in rehabilitation environment, which could be an important motivat-
ing condition for this population; second, the use of AAN strategies in specific subtasks
of walking might optimize the treatment by increasing the active patient’s participation;
third, the inclusion of di↵erent sensors to carry out novel strategies as the improvement
of postural control of head and trunk during robot-based therapy, was expected to pro-
vide progressions of the child’s gait patterns; and finally, the integration of CNS was
expected to boost the e↵ects of the therapy.
The new trainer promotes the progression of patients with CP into the rehabilitation
therapy, increasing the level of intensity and frequency of the exercises as well as enhanc-
ing the motivation and tailoring the therapy to each user. CPWalker is the first trainer
with PBWS and active driven gait in over-ground environments, a platform with an
interface that corrects the child’s posture while participating in robot-based therapies,
and a device which includes PNS and CNS into the treatment through the incorporation
of di↵erent technologies [99]. Overall, CPWalker provides the child with a structure that
rehabilitates their gait to physiological patterns.
2. Design of a Robot-Assisted Gait Trainer: CPWalker 36
Figure 2.4: Overview of CPWalker concept.
Following sections describe in depth the mechanical design of CPWalker, each active
system, their justifications, re-designs and the control architecture of the project.
2.3 Mechanical design of CPWalker
In order to define the mechanical design of the robot, some priority DOFs were selected
based on the conclusions derived from the gait cycle analysis (section 2.2.1). At the
beginning, hip, knee and ankle flexion/extension were required to be powered. Never-
theless, the active ankles were unnecessary after few preliminary tests with real pediatric
patients, due to children with CP usually use AFOs, so the movements of their ankle
joints are limited. On the other hand, pelvis movements could became important if an
unrestricted walking is desired. However, in this case of rehabilitation and taking into
account their complexity, pelvis movements were not assigned that importance (only
pelvis up/down is powered on CPWalker). Requirements for hip abduction/adduction
were constrained to prevent children walking with inadequate step width. Table 2.4
summarizes the prioritized DOFs in CPWalker.
With the selected DOFs in mind, CPWalker robotic platform was built based on the
commercially available device NF-Walker (Made for Movement, Norway). This decision
was taken as a consensus after talking to families and clinician partners, because the
existing passive device NF-Walker was familiar for most of them, and additionally, it was
an ideal base structure to provide the required compensation for our project. The con-
ceptual design of CPWalker incorporated mechanical modifications on the NF-Walker
in order to transform this passive device into an active rehabilitation robotic platform.
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Concretely, the intention was to design a fully active rehabilitation device, which be-
sides providing guided movement for the lower limbs, it also enabled the clinicians to
implement robot-based therapies including strategies of postural control and allowing
free displacement through real rehabilitation environments. In order to do so, four active
systems were incorporated: i) a drive system of the platform; ii) a PBWS system; iii)
an active system for the adaptation of hip height; and iv) a system for controlling joints
motion in the exoskeleton. Figure 2.5 presents a parametric CAD model of CPWalker,
which was developed as the base of the conceptual design. This 3D system includes the
mechanical adaptations of the NF-Walker and most of the necessities required by the
discussion group. The aid of IBV was very important to design a preliminary version
of the mechanical modifications implemented on the NF-Walker. In this regard, some
actuators requirements were defined based on previous work [100].
At a more detailed level, the information derived from the interviews with professionals
and real patients concluded that the maximal walking speed should be 0.6 m/s to achieve
a safe rehabilitation with the target patients. The robotic device should be able to
accommodate the anatomical measures of the population: children with CP aged among
11 and 18 years old, which dictates the wearer height and hip width. These data were
retrieved from population with CP recruited at HNJ. Likewise, the maximum weight the
robotic platform should support was 80 kg. As the weight of the robotic platform is not
supported by the user, but discharged through the own device, it was not a constraint
for the design.
Table 2.4: Prioritized DOFs in CPWalker platform. The type of actuation might be:
powered (P), free (F), or constrained (C)
DOF Type
Pelvis up/down P
Pelvis transversal rotation C
Pelvis frontal rotation C
Pelvis anterior/posterior tilt C
Hip flexion/extension P
Hip abduction/adduction C
Hip internal/external rotation C
Knee flexion/extension P
Ankle plantar/dorsiflexion F
Ankle inversion/eversion C
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Figure 2.5: Parametric CAD model of CPWalker: smart walker and exoskeleton.
2.3.1 Smart Walker
In the field of the robotic assistance for gait rehabilitation, the robotic version of walkers,
known as “smart walkers”, has been developed during the past decades. A smart walker
is a robotic device which provides assistance to the user using di↵erent levels, depending
of the patient’s needs [52]. The purpose of the smart walkers is to interface with the
user’s residual neuromusculoskeletal structures such that physical support, sensory or
cognitive assistance are reconnected [101]. A remarkable example of smart walker is the
PAMM system (Personal Aids for Mobility and Monitoring) [102], and GUIDO system, a
smart walker for people with visual impairment and cognitive deficit [103]. On the other
hand, the project SIMBIOSIS, from Bioengineering Group (CSIC) [104], introduced the
implementation of a robotic smart walker designed to help people with reduced mobility
through an adaptive control of the user’s residual capability. Recently, new types of
smart walkers have appeared with the same purpose [105].
The smart walker of CPWalker supports the patient with CP during over-ground reha-
bilitation. Its structure was complemented with three of the abovementioned actuated
systems: i) drive system; ii) PBWS system; and iii) system for the adaptation of hip
height. These systems, their actuators and sensors are described in the next points.
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Figure 2.6: Smart Walker structure of CPWalker.
2.3.1.1 Structure
The structure of the walker of CPWalker is represented in Figure 2.6. It is responsible
of supporting the child’s weight during gait, and provide the required balance. The
walker structure rests on four wheels (two of them in the front side and the other two in
the back). The front wheels are passive, being the traction system located in the back
wheels. The main function of the front wheels is to allow turns of the platform in case
of curved trajectories.
The structure of the smart walker may resist a total maximum weight (exoskeleton +
patient) of 80 kg as it was defined in the prerequisites. Assuming the weight of the
exoskeleton up to 5 kg, the maximum weight of the user should not be more than 75 kg.
2.3.1.2 Drive system
The drive system was located on the back wheels, and it provides the translation move-
ment required to achieve the necessary support for an over-ground treatment instead of
the ambulation on a treadmill (Figure 2.7). This system is composed by the following
components:
Figure 2.7: Drive system of CPWalker platform.
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Actuators: The drive system is constituted by two gearmotors of 24 Vcc and 50 W,
K80 63.105 (Kelvin, Spain) [106] coupled to each rear wheel. Motors work individually,
providing independent speed to left and right wheels. This characteristic allowed the
possibility of achieving turn displacements of the platform by providing di↵erent speeds
of each wheel. The speed range of the device was encompassed between [-0.60, +0.60]
m/s, being dependent on the diameter of the rear wheels (0.17 m).
Sensors: Two rotatory encoders were installed (HEDS-5540), one for each traction
engine. A rotary encoder, also called a shaft encoder, is an electromechanical device
that converts the angular position or motion of a shaft to an analogical or digital code.
Information provided by the encoders is used to control the velocity of the walker traction
[12, 99].
2.3.1.3 Partial body weight support system
The PBWS system (Figure 2.8) is responsible for the control of the user’s body weight
discharge. The ability of discharging a partial user’s weight during gait, improves the pa-
tients’ rehabilitation because they have to use less activity to neutralize the gravity and,
thereby, can take advantage of their residual force to learn and coordinate movements
[107]. It aimed at making easier the exercises along the first sessions (when the patient
is weaker) or with users with a greater GMFCS score [49, 94]. In CPWalker, user’s
weight is supported by a harness linked to the exoskeleton that attaches user’s trunk
and pelvis. Thereby, the total weight (user + exoskeleton) is discharged throughout the
platform. The actuators and sensors of this system are:
Figure 2.8: System for the control of user’s weight.
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Actuators: The PBWS system consists of an electric linear actuator CAHB-10-B5A-
050192-AAAP0A-000 (SKF, Sweden) [108], which with an input voltage of 24 Vcc can
achieve 1000 N of load. Its stroke length is 50 mm, and concretely, this model has a
potentiometer inside. The actuator compresses and decompresses the original springs of
NF-Walker (Figure 2.8 left), and therefore user’s weight is controlled by this compression
and decompression. It allows a significant unloading respect to the ground up to 45 kg.
The weight discharge will be from 0% (user is completely rested on the floor) to 100%
(user is suspended).
Sensors: The sensory part of the PBWS system is composed by a potentiometer and
a load cell:
• Potentiometer: the elevation system is equipped with one potentiometer, which
measures the compression or decompression of the springs of the suspension sys-
tem, being located between them (Figure 2.8 right). This measure is used to
implement the fine control of the user’s weight discharge.
• Load cell (AEP FT1 C2 class): this force sensor was integrated into the walker
structure (Figure 2.8 right) in order to measure the amount of user’s weight that
is supported by the robotic platform. This information is therefore used for the
control system.
2.3.1.4 System for the adaptation of hip height
This system is primarily used to adapt the robotic platform to di↵erent anthropomet-
ric users’ sizes by adjusting the hip joint of the exoskeleton at a specific distance from
the ground (Figure 2.9). The system is able to elevate the patients from the floor and
position them with legs stretched. Therefore, the user can walk without restrictions.
Additionally, this system is also part of the PBWS system, and allows the compensation
of hip movements during walking. After few tests with patients, author concluded that
if the static calibration of PBWS was performed correctly through the hip height adap-
tation system, the support of the previous actuator (presented for the PBWS system)
loses importance during walking. This fact implied the simply use of the load cell at the
same time than the system for the adaptation of hip height, to implement the statical
calibration. Subsequently, the active control of PBWS may be continuously generated
by the adaptation of hip height during walking, since this system is faster than the pre-
vious one. To perform such actions, the system is composed by the following actuators
and sensors:
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Figure 2.9: System for the control of hip height.
Actuators: The system for the control of hip height is activated by a linear actuator
E21BX300-U-001 (Bansbach easylift, Germany) [109] composed by a hydraulic pump
and two cylinder-pistons. The hydraulic pump is controlled by an electric motor. The
pistons are connected to the hip joint of the robot and their displacement is supported
by a rail linked to a slim-line carriage (LLTHR 20 D4 405 and LLTHC 20 LR T0,
respectively, (SKF, Sweden)). The system can control the height of the user’s hip in
relation to the ground (Figure 2.9). With a stroke length of 300 mm, this actuator is
able to generate forces high enough to elevate the child. The cylinders work in parallel
through a slideway that supports the bending moments generated by the user’s weight.
Sensors: This system has one potentiometer for the height regulation system (WS31-
500-R1K), which is located in the docking between the exoskeleton and the walker
(Figure 2.9). This potentiometer changes the measurement according to the hip elevation
with respect to the walker platform. This parameter gives information about the position
of the hydraulic linear actuator (maximum and minimum height). For security reasons,
these extremes (maximum and minimum) are controlled both via software (using the
information of the potentiometer) and via hardware through mechanical end-stops.
2.3.2 Exoskeleton
Exoskeletons are wearable devices with a kinematic configuration similar to the human
body, which have the ability of implementing guided and repetitive movements to the
user’s extremities [110]. The word exoskeleton comes from Greek e´xo¯ that means “outer”
and skeletos “skeleton”, thus it is designed with the aim of supporting and protecting
human body from the outside. Work with exoskeletons began in the early 1960s, but only
recently these devices have been applied in rehabilitation of patients su↵ering from motor
disorders. Repeatability allows exoskeletons to perform more intensive rehabilitation
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Figure 2.10: Anatomical planes and displacement ranges allowed by the exoskeleton
of CPWalker.
training than that done by conventional manually therapy, so it accelerates the function
recovery [111].
The exoskeleton of CPWalker was designed to guide user’s lower limbs in sagittal plane
with 6-DOFs (bilateral actuated hip and knee, and free ankle), remember Table 2.4.
The six joints may be adjusted following di↵erent requirements depending on the ap-
plication. In that way, the exoskeleton of CPWalker was defined as a modular lower
limb exoskeleton. The provided displacement ranges plenty satisfies the normal gait
patterns in sagittal plane [112]. These ranges were used as maximum boundaries for
safety reasons (represented in Figure 2.10).
2.3.2.1 Structure
The structure of the exoskeleton of CPWalker fulfils a set of functional roles including
patient’s support and protection. At the beginning, this structure was based on the
original NF-Walker device, but later author figured out that these original rods were
not strong enough to withstand the torque provided by the actuators. As a result, a
new structure was designed, in which the requirements of actuators were maintained
from previous design. Aluminium 7075 was mainly used in the structure of the exoskele-
ton and joints, due to its mechanical resistance and lightweight. The whole design of
the exoskeleton is lightweight and, at the same time, rigid and strong in order to al-
low walking and increase strength and endurance of people with mobility disorders, in
particular children with CP. As consequence, the structure is hard enough to support
its own weight and the user’s weight, as well as torsional stresses produced by patient’s
movements.
The joints of the exoskeleton correspond to the joints of human body, it means, hip,
knee and ankle. The design of these actuated joints was developed with the aid of IBV.
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Figure 2.11: Range of measures of CPWalker exoskeleton.
The structure of the exoskeleton must maintain the joint alignment in patient’s lower
limbs, provide movement assistance in sagittal plane, increase the coordination of the
tasks and prevent restrictions to the natural movement as far as possible. The rotation
and abduction/adduction movements are restricted in this system with the intention of
preventing the children get used to walk with legs spread wide (see also Table 2.4).
In order to make the robot compatible with di↵erent users, the length of the structure
can be adjusted to di↵erent patient’s anthropometric measures. The allowed range of
anthropometric measures is shown in Figure 2.11. Adjustable mechanisms, such as
telescopic structures in the thigh and shank and a sliding rail system in the pelvis, are
used to accommodate inter-subject anatomy diversities.
Besides the adjustment to di↵erent anthropometric measures, the joints of exoskeleton
must adapt to the patients’ mobility and follow their movements. In addition, the
exoskeleton prevents displacements of lower limbs to abnormal positions. The device has
been designed for over-ground walking training, and according to this, the maximum
allowed range during walking is: 60o for hip flexion, 40o for hip extension, 90o for
knee flexion and 0o for knee extension (Figure 2.10), which is in accordance with [112].
The movable range ensures the necessary motion for proper gait rehabilitation. For
safety reasons, the range limitation is kept by both hardware (adjustable end-stops) and
software.
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The exoskeleton is attached to the human body through three straps for each leg (one
on the thigh and two disposed on the shank). This attachment allows the distribution
of forces along all the implicated body segments. Finally, the exoskeleton of CPWalker
is linked to the smart walker through a held coupling, which blocks its liberation and
allows the possibility of PBWS.
2.3.2.2 Exoskeleton joints system
The exoskeleton joints system is the most complex system of CPWalker platform (see
Figure 2.12). As previously exposed, it is composed by six joints responsible for the
control of the patient’s lower-limbs (hips and knees are actuated and the ankles may
move freely). The goal of this active system was to guide the user’s lower limbs with
a predefined range of motion (ROM) accepted by the clinicians. The combination of
diverse configurations related to the number of allowed DOFs (Table 2.4), gave a de-
sirable modularity to the device, which was a required factor in order to adapt the
treatment to the patient’s progression. The system is composed by the actuators and
sensors described below.
Actuators: The actuation of each exoskeleton joint is composed by a harmonic drive
CSD-20-160-2AGR (Harmonic Drive LLC, USA) [113] coupled to a brushless flat DC
motor EC-60 flat 408057 (Maxon ag, Switzerland) [114].
Figure 2.12: User wearing the exoskeleton system.
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Figure 2.13: Harmonic drive exploded view.
The actuation with DC motors has the main advantage of being controlled with mod-
erated voltages and their response is fast. The energetic e ciency for these types of
actuators is good, and they behave linearly. The principal problem is that they are
noisy when working, specially if they are combined with reduction ensembles. The
brushless option was chosen due to brushless motors are smaller than brush ones for the
same power. Moreover, the maintenance for brushless motors is easier. The main char-
acteristics of the three-phase DC motor [114] of the exoskeleton joints are: maximum
speed of 6000 rpm, 100 W of power, nominal voltage of 24 V and a weight of 470 g.
The harmonic drive mechanism (Figure 2.13) was selected due to its capacity of work-
ing with high gear reduction ratios, allowing ensemble position accuracy with a low
weigh/volume ratio [115]. The strain wave gearing theory is based on elastic dynamics
and utilizes the flexibility of metal. The mechanism has three basic components: i) a
wave generator located inside the mechanism and where the ball bearing is situated;
ii) a flex spline that is like a shallow cup. It fits tightly over the wave generator and
has external teeth positioned around its; and iii) a circular spline, a rigid circular ring
with internal teeth. The flex spline is placed inside the circular spline meshing their
teeth. The selected harmonic drive has a rated torque of 28 N·m at 2000 rpm, limit for
momentary peak torque of 76 N·m, maximum input speed of 10000 rpm and positioning
accuracy of 2.9·10 4 rad.
The gear transmission of the whole joint is 1:160. This setup was adopted since it
allowed the design of a compact actuation system [116]. The assembly provides an
average torque of 35 N·m, which is in accordance with the requirements of [117, 118].
Sensors: The transmission of information related to the sensors of the exoskeleton
was carried out through two signal wires. This characteristic is highly favourable because
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Figure 2.14: Simulated deformation in the rods of the exoskeleton of CPWalker when
a force of 20 N is applied on the extreme. The finite methods calculation defines the
proper position of the selected strain gauges (R1, R2, R3 and R4), which is the zone
that su↵ers more e↵orts (light blue and green).
the converters used to transmit the information of the joints are disposed keeping a linear
distribution. The exoskeleton system is equipped with the following sensors:
• Potentiometers: the exoskeleton has one potentiometer placed on each joint as-
sembly (bilateral hip and knee). In the first design of the joint, each potentiometer
was coaxial with the axis of the joint and embedded in the centre of the assembly.
This location provided a more secure and robust connection. Nevertheless, after
several tests with patients, this position was changed due to its poor accessibility.
Nowadays, the potentiometers are located outside the joints, connected to the axis
through a pulley-belt system. Voltages values received from these potentiometers
are converted to angle values, which provide information of the angular position
of each joint. The model of the potentiometer is Vishay model 157 [119], with a
range of resistance between 1 k⌦ to 100 k⌦.
• Force sensors: force sensors based on strain gauges were located in the metal rods of
the exoskeleton, which are coupled to the joints. These sensors are responsible for
the measurement of the interaction forces between the robot and human body. The
strain gauges are electrical resistors fixed to the structure, and as consequence of
application of forces in the structure, these are transmitted to the gauge, resulting
variations in the electric resistors. Strain gauges are connected in a Wheatstone
bridge circuit with a combination of four active gauges (complete bridge), which
allows the possibility of achieving higher sensitivity [120].
The strain gauges selected for this project are uniaxial resistors of 120 ⌦ each,
with a contact surface of 5·1.8 mm2 (Figure 2.14 (a)). These parameters were
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chosen according to the main e↵ort to be measured (sagittal direction) and because
they provided a better heat dissipation than smaller sizes. The position of the
strain gauges in the exoskeleton of CPWalker is represented by Figure 2.14. The
Wheatstone bridge was built on the surface of the rods that is perpendicular to
the rotation radio. Thereby, the e↵ects of forces in other directions were reduced.
To calibrate the strain gauges in the Wheatstone bridge, each segment of the
robotic leg (thigh and shank) was fixed in horizontal position. Subsequently, some
calibrated masses of known weight were added to the opposite extreme from the
gauges location in order to take into account the highest torque. Concretely, author
chose a distance of 10 cm from the gauges to normalize the calibration for all the
joints.
The information provided by the force sensors will be used to implement di↵er-
ent control strategies as impedance or force controllers. These sensors allow the
possibility of applying the AAN philosophy in order to take advantage of user’s
residual movement.
• Insole Pressure sensor: a force-sensing resistor (FSR) is a component whose resis-
tance changes when a force or pressure is applied. CPWalker uses two FSRTM 406
(Interlink Electronics, United States) for each insole (one for the heel and other
for the tiptoe). These sensors provide information related to the user’s footsteps,
which is useful to assess the patient’s gait pattern.
2.4 Control Architecture
Once the mechanical design of the device has been presented, it is time to describe how
the interaction of the platform was performed. The control architecture of CPWalker,
represented in Figure 2.15, is basically composed by three main components:
• Clinician interface: consists of a tablet device that executes an application
developed for the interface between the system and the doctor who is using it.
Through this interface, the practitioner may configure the therapy, evaluate it
in real-time and save the necessary information. This unit will be presented in
chapter 3 after the definition of the control strategies in order to give a complete
version of CPWalker project.
• Control unit: responsible for acquiring information from the di↵erent sensors of
the robotic platform, executing the algorithms for the implementation of the ther-
apies in real-time, and generating the control signals for the actuators. Following
sections analyse this unit in more detail.
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Figure 2.15: CPWalker overall control architecture: clinician interface, control unit
and robotic platform. All sensors in both exoskeleton legs communicate to PC104-I
through a CAN bus (deterministic real-time) network (CAN1). Motor drivers of the
exoskeleton are connected to a D/A board of the PC104-I. PC104-II is responsible for
the control of the traction and body-weight support systems. Drivers for controlling the
motors of these systems and for reading their sensors are communicated with PC104-II
via another CAN bus (CAN2). PC104-I and PC104-II together constitute the control
unit of CPWalker platform. Both PC104 systems are connected to a WiFi hub that
enables the communication of both controllers with an external device or tablet that
executes the clinician interface and allows clinicians to access information of CPWalker
and to control it.
• Robotic platform: constituted by the exoskeleton and the smart walker with
their structure, sensors and actuators, as described in section 2.3.
The control architecture combines the control algorithms with the robotic platform. It
had two main functions: i) to obtain the signals that are necessary for the control,
data analysis and evaluation (position angles, velocities, forces...); ii) to generate the
control signals that activate the actuation systems. The communication between the
components of the control architecture is illustrated in Figure 2.15, and it is based on
the architecture of [121]. The communication protocol between the sensors and the
control unit is CAN bus (Controller Area Network), which is a standard vehicle bus
designed to allow microcontrollers and other devices to communicate with each other
without a host computer [122]. This communication topology was chosen due to its
facility for the transmission of messages. With CAN bus, the volume, complexity and
di culty of communication were reduced. With the aim of reading the messages, CAN
converters are distributed throughout the whole platform. Each CAN converter has
one identifier associated, which enabled the main controller to distinguish between them
[123]. Meanwhile, the communication among clinician and control units is performed
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through Ethernet-UDP and WiFi. UDP uses a simple connectionless transmission model
with a minimum of protocol mechanism.
2.4.1 Control unit
The control unit was composed by two PC104, one responsible for the control of the
smart walker, and the other responsible for the exoskeleton. PC104 is a family of
standard embedded computers, which defines both form factors and computer buses
[124]. The control of the entire robotic platform is implemented into MatLab real-time
environment. This environment enables the development of mathematically complex
control strategies in real-time. The two PC104s communicate with the di↵erent sensors
of the platform through CAN bus (1 Mbps). The communication with the exoskeleton
is done through PC104-I with “CAN bus 1”, and the smart walker follows PC104-II
with “CAN bus 2” (see Figure 2.15). On the other hand, both PC104s are connected
between them through Ethernet-UDP. As consequence, they can send messages to each
other without any additional device. The boards of PC104s are stacked on top of each
other like building blocks. In case of CPWalker, both PC104s have four stacked modules
that from bottom to top they are:
• Power supply (PCM-3910-00A1E): responsible of providing electrical current
to several circuitries of the control unit. The PC104 is powered with 24 V, and
internally it can supply voltages of ±12 V and ±5 V to provide energy to other
external devices besides the control unit.
• Central Processing Unit (PCM-4153F-L0A2E): ADM GeodeTM LX800 500
MHz is the electronic circuitry within the central unit that carries out the instruc-
tions of a computer program by performing the basic arithmetic, logical, control
and input/output operations specified by the algorithms.
• CAN board (CAN-AC2-104): which is used with the aim of establishing the
communication protocol based on bus topology for the transmission of messages.
Each PC104 has two independent CAN bus located on the CAN board, and the
transmission can achieve 1 Mbps.
• Data acquisition board (DMM-32-AT): the control unit is also equipped with
an acquisition module for the interface between the actuators and the controller.
The selected target is DMM-32-AT (Diamond System Corporation, United States)
[125], which measures data from the real world and converts the resulting samples
into digital values that can be manipulated by a computer. It is composed by: 32
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Figure 2.16: Communication architecture between control unit and both systems:
exoskeleton and walker. Dotted lines indicate CAN bus signals and solid lines indicate
analog signals.
analog inputs (16 di↵erentials) with a resolution of 16 bits, and 4 analog outputs
with a resolution of 12 bits and sample rate of 200 kHz.
The PC104s are responsible for transferring the control orders from the user’s interface
to the control drivers, which are the ones that command both the exoskeleton and the
smart walker. This communication is represented by solid lines in Figure 2.16. Likewise,
the PC104s receive information from the sensors of the whole platform via CAN bus
(dotted lines in Figure 2.16).
The drivers were selected individually and carefully for each system of CPWalker. In
consequence, with the aim of reading the information from the di↵erent sensors, CP-
Walker uses CAN converters based on [121]. The exoskeleton has one CAN converter for
each joint (six in total), which are responsible for acquiring position and force measured
on the joints by the potentiometers and the strain gauges respectively, and the pressure
on the FSR located on the insoles. Meanwhile, the smart walker uses four CAN con-
verters: two converters for the drive system, one for the PBWS system and one for the
control of hip height system. They send the measures of the potentiometers, encoders
and weight gauge to the corresponding PC104 via CAN bus.
The drivers that produce the control signals to command the motors, are commercial de-
vices. Specifically, the drivers used to control the brushless DC-motors of the exoskeleton
have the reference AZBH12A8 (Advanced Motion Control, United States). Meanwhile,
the smart walker presents two control drivers: one driver is capable of controlling both
traction motors and a second driver that controls the system for the hip height and the
PBWS system. These commercial drivers have the reference MD22, with dual channel
and an output current of 5 A for each channel.
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Finally, the control algorithms of the platform are developed in Simulink, which is a
graphical extension of MatLab that uses block diagram environment for model-based
design. The Simulink models are built by MatLab Real-Time Workshop [126], which
generates and executes C and C++ code from Simulink. The generated source code is
used for real-time applications in any compatible computer. In this process, xPC Target
is involved, which is a host-target PC solution for prototyping and testing real-time
systems.
The communication cycles of the system occur at a fixed rate (1 kHz) set by the control
scheme on the control unit. As a result, this protocol allows for deterministic control and
it provides built-in network error detection as, for every message received, each system
has to return data information to the control unit. For safety reasons, the control
architecture and thereby, the control unit, have an emergency button that instantly
shuts down the power of the robotic platform if any failure occurs on the network.
2.5 Conclusions
This chapter presented the design and development of a robotic platform for gait re-
habilitation of children with CP and related motor disorders. Before to start with the
design of the robotic device, the patients’ necessities were identified, as well as the prin-
cipal demands to cover by the new system. These requirements were selected based on
user-centered decisions, involving pediatric patients and relatives throughout the whole
design process.
The final mechanical design of the smart walker and the exoskeleton took into account
the conclusions of an expert panel comprised by engineers, clinicians and researches.
CPWalker robotic platform incorporates several systems that will allow the implemen-
tation of di↵erent and novel control strategies to address the limitations of current
rehabilitation devices for CP.
Finally, the chapter defined the control architecture of the whole platform. The inter-
action between the components of CPWalker was mainly carried out by WiFi and UDP
protocol. The most important part was the control unit, responsible of processing the
control signals. This unit will also holds the control algorithms created with Simulink.
Next chapter will introduce the MHRI of CPWalker and its components. Some of the
technologies of the MHRI will be used to develop diverse control strategies at high, mid
and low levels, which will be the support of therapies carried out with the robot.
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Subsequently, and following several elemental control strategies, a preliminary clinical
protocol will be proposed taking advantage from all the possibilities of CPWalker.

Chapter 3
Development and Preliminary
Validation of Robot-Based
Rehabilitation Therapies with
CPWalker Platform
Current robotic systems have the advantage of inducing movements based on normal
patterns without patient’s commands. However, they should be more challenging in cases
of subjects with residual motor capacities. This chapter presents the development and
definition of diverse control strategies for CPWalker platform. These strategies, both
passive and active, will use novel principles of gait rehabilitation to encourage users
to participate actively into the therapy. They will look for the best adaptation to the
subject’s needs for an appropriate recovery.
The elemental control strategies are the base for programming new therapies in CP-
Walker. To do that, the chapter describes the frame of a clinician interface through
which the physiotherapist can interact with the robot to define a specific therapy. This
clinician interface, in conjunction with the control unit and the robotic platform, com-
plete the control architecture of the system.
Finally, selected patient-tailored therapies will be programmed in CPWalker for a first
evaluation in three children with spastic diplegia for five weeks. This preliminary clinical
evaluation shows the usefulness of CPWalker to serve as a rehabilitation tool.
At the end of the chapter, a control strategy developed for CPWalker is also adapted
and applied to LOPES II gait trainer. This implementation shows the potential of the
controller and its interaction and applicability to other gait rehabilitation platforms. The
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study will be focused on evaluating the algorithm at several amounts of gait speed and
PBWS not only for training, but also for a possible assessment tool.
3.1 Multimodal Human-Robot interface of CPWalker
Brain scans of children with CP (specifically diplegia and hemiplegia) show that the most
common finding is damage to Corticospinal Tracts (CSTs) within the Periventricular
White Matter (PWM) [127]. These injuries are directly correlated with motor disabilities
and voluntary movements performance, since the last are produced through the CSTs
[128], see Figure 3.1. To define elemental control strategies of CPWalker, it was required
not only a simple rehabilitation of children’s gait function, but also the possibility of
making discrimination between joints motions and the inclusion of CNS into the human-
robot loop. Accordingly, more improvements are expected in the execution of individual
movements (both for lower and upper body), and therefore, in the complete gait task.
A MHRI is an interface designed with the aim of integrating the information of both
CNS and PNS in order to create a communication bus between the human subject
and the robotic device. This technology allows the complete characterization of the
patient’s state with high details. The MHRIs appeared into the field of rehabilitation
with the aim of improving the traditional brain-computer interfaces (BCIs) and brain-
machine interfaces (BMIs). These conventional interfaces have been recently used into
di↵erent contexts, e.g. wheelchairs control [129], reading systems [130, 131], to restore
the hand grip function [132], or for the rehabilitation of di↵erent motor disorders from
Figure 3.1: Scheme correlation between injury to PWM + CSTs and its interferences
with volitional movements in children with CP.
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both lower and upper limbs [133–135]. The MHRIs developed in the last years utilized
a large number of technologies, which range from very invasive interfaces to measure
highly localized groups of neurons [136, 137], to non-invasive interfaces that are based
on systems as electroencephalography (EEG) or surface electromyography (EMG) [10].
CPWalker robotic platform has its own MHRI (Figure 3.2), an interface developed to
enable the implementation of novel rehabilitation strategies for robot-based therapies.
The rationale of the MHRI of CPWalker was to allow integrated PNS and CNS into
physical and cognitive interventions, and in a second place, to provide a high versatility
to the robotic platform allowing greater adaptability of the therapies to the patient’s
needs. The combination of the MHRI with therapeutically selected tasks promotes the
reorganization of motor planning brain structures and thus, integrating the CNS into
the robot-based therapies [138].
In order to develop the MHRI of CPWalker and to select the di↵erent technologies that
should compose it, three main points were taken into account: i) a previous characteri-
zation of the strategies underlying the voluntary movement of children with CP; ii) the
neural command from the brain to the muscles (defined as activation patterns [139], and
central patterns generators [140]); and iii) the kinematics of measured movements [141].
According to that, the MHRI of CPWalker consists of di↵erent sensors (see Figure 3.2):
i) an EEG acquisition unit, which is used as a non-invasive way to initiate the therapy
basing the decision on patient’s intention; ii) inertial measurement units (IMUs) to im-
prove the patients’ postural control through active exercises centered on upper body,
which are executed in parallel with human-walking patterns; iii) a Laser Range Finder
(LRF) to measure free human locomotor patterns and control the robotic platform ac-
cordingly; and iv) force sensors located on the structure of the exoskeleton, which are
used to implement gait strategies that utilize the patient’s collaboration, or to apply
adjusted controllers related to intensity and force of each subject. All these emerging
sensors gave to clinicians a great possibility of defining specialized and tailored therapies
depending on the patient’s characteristics, which is a novel concept in the lower-limbs
rehabilitation field of children with these types of neurological and motor disorders.
In a nutshell, the MHRI of CPWalker constituted an innovative means to integrate
the CNS and PNS into the robotic therapy. First, online characterization of the level
of attention (at the CNS) and of the neural drive to muscle (at the PNS) permitted
optimizing the therapy in terms of intensity and duration for each user. Second, it
enabled the investigation of the motor patterns (at the CNS and PNS) as a method to
objectively assess the outcome of the therapy, and also elucidate the neural mechanisms
that mediate the recovery. Finally, the adaptation of the therapy by choosing the best
sensor-solution for each subject is considered a key feature of CPWalker project. The
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Figure 3.2: CPWalker platform and the technology used in the multimodal human-
robot interface (MHRI): force sensors, electroencephalography unit, inertial sensors for
postural control and laser range finder.
data related to this MHRI is also used to evaluate the results of the therapy regarding
the reorganization of neural structures.
The general control scheme that was defined for rehabilitation with CPWalker is shown
in Figure 3.3. This conception supported the elemental strategies developed to rehabili-
tate gait function with the proposed robotic platform. The strategies may be combined,
selecting di↵erent subtasks of walking for each controller and giving higher versatility to
the device. The possibility of selecting the type of control for each joint and for di↵erent
subtasks of walking is in fact one of the major advantages of CPWalker. It could be asso-
ciated with better treatment outcomes related with motor control improvements due to
the modularity. Moreover, it allows the opportunity of adapting the therapy depending
on the user’s asymmetry or necessities. One of the goals of making independence be-
tween the control of these subtasks is that the patients will be more focused on training
specific aspects of walking pattern according to their needs. The hypothesis is that this
procedure will help to upgrade results from di↵erent measurement scales as the Selective
Control Assessment of the Lower Extremity (SCALE) score [128, 142, 143], trying to
encourage the children to perform selective voluntary movements. The modular robotic
platform, in addition of allowing the individual selection of control strategies, also per-
mits the clinician to enable or disable active joints during training. Greater benefits
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Figure 3.3: General control scheme developed to implement gait rehabilitation strate-
gies through CPWalker robotic platform.
can be obtained when the patients are focused on defined subtasks than if they have to
control all the variables in the first stages of treatment.
Despite all the technologies presented for the MHRI of CPWalker in Figure 3.2, this
thesis encompasses the integration of all of them but not their complete development.
Concretely, the development of gait guiding strategies and postural control strategies
are in the frame of the thesis, being, in contrast, the EEG system [144] and the LRF
system [12, 145] studied by other colleagues at gNEC. However all of these systems were
part of CPWalker project, and indeed, the author worked to combined all the strategies
in CPWalker robotic platform. Subsections below deeply describe the di↵erent control
strategies developed for CPWalker that were in the frame of this thesis. These strategies
had the main goal of making the device adaptable for the implementation of robotic
therapies in children with CP.
3.2 Control strategies for robot-based therapies
Gait training in CPWalker is provided according to the level of disability while encour-
aging patient’s participation in the training process. The elemental control strategies of
CPWalker were encompassed within a three-tier hierarchical framework that resembles
the structure and functionality of the human nervous system (see Figure 3.4). These
levels are independent from each other, being able to work together or separately:
• Low-level: At the low-level, diverse gait guiding strategies are used to calculate
the error between the current and desired position of the device. These strategies
are individually defined for each actuated joint and di↵erent levels of assistance
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depending on the user’s capabilities. At this level, the actuation of the device is
predominant over patient’s operation.
• Mid-level: At the mid-level, a multi-joint adaptive controller is the responsible
of autonomously switching between the di↵erent locomotive strategies of the low-
level. The decision of the adaptive controller is based on user’s performance during
the exercise, and can vary in real-time fitting the robotic assistance for various
subtasks of walking within the gait cycle.
• High-level: At the high-level, several control strategies perceive user’s intent
related to di↵erent locomotive aspects. In this regard, user’s intention is predom-
inant over robot state, and it is mainly represented by three technologies of the
MHRI of CPWalker: EEG unit for triggering the begin of the gait [144], LRF for
commanding the walking speed through free human locomotor patterns [12, 145],
and IMUs for active postural control of head and trunk. As was previously in-
dicated, of these three strategies, the two first are out of the framework of this
thesis, so only the last one is covered in details by the sections below.
Following subsections explain in detail the technological and theoretical approaches im-
plemented to fulfil the three levels previously described. At the end of each point,
author gives a technical evaluation of the essential parts presented. They are not clini-
cal validations, instead they were designed to demonstrate that the di↵erent components
were integrated into the control strategies and crucial systems were correctly performed.
These technical evaluations had the main goal of enabling the author and clinical sta↵ to
design a robot-based protocol for a future use of CPWalker platform as benchmark for
Figure 3.4: Hierarchical framework for elemental control strategies of CPWalker plat-
form. At the high level, only the postural control strategy is within the framework of
this thesis.
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the experimentation with real pediatric patients. The possibilities o↵ered by CPWalker
were the base of this future novel protocol, which will be exposed in the next chapter.
Technical evaluations were tested in both, healthy users and in some cases, in children
with CP. The tests with children were under the supervision of the clinical sta↵ at
HNJ. For these cases, the local ethical committee of HNJ gave approval to the technical
experiment and warranted its accordance with the Declaration of Helsinki. All patients
were informed beforehand and signed through parents a written informed consent to
participate.
3.2.1 Low-level: gait guiding strategies
The control of gait guiding strategies for lower-limbs exoskeletons is an essential part of
desired robot-based therapies. Fixing prescribed gait patterns is important in order to
teach proper movements to the patients. With them, robot-aided gait training reduces
physical load on the therapists at the same time that the number of sessions and the
precision of the exercises are increased. However, once patients perform a phase with
enforcing gait to fixed trajectories in space and time, next step should be to encour-
age them to a more active participation. Therapies may be tailored depending on the
phase of rehabilitation and the patient, increasing patient’s collaboration to optimize
the e ciency of robotic rehabilitation.
This section describes the control algorithms developed in CPWalker to implement gait
strategies that served as the base for future exercises with the exoskeleton. First re-
habilitation phases will be covered by strategies that will guide lower limbs following
predefined and fixed gait patterns. Nevertheless, AAN strategies will be part of more
advanced trainings that will require patients’ movement collaboration. Training with
adaptive gait patterns through impedance controllers has the main advantage of giv-
ing more physiological and variable sensory input to CNS, and it also increases the
patient’s motivation. Force sensors are indispensable elements to put into e↵ect these
novel strategies as impedance control, or force resistor control besides trajectory track-
ing. Moreover, force sensors also provide measurements in order to prevent undesired
e↵orts of the robot on child’s body.
In CPWalker, di↵erent control modes individualized per joint distinguish several robotic
assistance levels in between two extremes: “robot in charge” and “patient in charge”
(Figure 3.5). Three levels of impedance were taken into account in addition to posi-
tion control (P) and force control (F): high impedance (HI, more proximal to “robot
in charge” mode), medium impedance (MI) and low impedance (LI) controllers, respec-
tively. These controllers may be individually established per joint, defining the patients’
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Figure 3.5: Scheme of controllers according to “robot in charge” or “patient in charge”
levels. From less to more patient’s collaboration the control modes are: (a) position
control mode, P; (b) high impedance control mode, HI; (c) medium impedance control
mode, MI; (d) low impedance control mode, LI; and (e) force control mode, F.
collaboration according to their capacities. This possibility made CPWalker a modular
robotic platform. Subsections below describe the individualized controllers and a brief
technical validation of them.
3.2.1.1 Position control strategy
Trajectory tracking or position control is a strategy based on the principle of guiding the
user’s limbs on fixed reference gait trajectories, [121, 146, 147]. This method was one
of the first implemented in the rehabilitation robots and has been proven to be e↵ective
for severely a↵ected patients [61, 148–150].
Trajectory control strategy consists on an internal control loop which uses the error
angle (✓error) provided by the di↵erence between a reference of prescribed gait pattern
(✓ref ) and the angle measured on each exoskeleton joint (✓), (see Figure 3.6). For
its control, reference trajectories are required, which normally consist of normal gait
patterns represented by joint angles that are highly dependent on walking speed [151].
An important question for gait rehabilitation devices is how to assist the patient with
the minimum interaction forces between robot and human. This implies that subjects
will be able to walk more naturally maintaining the safety, stability and e↵ectiveness
of the system. In order to achieve this, the gait pattern applied by the robotic device
Figure 3.6: Position control algorithm. The error of each joint (✓error) passes through
a position controller box, which is a proportional controller whose parameters are in-
dividually selected for each joint of the exoskeleton.
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must be adapted both to the individual user and to the characteristics of the gait. The
reference trajectories of CPWalker platform were generated according to the algorithm
presented by Koopman et al. in [151], which reconstructs reference joints trajectories
based on user’s height and gait speed. These reference trajectories are given by joint
angles (✓ref ) in a complete gait cycle. The controller of each joint was responsible of
ensuring the guidance of its own motion in order to get a correct normal gait pattern in
the whole exoskeleton.
The reference trajectory corresponded to a matrix of three columns (hip, knee and ankle)
and 200 rows (angles of the ROM required in sagittal plane along the gait cycle) (3.1),
which came from the spline-interpolation of the result obtained with the regression
models of [151]. The number 200 was chosen with the goal of getting a gait pattern
signal with enough sampling rate, such that it does not lose accuracy with the minimum
number of points.
✓error = ✓ref   ✓ =
0BB@
✓refHip
✓refKnee
✓refAnkle
1CCA
T
 
0BB@
✓Hip
✓Knee
✓Ankle
1CCA
T
=
0BB@
✓errorHip
✓errorKnee
✓errorAnkle
1CCA
T
(3.1)
One of the main parameters that may be selected by the clinician and that has direct
e↵ect on the generated gait pattern is the total percentage of ROM applied. In that way,
the amplitude of the calculated trajectory will be reduced as much as this percentage
indicates. On the other hand, if the gait speed is modified, the number of rows in the gait
pattern will be the same, but it will change the time of permanence in each sample, and
consequently, the sample frequency. Figure 3.7 illustrates an example of these changes,
where four reference trajectories for a person of 1.7 m of total height, are represented
respect to percent of gait cycle: i) Trajectory 1 (continuous yellow line in Figure 3.7)
corresponds to a gait speed of 0.55 m/s and ROM of 100%; ii) Trajectory 2 (dotted
yellow line in Figure 3.7) corresponds to a gait speed of 0.55 m/s and ROM of 70%; iii)
Trajectory 3 (continuous blue line in Figure 3.7) corresponds to a gait speed of 0.28 m/s
and ROM of 100%; and iv) Trajectory 4 (dotted blue line) corresponds to a gait speed of
0.28 m/s and ROM of 70%. Note that ankle reference trajectory was also implemented
in the calculation algorithm in case that CPWalker incorporates active ankles in the
future.
With this simple strategy, the exoskeleton was able to guide patient’s lower limbs fol-
lowing reconstructed normal trajectories for any given speed.
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Figure 3.7: Changes in reference trajectories (✓ref ) for hip, knee and ankle flexion-
extension depending on di↵erent parameters as percentage of ROM applied and gait
speed.
3.2.1.2 Selective impedance control strategy
Although position control has been proven with positive results in several cases [61,
148–150], robot-based therapies might be optimized in order to increase the patient’s
participation, because with a pure training of trajectory tracking, users might tend
to walk passively. Moreover, user’s contribution is an important aspect to develop
neuroplaticity and motor control [7, 8, 146]. The active participation may be achieved
both by incrementing the user’s motivation or by requiring self activity [85]. The latter
can be implemented through AAN algorithms and impedance methods.
The impedance control was introduced by Hogan in 1985 in three parts [152]. In his
work, Hogan presented an approach to the control of dynamic interaction between a
manipulator and its environment. In the study, the concept of “mechanical impedance”
was applied to search an approximation for robotic control. The impedance of a system
(Z(s)) is defined as the relation between the force of this system (F(s)) against an
external movement imposed upon it and the movement itself (✓(s)) [152]. This relation
between interaction forces and position angles is known as “mechanical impedance”,
and in biomechanics it is often defined as the dynamic behaviour between joint torque
and angular displacement [153]. In general, the impedance involves three components:
sti↵ness, damping and inertia. The equation that relates force and position is shown
below:
Z(s) =
F (s)
✓(s)
= I · s2 +B · s+K (3.2)
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that means:
F (t) = I · ✓¨ +B · ✓˙ +K · ✓ (3.3)
In Equations 3.2 and 3.3, the zero order term (K) is called sti↵ness and describes the
relation between the force exerted by the actuator and its position; the first order term
(B) is the damping and represents the relation between force and velocity; and the
second order term (I) is named inertia and describes the relation between force and
acceleration of the system. ✓, ✓˙ and ✓¨ are position, velocity and acceleration of the
device respectively.
Following the impedance concept developed by Jezernik [146], and Riener et al. [111], for
the Lokomat robotic trainee, a new impedance algorithm was implemented in CPWalker,
which attempted to prevent undesired e↵orts on patients’ lower limbs and, most impor-
tant, to apply the philosophy of AAN to take advantage of patients’ residual movement.
The method considered the human-exoskeleton interaction to allow a variable deviation
from the predefined reference trajectory, [111, 121, 146, 147]. The approach proposed
(Figure 3.8) was based on a cascaded position and force controllers, whose internal loop
was able to track force profiles in a determined bandwidth. In case of CPWalker, real
rotation angles (✓ in Figure 3.8) were provided by the potentiometers located in each
joint of the exoskeleton and torques (⌧ in Figure 3.8) were measured by the force sensors
coupled to the structure.
In order to perform parameters identification for both position and torque controllers,
author took into account that CPWalker moves with su ciently low values of velocity
and acceleration and, consequently, the e↵ects of inertia and damping could be disre-
garded. Besides, the adjustment followed empiric trial and error calibrations without
human users. The torque controller was adapted in first place, keeping the proportional
position controller equals to zero. Once a proper torque tracking with a zero set point
was ensured, the external position loop started to be adjusted, which tries to perform
Figure 3.8: Impedance control algorithm. Two loops compose the impedance algo-
rithm, treating the error generated through two controllers: position controller box and
torque controller box. The parameters of each controller are individually selected for
each joint.
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Figure 3.9: Di↵erent levels of impedance control strategy depending on the assistance
provided: (a) high impedance, (b) medium impedance and (c) low impedance. Similar
values of references (blue lines) and forces (green lines) cause diverse real trajectories
(yellow lines) according to the type of impedance level.
the generated trajectories in joint-space if the force detected by the strain gauges of the
exoskeleton is close to zero. The relation between both loops determines the impedance
applied by the exoskeleton to user’s lower limb movements.
Following this approach, the impedance control algorithm of CPWalker was set to pro-
vide three levels of AAN (see Figure 3.5): i) high impedance (HI); ii) medium impedance
(MI); and iii) low impedance (LI). The relations between the extremes of impedance
modes (HI and LI modes) respect to the MI were determined increasing and decreas-
ing around 50% the impedance parameters. Consequently, if the position controller is
higher, the torque controller must be reduced and vice versa. Figure 3.9 represents the
e↵ects of each level of impedance in hip joint for the same values of reference trajectory
(blue line) when similar force values (green line) were intentionally applied in opposition
of movement. With a high level of impedance established (Figure 3.9 (a)), the real tra-
jectory of the exoskeleton (yellow line) followed in a better way the imposed reference
(blue line). This situation is closer to trajectory tracking control. The opposite situa-
tion occurred with a low level of impedance (Figure 3.9 (c)), since in this case, the user
is who has more participation in the control of CPWalker, without becoming a total
management of the device.
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Each joint of the exoskeleton has its own impedance controller with specific parame-
ters estimated individually for each case and control mode, so the assistance may be
generated separately for each part of the exoskeleton. That means that the type of
control may be selected separately for each joint, but the tracking is ensured in all the
exoskeleton because the reference is sent for all the controllers in each cycle. As it was
previously indicated, this possibility increased the modularity of the system.
3.2.1.3 Force control strategy
The last strategy related to gait guiding is a force-based walking controller developed
with two aims: i) to give the complete control to the user (“patient in charge” mode);
and ii) to allow strength training exercises with CPWalker in order to increase the
benefits of the treatment and to contribute with a high versatility of the device. This
strategy, which was based on the algorithm exposed by Figure 3.10, was intended for
the final stage of a robot-based training program, when the patient has already learned
the correct movements of lower limbs for a proper normal walking through other control
strategies as trajectory tracking or impedance modes.
In the case of force strategy, a reference pattern is not necessary, because the user is now
encouraged to handle the motion. In the diagram of Figure 3.10, an absolute value of set
point force is selected by the clinician (Fref ), and it is compared with the real forces (F)
measured through the strain gauges of the joints. The box error adjustment algorithm
in Figure 3.10 has the purpose of classifying the force error (Ferror) depending on which
movement is being performed: flexion or extension. Concretely, the classification is done
following the Equation 3.4:
Ferror
8>>><>>>:
Fref   F, |F | > Fref and F > 0
 Fref   F, |F | > Fref and F < 0
0, |F |  Fref
(3.4)
The classified error passes through a force controller that fits the control signal for the
individual joints of the exoskeleton with the goal of getting a Ferror = 0.
The value of Fref selected by the clinician was understood as a force that needs to be
overcome by the patient in order to produce a movement. This type of exercises are
expected to enhance the user’s active participation, training in that way the strength
capabilities. A concrete and interesting mode of this strategy is the zero-force control
(Fref = 0), where the patient may move the lower limbs with free motion and minimum
interaction with the exoskeleton. When zero-force control is applied, the smart walker
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Figure 3.10: Force control algorithm. The measured force for each joint of the ex-
oskeleton is compared to a force to overcome selected by the clinician. The error is
adjusted depending of movement (flexion or extension), and subsequently, it passes
through a force controller box whose parameters are individual for each joint.
calculates the speed for the displacement through the LRF sensor. The algorithm of the
LRF sensor scans the location of the patient’s lower limbs and measures the cadence
and step length to calculate de velocity for the drive system. More details related to the
LRF algorithm may be consulted in [12, 145].
3.2.1.4 Technical evaluation of gait guiding strategies
The fact of obtaining positive results from the technical validation of gait guiding strate-
gies is a fundamental point to prove that CPWalker could serve as a novel rehabilitation
tool. The control strategies as trajectory tracking and selective impedance were previ-
ously tested in healthy subjects before to perform a studied clinical evaluation. After
these experiments with healthy users, author evaluated if the behaviour of the system
was maintained with two children with CP. As an example of the obtained outcomes,
Figure 3.11 represents graphics of 100 s capture data from the technical validation with
one of the pediatric patients (GMFCS IV) at the HNJ. In this case, the training consisted
on walking with CPWalker with position control (P) applied on the knee joints and high
impedance control (HI) imposed on the hips, in order to test both control strategies at
the same time. In Figure 3.11 (a) and (b) it is possible to see that the delay between
“real movement” (yellow) and “set point” (blue) for both knees is almost non-existent,
which means that the prescribed walking pattern is imposed upon the subject, and the
legs were moved following this prescribed pattern. However, in graphics that correspond
to hips (Figure 3.11 (c) and (d)), it is possible to appreciate that the “real movement” in
yellow lines di↵ers from “set point” (blue lines) according to the measures of the strain
gauges or force sensors (green lines). There is here the evidence that the human-robot
interaction is presented through the impedance control strategy, and with it, the patient
was encouraged to actively participate in the exercise. Concretely, for this user, the
biggest challenge was the extension movement on the hip joints, as can be verified in
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Figure 3.11: 100 s capture data from a technical validation with a patient with
CP (GMFCS level IV), using position control (P) on the knees and high impedance
control (HI) on the hips. Blue lines represent the reference trajectories provided by the
mathematical models implemented in CPWalker; yellow lines are the real movements
described by the user’s lower limbs; finally, green lines denote the measures of the strain
gauges in case of impedance control.
Figure 3.11 (maximal hip extension movement is where “real” and “set point” di↵er the
most).
As another example, Figure 3.12 represents an interval of 60 s recorded with a second
patient with CP (GMFCS II). In this case, the child walked with CPWalker following
medium impedance for all the joints. The colour code is the same than the previous
figure, but in this case the data for knee-gauges is also represented (green lines in Fig-
ure 3.12 (a) and (b)). The controller actuated under the same approach for knees and
hips, save that during the stance phase of gait, data from knee-gauges was not taken
into account, leaving the knees to follow the impedance mode only during the swing
period.
The presented strategies, working in parallel with others technologies as EEG or tactics
as the improvement of postural control, o↵er the contribution of supraspinal structures
in the control of walking, which is a key factor for the recovery of patients with this type
of disorders.
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Figure 3.12: 60 s capture data from a technical validation with a second patient with
CP (GMFCS II), following medium impedance (MI) for all the joints of the exoskeleton.
Blue lines represent the reference trajectories provided by the mathematical models
implemented in CPWalker; yellow lines are the real movements described by the user’s
lower limbs; finally, green lines denote the measures of the strain gauges in case of
impedance control. Impedance mode for knee joints is only available during swing
phase of gait.
3.2.2 Mid-level: multi-joint performance-based adaptive algorithm
One of the main limitations to implement robotic rehabilitation in children is the therapy
design. There is not an optimal treatment that covers all the requirements independently
of the user. Previous subsections have exposed di↵erent gait guiding strategies, which
could be implemented in the exoskeleton of CPWalker or another lower-limb exoskeleton
prepared for that. Although the possibility of adjusting diverse assistance individually
per joint gives a high versatility for the treatment design, so far must be the therapist
who manually chooses the parameters for the therapy. The future technical challenges
should encourage the patients, introducing not only specific and repetitive movements
with a high intensity, but also innovative strategies that help to improve the e↵ectiveness
of the therapy through objective decisions. Physiotherapists or practitioners need some
tools to objectively decide the best treatment option for each patient, specially if they
can select from too many options as CPWalker o↵ers for each joint. Thereby, the
customization of the exercise to the patient’s progression will be as good as desirable.
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Throughout this thesis, author has demonstrated important advantages of developing
tailored therapies to address di↵erent patients’ needs and capabilities, some of them
collected in the bibliography [13, 154, 155]. Task-specific and active participation are
crucial factors for motor learning. The grade of assistance through di↵erent levels of
impedance as those exposed previously, is important to enhance the voluntary partici-
pation and thereby, the patients’ motor plasticity [156, 157]. Decreasing the assistance
during learning new exercises encourages the user to generate muscle force to fulfil the
task. Some of the current robotic devices (not only for CP, but also other neurological
diseases) have incorporated novel AAN strategies to stimulate the user’s contribution:
e.g. MIT-MANUS [154] for upper limbs or Lokomat [158] and LOPES II [91] for lower
limbs. In general, the AAN strategies, which are normally based on impedance con-
trollers, could be divided in two groups: i) basic impedance, which assists the user as
needed in order to ensure a correct position tracking despite the high or low patient’s
collaboration; and ii) robust impedance, which helps the patient when motion begins but
limits the assistance while the user completes a pre-defined task, whose challenge could
vary depending on the user’s performance. So far, both basic and robust controllers
have the same disadvantage that the therapy could be a↵ected by subjective decisions.
To address the presented issues, a novel and robust multi-joint adaptive impedance
behaviour was implemented in CPWalker looking for more flexible and tailored ther-
apies for pediatric population. The model (represented in Figure 3.13) is capable of
autonomously adapting the robotic assistance within the exercise based on patient’s
performance. The controller evaluates patients’ performance (✓) with respect to the
reference trajectory (✓ref ) in a defined number of preceding steps (Tevaluation). The
evaluation is carried out looking at specific key points into the gait cycle (concretely
maximal flexion and extension values for hip and knee joints). Based on this evalua-
tion, the adaptive controller calculates the new control mode of assistance for each joint
( new). The parameters that are needed to be selected only once and before to start
the therapy are: i) the gait velocity; ii) the percentage of ROM; iii) the default control
mode for each joint ( default); iv) the challenge of the task (% ); and v) the evaluation
time (Tevaluation) of the performance.
The adaptive impedance controller starts with a default control mode of assistance
per joint ( default), and progresses toward more di cult control modes (more patient’s
participation) as the patient performs the required movement together with the proposed
challenge (% ). The decision of changing the control mode autonomously is made in
the Performance-based adaptive controller box of Figure 3.13. If the challenge is not
achieved in the Tevaluation, the control mode returns to an easier level (i.e. the robot
provides more assistance). In summary, the adaptive controller may adjust the robotic
assistance individually per joint in three ways:
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• By adapting the mechanical support of each joint to the five possible control modes
of CPWalker (Control mode implementation box in Figure 3.13; i.e.  new may take
any value of the five control modes: P, HI, MI, LI or F). Control modes with lower
impedance (more di cult levels) require more patient’s collaboration to achieve
the desired gait pattern (✓ref ). In that case, the width of the tunnel permitted
around the ✓ref becomes bigger as the level is more di cult, resulting in a increased
possibility of making movement errors (patient’s performance ✓ remote from the
desired pattern ✓ref ).
• By modifying the challenge of the task (% in Figure 3.13). The challenge is
referred to the percentage of the ✓ref that is required to be achieved by the patient.
For the calculation (Performance-based adaptive controller box in Figure 3.13),
author took into account the di↵erences between the patient’s performance (✓)
and the requested pattern (✓ref ) at the maximum values of flexion and extension
of each joint in each step. The percentage per joint is calculated as the average of
both values (flexion an extension), assuming that if these peak values are achieved
in amplitude and time, the rest of gait pattern is well performed since they are the
most critical points and the gait pattern is repeated periodically in rehabilitation
exercises.
• By adjusting the evaluation time (Tevaluation in Figure 3.13) considered as number
of previous steps to evaluate the performance before to update the new control
mode ( new) that will be implemented in the joint. Therefore, the  new is actual-
ized after groups of n steps (Tevaluation = n).
Summary:
• Position (P), High impedance (HI), Medium impedance (MI), Low impedance
(LI), Force (F).
• Desired gait pattern (✓ref ), patient’s pattern performance (✓).
• Control mode of assistance  , which could be default ( default) or new ( new).
It can take any value of the possible modes (P, HI, MI, LI, F).
• Challenge % , which is a threshold that indicates the percentage of ✓ref to
achieve.
• Evaluation time of performance Tevaluation, measured in number of steps.
In order to succeed the previous points, the percentages of performance for hips and
knees (flexion = maximum value; extension = minimum value), were decided to be
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Figure 3.13: Adaptive impedance controller of CPWalker. Brown square is the calcu-
lation block, where the user’s performance is analysed based on the achievement of % 
in Tevaluation. When  new is determined, it needs to be chosen from the five control
modes of CPWalker (blue square). The control signal produced by the control mode is
sent to CPWalker joint (green square) in order to produce the movement.
normalized and calculated as Equations 3.5, 3.6 and 3.7 indicate. These equations
“penalize” users’ performance applying more robotic assistance in case that they do not
reach the desired reference, but not if they overcome it. Concretely, the hip flexion-
performance was determined similarly to the knee formulation, taking the appropriate
parameters for each joint (Equation 3.5), where Tevaluation = n.
%FlexHip = %FlexKnee =
Pn
i=1(✓
max)i
nPn
i=1(✓
max
ref )i
n
· 100 =
Pn
i=1(✓
max)iPn
i=1(✓
max
ref )i
· 100 (3.5)
Nevertheless, for the extension-performance di↵erent calculations are necessary (Equa-
tions 3.6 and 3.7) due to the hip extension achieves negative values but the motion for
knee joint is always positive in CPWalker.
%ExtHip =
Pn
i=1(✓
min)i
nPn
i=1(✓
min
ref )i
n
· 100 =
Pn
i=1(✓
min)iPn
i=1(✓
min
ref )i
· 100 (3.6)
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%ExtKnee =
2 ·
Pn
i=1(✓
min
ref )i
n
 
Pn
i=1(✓
min)i
nPn
i=1(✓
min
ref )i
n
· 100 =
=
2 ·Pni=1(✓minref )i  Pni=1(✓min)iPn
i=1(✓
min
ref )i
· 100
(3.7)
The total percentage for each joint is determined averaging the results obtained for
flexion and extension of the respective joint in the group of “n” steps (Equation 3.8):
%Totaljoint =
%Flexjoint +%Extjoint
2
(3.8)
Once the total percentages of performance are obtained, the new control modes ( new)
are actualized individually following the criteria exposed before, where two situations
may be found (Equation 3.9): i) if the total percentage is lower than the selected thresh-
old or challenge (% ), this means that the patient did not achieve the goal in Tevaluation,
so  new will decrease to an easier level (higher impedance, " k, which implies more as-
sistance); ii) if the total percentage is equal or bigger than % , the di culty of the level
may be increased (lower impedance, # k, which implies less assistance).
8<:%Totaljoint < % ) #  
joint
new ) " kjoint
%Totaljoint   % ) "  jointnew ) # kjoint
(3.9)
The controller proposed here is multi-joint adaptive, which means that each joint may
be adjusted independently into the same exercise. The major advantage of using this
controller is not only assist the patients as needed, but also encourage the users to reach
the motion goals by changing the challenge according to their performance. The active
promotion of user’s participation through voluntary motion is expected to contribute
with larger functional gains. Furthermore, as the user’s performance is evaluated in
real-time, the patients’ motivation could be increased, avoiding discouraging them by
the adaptation of the challenge task in order to promote the success rate. Finally, the
design of the therapy should improve because it is not a↵ected by subjective decisions
from physiotherapist’s human behaviour.
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3.2.2.1 Technical evaluation of performance-based adaptive algorithm
The proposed algorithm was in a first place modeled in Simulink in order to test a brief
simulation of its functioning for each joint, and subsequently, it was technically evaluated
with a female healthy user of 58 kg of weight. The exercise with the healthy user was
implemented through a flat and straight surface, and it consisted of two phases: i) a first
phase to get accustomed to the device, in which the user walked with the robot around
30 m following a permanent position mode in all the joints; ii) a second phase where
the adaptive impedance controller was evaluated in the exoskeleton of CPWalker for a
similar distance of 30 m. In this phase, the user walked with the multi-joint adaptive
controller activated in the exoskeleton, starting with  default = P for all the joints,
and progressing according to her performance. The selected constant parameters for
the adaptive controller where: % = 85% and Tevaluation = 3 steps. Both phases were
carried out with ROM = 100% of the maximum gait pattern of CPWalker, PBWS =
20% of the total user’s weight, and velocity = 30% of the total provided by CPWalker
(100% correspond to 0.6 m/s).
Figure 3.14 represents an interval of 70 s selected from the total path performed by the
healthy user with the adaptive controller activated. The shown data correspond to the
movement of right hip during this interval. Concretely, Figure 3.14 (a) is the comparison
of the percentage of user’s right hip evaluated each 3 steps (pink line), respect to the
desired percentage ( = 85%, represented in blue line). Figure 3.14 (b) represents the
blocks of three steps (blue line), and the change of the control mode for right hip ( new,
pink line) according to the percentages achieved in Figure 3.14 (a): if the achieved
percentage is bigger than % ,  new goes towards a more di cult control mode, and the
opposite. Finally, Figure 3.14 (c) is the representation of the user’s performance on right
hip for each step (blue line is the reference of the set point ✓ref , and yellow line is the
real movement of the user ✓). As may be observed, cases in which user’s performance
decreased were mainly caused because of the fact that maximal hip extension was not
enough. The performance data for the rest of joints in the same period of time is
collected in Table 3.1, where bold values mean that % was overcome by the user, and
(*) is referred to values higher than 100% because the user’s flexion-extension set was
bigger than that given by the set point.
3.2.3 High-level: biofeedback strategy for postural control
Children with CP present an altered gait pattern with an increased ROM of the trunk
during gait. Usually, they walk looking at the ground, with their head down. Some
references in the bibliography ensure that to maintain a proper posture during walking
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Figure 3.14: Right hip interval of 70s selected from the user’s performance with
CPWalker using the multi-joint adaptive impedance controller. (a) represents the com-
parison between the percentage achieved by the user each 3 steps (pink line) respect
to the desired challenge % (blue line). (b) shows the change of  new (pink line) each
3 steps (blue line) depending on the percentage in (a). (c) is the graph of the user’s
performance: yellow line is the real motion and blue line is the set point.
Table 3.1: Data for all the joints during the period of 70 s selected from the exercise
with the healthy user. G0 to G6 are the groups of 3 steps implemented during this
period. The table gives the progression of  new depending on the % achieved in the
last group of steps. Bold values represent % achieved > % , and (*) means % achieved
> 100% because the user’s flexion-extension set was bigger than that given by the set
point.
G0 G1 G2 G3 G4 G5 G6
Right hip
 new P HI P HI MI HI MI
 achieved 95.43 82.05 92.18 86.14 79.08 86.29 76.38
Left hip
 new MI HI P HI P HI P
 achieved 78.64 77.11 91.17 82.19 97.09 84.59 95.67
Right knee
 new P HI MI LI LI LI LI
 achieved 113* 100.6* 95.89 100.9* 95.27 102.7* 93.11
Left knee
 new P HI MI LI LI LI LI
 achieved 95 96.67 97.13 96.50 97.19 95.77 90.87
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is a relevant aspect, specially in the case of children with CP [88, 96, 97, 159]. These
problems must be attended as independent movements limitations, and rehabilitation
strategies must be oriented to correct them [160].
To address these issues, author developed an active postural control strategy based on
CPWalker, which is intended to be used while over-ground movement in real environment
is allowed. The rationale of this control strategy was to enhance the cognitive interaction
between the child and the robot, improving the postural control through that.
IMUs sensors (TechMCS, Technaid, Spain) were used as the main part of a biofeedback
strategy developed to improve the children’s postural control during robot-based gait
therapies. Two IMU sensors, placed on the user’s chest and head, measure in real-
time the orientation of the trunk and head respectively. The procedure based on this
approach consists in giving acoustic feedback to the patients when they lose the control
of a desirable orientation of the body. The range for a proper posture could be defined by
the clinician at the beginning of the exercise, and the acoustic feedback, which is normally
selected from disturbing sounds or alarms, alerts the child of the incorrect position.
With this method, while the exoskeleton corrects the patients’ gait, the postural control
strategy motivates the children to maintain a proper posture during ambulation. This
information provided by the biofeedback strategy was a request of our clinical partners
since it is a parameter of paramount importance during the execution of the robotic
therapy [96, 97, 159]. The exercises with IMUs supported the correction of the patient’s
crouched gait in order to achieve a better extended hip position, besides correcting the
posture and improve motor control.
To monitor the orientation of trunk and head for the postural control strategy of CP-
Walker, the information of both IMUs sensors (head and trunk) was sent to the clinician
interface through rotation matrices (R, Equation 3.10):
R =
2664
Xx Xy Xz
Yx Yy Yz
Zx Zy Zz
3775 (3.10)
Each IMU sensor is referenced to the magnetic north and the maximum value of accelera-
tion corresponds with z axis. This means that in order to measure rotations movements
respect to an initial position, it is necessary to complete a calibration process [161].
During the execution of the therapy with CPWalker, the IMUs-based algorithm distin-
guishes between the rotation matrix collected at the time of calibration (RG) and the
rotation matrix captured by the IMU sensor in each instant (RS). With these data, a
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new matrix (RGS) for the reference system is calculated as Equation 3.11 indicates:
RGS = RS · (RG) 1 (3.11)
The algorithm obtains the Euler angles (↵,   and  , related with rotation in frontal,
sagittal and transversal planes respectively) using the Equations 3.12, 3.13 and 3.14
based on the development carried out in [161]:
↵ = atan
✓
 RGS(2, 3)
RGS(3, 3)
◆
(3.12)
  = asin (RGS(1, 3)) (3.13)
  = atan
✓
 RGS(1, 2)
RGS(1, 1)
◆
(3.14)
In rest position, RGS is the identity matrix and consequently, the Euler angles are equals
to zero.
The information provided by the sensors is represented in real-time after undergoing
the conversion algorithms. Figure 3.15-right shows an example of recording data in
real-time from IMUs-based system, where the measured angles for head and trunk (blue
lines) in three spatial planes were compared to the ROM of the left hip during walking
(red lines). Red squares in Figure 3.15-left represent posture out of the permitted range
(acoustic feedback playing).
3.2.3.1 Technical evaluation of the biofeedback strategy for postural control
The postural control therapy was preliminarily evaluated in one child with spastic diple-
gia in order to assess the usability of the system in clinical practice. The exercise
consisted on using the biofeedback strategy for postural control at the same time than
the user was walking following position control in the exoskeleton of CPWalker. The
training lasted 5 sessions of 40 minutes each, one session/day. The main objective of
this trial was oriented to assess the motor control improvements of the trunk during
gait.
With the aim of objectively measuring the progress of the subject after this robot-based
therapy, trunk kinematic data was obtained from 3D gait analysis before and after the
experiment. The data collection was performed using an eight infrared cameras system
(BTS BioEngineering, Italy). Reflective markers were applied on the shoulder girdle
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Figure 3.15: IMUs based interface to give biofeedback of postural control in head
and trunk. The graphics show IMUs data collected in real time for head and trunk in
three planes (blue lines), and these were compared with hip ROM (red lines). The red
squares represent postures out of the limit values (acoustic feedback playing).
(spinous process of C7 and both acromio-clavicular joints). Marker trajectories were
processed and analysed. For comparisons, a pre-post graph was performed for the child
(Figure 3.16). In this graph it is possible to see that post-training data (continuous
lines) are closer to normal values (grey zone) than data from the pre-study (dotted
lines). These preliminary outcomes reveal the potential of recovery of this strategy.
Figure 3.16: Patient’s trunk kinematics during the pilot technical experiment. Nor-
mal trunk kinematics data is represented in grey. Pre-intervention data is represented
through dotted lines. Post-intervention data is represented through continuous lines.
Left side in red and Right side in green.
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Figure 3.17: Schematic view of the methodology used for the CPWalker graphic
interface.
3.3 Clinician interface of CPWalker
In order to facilitate the display and the interaction between the robot and the clinician,
a graphic interface was developed. This interface allows the selection and evaluation
of the di↵erent control strategies, as well as the parameters setting in real-time. The
clinician interface consists of a tablet device that executes an application programmed
for Windows 8.1. This unit monitors signals and tunes control parameters in real-time
during the execution of the control strategy. It has the following main objectives: i)
monitoring and validation of parameters for CP rehabilitation; ii) data analysis (statis-
tics, algorithms performance, etc.); iii) storage of user’s information such as clinical and
anthropometrics data; iv) adjustment of the parameters of the therapy in real-time;
and v) comparison between di↵erent robot-based rehabilitation therapies. Figure 3.17
shows a schematic view of the methodology used to implement the graphic interface of
CPWalker.
The application to command the clinician interface (Figure 3.18) was developed with
Visual Studio software, using Windows Form and C-sharp programming language. WiFi
and UDP protocol are used to send the data to the control unit. This means that the
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application can transfer messages to other hosts (both PC104s) without prior commu-
nications to set up special transmission channels or data paths.
Figure 3.18 shows di↵erent screen-shots from the application of CPWalker. Its content
is decorated with childhood drawings in order to be more appealing to the children.
The current interface is very intuitive, developed with the aim of removing the frequent
criticism from clinicians towards the di culty and the required technical knowledge to
often operate with robotic devices [43]. As Figure 3.17 showed, it is divided into three
main menus (Data base, Control and Outcomes), which can be accessed from the Home
Menu. Points below describe each main menu.
• Data Base Menu: this part is responsible of saving new user’s information
related with personal, clinical and anthropometrics data. It allows the therapist
the possibility of having organized documentation about the patients who use
CPWalker. This information is useful to tailor the therapy for a specific subject
and to record data collected in each exercise in an orderly manner, classified by
date, time and child’s identification. The Patient’s Data Base Menu also has the
option of modifying existing data previously saved.
• Control Menu: the Control Menu is the most important part of the application.
It provides the definition of therapies for each patient and its implementation in
CPWalker. Before to specify the di↵erent parameters of the exercise, the therapist
must choose an existing patient from the data base. Once the user has been
selected, there are three possibilities of control: smart walker, exoskeleton or the
complete CPWalker (smart walker + exoskeleton).
The submenu to control only the smart walker gives the options of controlling the
drive system by personal control or by using the LRF control [12, 145]. With
the first option, is the clinician who chooses the speed of the displacement, while
with the LRF control, this speed is determined by the recognition of patient’s legs
movement. With both controls is possible to save the data collected during the
training.
The submenu to control only the exoskeleton is used in first sessions of the rehabil-
itation process (when the user is completely suspended and therefore, the traction
is not necessary). It has some fields to adjust the parameters of the therapy as: the
type of control (position, force or impedance-high-medium-low modes), gait speed,
ROM of gait pattern and number of steps. It also incorporates the possibility of
using the BCI based on EEG system. Finally, within this submenu the therapist
can also choose what joints wants to move, specifying an individual control for
each of them. A button to save data during the gait training is also available here.
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Figure 3.18: Windows of the Clinical Application developed to control CPWalker
platform.
3. Robot-Based Rehabilitation Therapies with CPWalker Platform 83
The submenu to control the whole platform is chosen when completed exercises
are required (i.e. over-ground walking training with displacement through hospital
facilities). The distribution of the components for this menu is similar to the
one presented for the control of exoskeleton in the paragraph above. The main
di↵erence is that in this case the clinician can decide how much weight discharge
is implemented by the robotic platform.
Every control menus have an available button to link the definition of the therapy
with an interface to improve the patient’s postural control.
• Outcomes Menu: this menu is used to analyse the recorded data of di↵erent
therapies that have been made previously. The therapist has to choose one of the
saved files specifying the patient’s identification, date and time, and according to
that, some graphics will be represented in a new window.
The graphics provide information related to three fields: i) averaged performance
of flexion-extension movements for hip, knee and ankle of both sides (right and
left). This compares the averaged percentages achieved by the patient during all
the therapy with the 100% required; ii) percentages of gait pattern, velocity and
PBWS selected in the therapy associated with the selected file; iii) type of control
that was chosen for each joint and data related to file information as date, time,
patient or number of steps.
This menu gives the opportunity of seeing the patient’s progression and perfor-
mance by an objective way and with clear information in order to select the vari-
ables for the next therapy. Quantifying and recording feedback content is very
important because it e↵ectively modulates motor learning and rehabilitation [162].
3.4 Preliminary locomotor training in pediatric popula-
tion through CPWalker
Once each subsystem was evaluated in simulations, healthy subjects, or real patients,
and an interface was developed for the therapist to control the robot, the next objective
was to evaluate the concept of tailored-therapies depending on the patients’ necessi-
ties. This section presents a preliminary locomotor training in pediatric population
with spastic diplegia. The evaluation was implemented through the combination of dif-
ferent strategies defined in the previous points, solving each combination depending on
the specific patient’s needs. Concretely, the therapies designed in this preliminary study
were defined with the aid of our clinical partners from HNJ, and were based on two key
features: the IMUs-based interface to correct the user’s posture during robot-assisted
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Table 3.2: Description of the patients recruited for a preliminary clinical training
with CPWalker robotic platform
Patient Disease GMFCS Age (years) Weight (kg)
P1 Spastic diplegia - CP III 14 32
P2 Spastic diplegia - CP II 12 40
P3 Spastic diplegia - HSP - 13 43
walking, and the selective impedance control to achieve improvements of ROM for spe-
cific joints through the active collaboration of the patients’. Points below explain the
patients’ recruitment, therapy definition and the achieved outcomes after five weeks of
treatment. These outcomes provided a preface to develop a future robot-based treatment
protocol.
3.4.1 Patients
Three pediatric patients with spastic diplegia (one female), two su↵ering from spastic
CP and one from Hereditary Spastic Paraparesis (HSP), were recruited to participate
in this study (P1, P2 and P3 in Table 3.2). The inclusion criteria for the patient’s
recruitment were: i) capable of understanding the proposed exercises; ii) aged 11 to 18
years; iii) maximum weight 75 kg; iv) children with no deformations that could prevent
the use of the exoskeleton; v) GMFCS levels I to III; and vi) abled to signal pain or
discomfort. The exclusion criteria of this study were defined as: i) unhealed skin lesions
in the lower limbs; ii) aggressive or self-harming behaviours; and iii) severe cognitive
impairment.
The clinical trial was carried out at ”Hospital Infantil Universitario Nin˜o Jesu´s”. The
study was assigned the number R-0032/12 from the Local Ethical Committee of this
hospital, and warranted its accordance with the Declaration of Helsinki. All patients and
families were informed beforehand, and provided consent through parents to participate.
3.4.2 Therapy
The training with CPWalker was performed for five weeks, two days per week (10 training
sessions), with the exercise time for each day set at 60 minutes, including 10 minutes of
setup time. The exercises consisted of walking with the robotic device through routes
in flat and straight lines into the hospital facilities.
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The therapies were individually adapted for each patient aiming at enhancing the most
a↵ected region in each case. The criteria to select the most a↵ected domain of each pa-
tient were in accordance to the results of gait assessments carried out before to start with
robot-based therapies). Specifically, the treatment defined for P1 and P3 attempted to
improve the postural control of the trunk during walking. As a result, a sti↵er impedance
control (position mode) of the lower limbs joints was set to assist the users’ movement
while they were more focused on posture control using the biofeedback strategy of CP-
Walker (see section 3.2.3). In case of P2, the main purpose was to improve the ROM
of the hip joint, primarily the extension movement. To perform this rehabilitation, a
less sti↵ impedance control (medium impedance mode) of this joint was adjusted to
intensify P2’s collaboration in reaching the maximum extension of the hip. For this
patient the biofeedback strategy for postural control was set with a bigger tolerance,
which enabled the patient to be more focused on improving the hip movement. Given
that these children had rigid AFOs, the ankle joints were fixed to 90 degrees. With no
actuation on ankles, the propulsion on the ground was not high enough, so we imposed
position control to knee joints in order to achieve a proper knee flexion.
With the aim of accommodating the patients to the robotic platform and following
therapists’ recommendations, all of them were completely suspended during the first
sessions (PBWS of 100%), and the PBWS was gradually decreased along the course of
five weeks of the study (e.g. Figure 3.19-yellow line for P1). This approach allowed the
Figure 3.19: Evolution of therapy parameters in P1. Blue line is the percentage of
amplitude of the range of motion programmed in the robot. Yellow line corresponds
to the percentage of the patient’s body weight that is supported by the platform.
These parameters were adjusted individually during the treatment in order to tailor
the therapy to each patient.
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Table 3.3: Selected parameters according to the patients’ capabilities
% ROM % PBWS Gait velocity [m/s]
Beginning Desired End Beginning Desired End Beginning Desired End
P1 80 100 100 50 0.172 0.210
P2 85 90 100 60 0.159 0.210
P3 73 88 100 65 0.133 0.188
subjects to gradually get used to bearing their weight on their own legs. In the same
way, the percent of ROM applied for each joint respect to a normal gait pattern (e.g.
Figure 3.19-blue line for P1) and the gait speed were updated during the therapy with
the purpose of increasing the di culty of the exercise.
According to the pre-measured capabilities for each child and following recommendations
from our clinical partners, the progression of the main parameters were selected before
to start the robotic therapy (see Table 3.3).
In order to measure the patients’ progression, 3D gait assessments without the aid of
CPWalker were conducted before and after the robot-based therapy. These analysis
provided kinematic data and temporal-spatial parameters that were used to evaluate
the improvements of the therapy.
3.4.3 Results
After five weeks of robot-based training with CPWalker, the three children improved the
mean velocity, cadence and step length (Table 3.4). Additionally, within the kinematic
analysis, the three subjects progressed in their gait as Figure 3.20 and Table 3.4 show.
Post-3D studies revealed that the trajectories for right and left lower limbs were closer
to the normal values when compared to pre-3D studies. All children succeeded the goals
proposed on Table 3.3.
As the therapies were individually tailored for each patient, the results have to be un-
derstood as separate case studies.
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Figure 3.20: Outcomes from kinematic analysis in patients P1, P2 and P3 without
robotic aid. The graphics show the improvements for each patient depending on the
focus of each therapy. Green lines are referred to right side and red lines to left side.
Dashed lines correspond to 3D studies done before the robotic treatment and continuous
lines to 3D studies done after five weeks of robot-based therapy.
3.5 Application of the performance-based adaptive algo-
rithm to LOPES II gait trainer
Within the mid-level of the framework for control strategies of CPWalker, the author
proposed a new approach for adapting the robotic assistance based on user’s performance
(see subsection 3.2.2). This approach was also of important interest for other research
groups, and indeed the author collaborated with the “Department of Biomechanical
Engineering” at University of Twente (UT, The Netherlands), in order to apply the
adaptive approach to the LOPES II robotic gait trainer [91]. This work was carried
out during a research fellowship awarded by the Spanish Ministry of Economy and
Competitiveness under contract EEBB-17-12035.
Several changes were implemented in the controller of CPWalker to adapt it to LOPES II.
With the aim of providing the last advancements in relation with the assistive algorithm,
and in order to develop new future therapies in CPWalker, this section presents the
main improvements implemented in the performance-based adaptive algorithm and its
preliminary implementation in LOPES II gait trainer [163].
3.5.1 LOPES II robotic trainer
LOPES II is a treadmill-based, admittance controlled robotic gait trainer that has eight
actuated degrees of freedom (hip flexion/extension, hip abduction/adduction, knee flex-
ion/extension, pelvis forward/aft and pelvis mediolateral) to control the motion of the
lower limbs and pelvis [91]. It is primarily used for rehabilitation of stroke survivors and
patients with SCI. The device is currently controlled through a graphical user interface
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in which the operator can manually adjust the level of robotic assistance for several
subtasks of gait (i.e. step length, step height, stability during stance, prepositioning
and weight shift). For each subtask, the assistance provided by LOPES II can be scaled
from no support (minimal impedance mode) to 100% of support. These settings are
maintained during a therapy session unless the therapist changes it.
Despite the existence of many di↵erences between CPWalker and LOPES II (e.g. de-
vice purpose, over-ground training vs treadmill, children vs adults rehabilitation...), the
background for the control of both robotic platforms is very similar. According to that,
the performance-based adaptive algorithm presented in subsection 3.2.2 was adapted
through some improvements to be applied in LOPES II, with two main goals: i) to
enrich the current robotic rehabilitation supporting the physiotherapists with novel ob-
jective tools; and ii) to test the potential of this controller as an assessment tool for
rehabilitation.
3.5.2 Improvements of the performance-based adaptive algorithm
Figure 3.21 represents the new scheme of the adaptive controller adjusted for LOPES
II. Comparing this scheme to the one developed for CPWalker (remember Figure 3.13),
it is possible to observe several changes, which were introduced in order to improve the
previous algorithm and to adapt it to the LOPES II control architecture. The most
important improvements are described below.
3.5.2.1 Subtask-based besides joint-based
In CPWalker, the adaptive algorithm evaluated user’s performance for each joint ROM
(i.e. the new assistance, updated based on the performance, involved the whole gait
cycle for each joint). In that sense, the equations used to calculate the performance
(Equations 3.5 to 3.7), took into account the average of the user’s behaviour reaching
specific key points of the gait cycle (Equation 3.8, maximal flexion-extension angles).
However, for LOPES II, this evaluation was improved in order to be subtask-based
besides joint-based (Figure 3.21). The subtasks were classified in: step height, stability
during stance, prepositioning and step length.
To calculate the performance for di↵erent subtasks of walking within each joint, author
used the same concept of key points of the gait cycle, localizing each subtask in one
of these points (see black dots in Performance-based evaluation box of Figure 3.21).
The equations to calculate the new subtask-based performances (Perfj) were modified
from the previous algorithm, normalizing the deviations from the reference pattern as
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Figure 3.21: Overview of the performance-based adaptive controller adjusted for
LOPES II gait trainer. User’s performance is evaluated based on the di↵erence be-
tween measured (✓) and reference (✓ref ) joint angles for each subtask j and in each leg
separately, looking at some “key points” of the gait cycle (deviations at black dots in
“Performance-based evaluation” box). The performances per subtask are compared to
the challenge and tolerance ( ± tol) after a specific number of steps (Tevaluation), and
based on this, a new level of assistance (klevel,j from 0% to 100%) is applied for each
subtask. Depending on the subtask of gait that is assisted, specific assistance profiles
are applied by the robotic gait trainer (green lines in “Subtask-based profiles” box).
Equation 3.15 indicates. In Equation 3.15 “j” is the subtask, Gj is a subtask-specific gain,
✓ref and ✓ (expressed in radians) are the reference and measured angles at the subtask-
specific key points, and “n” is the number of previous steps in which the performance
was evaluated (also called time of evaluation Tevaluation = n):
Perfj = Gj ·
0@Pni=1(✓ref,j)i  Pni=1(✓j)i
n
1A+ 100 (3.15)
Table 3.5 shows the assistance profiles, key points locations and gains (Gj) to apply
Equation 3.15 for each subtask. The specific gains were defined based on acceptable
deviations from the normal reference gait pattern of previous pilot studies conducted
with healthy users using LOPES II. As Table 3.5 shows, gains are negative or positive
depending on the supported movement (flexion and extension respectively). According
to this and following the concept implemented in CPWalker, users’ performance was
penalized if they did not reach the reference pattern, but not if they overcame it.
Once the performance is calculated for each subtask “j”, it is compared to the challenge in
order to update the robotic assistance per subtask (kj). The assistance profiles depended
on the subtask that was supported (see green lines in the Subtask-based profiles box of
Figure 3.21 or “Profile” column in Table 3.5). Any combination of assistance profiles was
3. Robot-Based Rehabilitation Therapies with CPWalker Platform 91
Table 3.5: Supported movements and gains for diverse subtasks of gait to calculate
performances using Equation 3.15. Assistance profiles (green lines) applied for each
subtask are shown with respect to the joint angle for hip or knee (blue lines).
Subtask
Profile Supported Key point Gain
(green line) movement location (Gj)
Step height Knee flexion
Maximal
-175knee
flexion
Stability
Knee Knee
300extension weight
acceptance acceptance
Prepositioning
Knee extension Maximal
250
and hip flexion knee extension
late swing late swing
Step length
Hip flexion
Maximal hip
-300flexion
Hip extension
Maximal hip
350extension
possible, which means that the user could receive robotic assistance for various subtasks
and both legs simultaneously.
3.5.2.2 Tolerance zone around the challenge
One of the main limitations of the adaptive algorithm of CPWalker was that the level of
assistance continuously changed after each group of “n” steps. This fact caused a high
variability within the control modes and therefore, the user could not get used to walk
with a concrete assistance.
To address this issue in LOPES II, a tolerance (tol) zone was added around the selected
challenge. Based on this, the robotic assistance per subtask of gait was also automat-
ically adjusted each group of “n” steps, but in that case by o↵ering the possibility of
maintaining the previous value. It might be a↵ected in di↵erent ways: first, if perfor-
mance was within a specific range around the previously selected challenge, amount of
robotic assistance in the particular subtask remained constant; and second, assistance
increased or decreased depending on whether the performance was below or above the
specified range respectively (see Equation 3.16).
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8>>><>>>:
Perfj <    tol ) " klevel,j
Perfj >  + tol ) # klevel,j
   tol  Perfj   + tol ) = klevel,j
(3.16)
3.5.2.3 Six levels of assistance
In CPWalker, the mechanical support of each joint was classified as one of the possible
control modes (P, HI, MI, LI or F) implemented in the robotic trainer. In case of LOPES
II, the robotic assistance was classified into six discrete levels of support (from 0 to 100%
with steps of 20%). The author together with other colleagues from UT considered this
number of levels enough to provide the required assistance, also making it easier to
interpret when the controller is used for assessment. Assistance levels per subtask went
either one level up or down or remained constant based on Equation 3.16.
3.5.3 Preliminary implementation
Walking speed and PBWS are two parameters that often change during gait training in
people with neurological disorders. These variations could became confounding factors
for assessment, and hamper reliable measure of walking impairments [164, 165]. To
design future training protocols, it is very important to understand whether walking
guidance provided by the robotic trainer is a↵ected by gait speed and PBWS [164].
Moreover, these parameters are crucial to evaluate the feasibility of the controller not
only for training but also for the assessment of patients’ abilities.
3.5.3.1 Participants
In order to study these e↵ects of amount of walking speed and PBWS on the assistance
provided by the adaptive AAN algorithm applied in LOPES II, ten volunteers without
neurological, muscular or orthopaedic problems were recruited to participated in this
study (seven male, three female, weight 72.79 ± 12.11 kg, height 1.80 ± .07 m and
age 26.3 ± 2.36 years). The protocol was approved by the Medical Ethical Committee
Twente (The Netherlands), and all subjects were informed about the experiment and
signed informed consent forms.
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Table 3.6: Overview of trials to test the e↵ects of walking speed and PBWS on the
behaviour of the adaptive controller in LOPES II.
Task Speed (m/s) PBWS (%) mImp (min) rAAN (min)
T0 0.3 0 5 -
T1
0.2
0 1.5 3
T2 20 1.5 3
T3 40 1.5 3
T4
0.4
0 1.5 3
T5 20 1.5 3
T6 40 1.5 3
T7
0.6
0 1.5 3
T8 20 1.5 3
T9 40 1.5 3
3.5.3.2 Protocol
LOPES II was fitted to each user and attached to the user’s lower legs and feet. Sub-
sequently, the harness was fixed to the pelvis and trunk to provide fall protection and
PBWS.
The protocol consisted of several trials (T0-T9) presented in Table 3.6. Participants
firstly walked at 0.3 m/s without robotic assistance and no PBWS to become used to
walking in LOPES II (T0). The order of the rest of the trials (T1-T9) was randomized
for each participant, considering every possible combination of three gait speeds (0.2,
0.4 and 0.6 m/s) and three levels of PBWS (0%, 20% and 40%). In all of these trials,
participants walked for 1.5 minutes in minimal impedance mode (no assistance, see mImp
column in Table 3.6), followed by 3 minutes in which the adaptive AAN controller was
turned on (rAAN column in Table 3.6). A challenge of 80 was used with a tolerance
of ±5 (equation Equation 3.15 and Equation 3.16,  ± tol = 80 ± 5). Subjects were
blinded to the robotic assistance, as they did not receive any information on the provided
assistance to minimize bias.
3.5.3.3 Analysis
Hip and knee joint angles, step length, user’ performances and received robotic assis-
tance were analysed for the abovementioned subtasks of gait, and compared between
the various walking speeds and amounts of PBWS.
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Author conducted statistical calculations using IBM SPSS Statistics v.23 (IBM, United
States). Two-way repeated measures ANOVA were applied to evaluate di↵erences in
the performances per subtask for the SPEED (3 levels) and PBWS (3 levels) during
minimal impedance mode (no assistance). This period without assistance was chosen
to prevent that the robotic assistance resulting from the adaptive controller influenced
the performances and the results from the statistical analysis. Pairwise comparisons
with Bonferroni corrections were applied for all main e↵ects and interactions that were
significant for the repeated measures ANOVA.
3.5.3.4 Results and discussion
As the experiments were performed on healthy participants, similar results were found
for both legs. Therefore, I only show the results for the participants’ right legs.
E↵ects on kinematics: As the reference gait trajectories for LOPES II were only
adjusted based on walking speed but not for PBWS [151], author and colleagues from UT
focused on di↵erences in kinematics between the di↵erent levels of PBWS. Figure 3.22
shows averaged changes on measured joint angles depending on the amount of PBWS
when no assistance was applied at 0.4 m/s. Maximal hip flexion and extension angles
decreased when the amount of PBWS increased (see hip joint in Figure 3.22). Similar
results were found for the other walking speeds. These decrements in maximal hip flexion
and extension resulted in shorter step length for larger amounts of PBWS (Figure 3.23).
For the knee joint, author found a decrease in the knee flexion peak for an increased
amount of PBWS (Figure 3.22). In contrast, more knee extension at heel strike was
achieved for larger amounts of PBWS.
E↵ects of walking speed and PBWS on the users’ performance without
robotic assistance: The changes in joint angles when no robotic assistance was ap-
plied also led to changes in the performances calculated with Equation 3.15 (see unfilled
boxplots of Figure 3.24). Performances for step length (hip flexion and extension) and
step height (knee flexion) decreased when PBWS increased. In contrast, performances
for prepositioning and stability (knee extension) increased when more PBWS was ap-
plied. Two-way repeated measures ANOVA confirmed significant e↵ects of PBWS for
all subtasks-based performances (Table 3.7). Moreover, two of five subtasks also showed
significant e↵ects of walking speed.
The fact that gait performances were significantly a↵ected by PBWS is in agreement
with previous studies about changes in kinematics with PBWS [164, 165]. However,
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Figure 3.22: E↵ects of various amounts of PBWS on mean joint angles for ten healthy
users walking at 0.4m/s when no robotic assistance was provided. Black dots indicate
key points for each subtask.
Figure 3.23: E↵ects of various amounts of PBWS on right step length for ten healthy
participants when no robotic assistance was provided.
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Table 3.7: p-values for the 2-way repeated measures ANOVA for each subtask of gait.
(*) indicates significant di↵erences with p < .05 and (**) significant di↵erences with
p < .001.
Subtask Speed PBWS Speed*PBWS
Step height .799 .018* .525
Stability during stance .023 .021 .085
Prepositioning .261 .004 .748
Step length (hip flexion) .451 .000** .057
Step length (hip extension) .003 .000** .714
these previous studies mainly found significant changes when PBWS was 50% or higher,
while we already found significant di↵erences in performance for PBWS lower than 50%.
A possible reason for this might be that participants in our study walked in a robotic
gait trainer, while participants in other studies walked freely on a treadmill.
Pairwise comparisons showed the following significant di↵erences (p¡.05) for PBWS: be-
tween 0% and 20%: step length (hip flexion (p=.001) and extension (p=.040)), step
height (p=.019) and stability during stance (p=.032); between 0% and 40%: step length
(hip flexion (p=.001) and extension (p=.033)), step height (p=.038) and prepositioning
(p=.016); and between 20% and 40%: step length (hip flexion (p=.003) and preposition-
ing (p=.024). In case of walking speed, significant di↵erences (p¡.05) in performances
were found between 0.2 m/s and 0.6 m/s for step length (hip extension (p=.033); and
between 0.2 m/s and 0.4 m/s for knee stability (p=.005) and step length (p=.040).
E↵ects of walking speed and PBWS on the performance-based adaptive con-
troller: The controller gave good response, adapting robotic assistance in case that
was required. However, as expected, most participants did not receive much robotic
assistance, as their performances were larger than the selected challenge of 80. For this
reason, medians of robotic assistance (red boxplots in Figure 3.24) are close to zero for
most trials. Further experiments with people with neurological disorders are needed to
evaluate the performance of the controller.
Only the performance of some subtasks in a limited number of participants and condi-
tions was lower than the selected challenge of 80 minus the tolerance (Perfj < 80  5).
In these cases, the controller increased the robotic assistance that was provided to the
users (see red boxplots in Figure 3.24) to improve the gait performance per subtask (blue
boxplots in Figure 3.24). For example, in T1 (0.2 m/s and 0% PBWS), gait performance
was very low for knee stability when no assistance was applied (unfilled blue box for this
condition of knee stability in Figure 3.24). However, when the controller was turned
on, gait performance increased for this condition as the participants received robotic
assistance (filled blue box for same condition in Figure 3.24).
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The results indicated that the new controller cannot directly be used as an assessment
tool as the performances depended on the levels of PBWS and walking speed. Changes
in performance and assistance during therapy might be falsely attributed to changes in
patients’ capacities whereas they are actually caused by changes in PBWS or walking
speed. This means that it is necessary to maintain the control for PBWS and walking
speed when making comparisons within patients, or the references trajectories need to
be improved including the dependencies on PBWS. However, in the latter aspect, it
might be di cult to do this, as the speed dependencies are already incorporated and the
results also shown e↵ects of speed. Nevertheless, the controller could be used as a tool to
monitor progression during therapy and to improve RAGT by helping physiotherapists
to tailor the exercises to the capacities of a specific patient. Decrements in robotic
assistance required by a patient who walks at a specific amount of speed and PBWS,
might be treated as a measure of walking improvements.
In future studies, the adaptive controller will be tested in stroke survivors to get more
insight into its capacities as a monitoring tool during therapy after stroke and as a
therapeutic tool after neurological disorders.
3.6 Conclusions
According to the main objectives of this chapter, it presented the principal components
of the MHRI, and di↵erent control strategies for gait rehabilitation through CPWalker
robotic platform were designed and implemented. The modularity of the robotic trainer
was evidenced in order to adapt the robot to the patient’s needs. Beyond the trajectory
tracking, other AAN strategies were exposed, as well as a method to improve the pos-
tural control for over-ground training. All the control strategies were conceived in the
development of a clinician interface to command the exercises.
The major contribution of this chapter has been the definition of novel control strategies
using diverse technologies and their integration. This fact di↵ers from the current robot-
based therapies in which none of the robotic trainers for gait rehabilitation in pediatric
population includes as many possibilities as were exposed here. All the strategies were
technically validated and, furthermore, a previous clinical validation with three patients
was presented. The multi-joint adaptive algorithm for performance-based therapies gave
the great advantage of tailoring the exercise in real-time. This algorithm was also
implemented and evaluated in LOPES II gait trainer with the goal of improving the
current robotic therapies in stroke survivors and testing the influences of walking speed
and PBWS on gait performances.
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Figure 3.24: Gait performances determined with (1) in ten healthy users for diverse
subtasks of walking in two situations: i) when no robotic assistance is applied (unfilled
blue boxes), and ii) when the performance-based controller applied robotic assistance
(filled blue boxed). The applied robotic assistance is represented in % (red boxes).
Within each subtask, various amounts of gait speed and PBWS were evaluated.
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Previous results from preliminary validations showed the importance of considering novel
robot-based strategies through CPWalker into gait rehabilitation. The major strength
of the robotic platform is the capability of selecting individual AAN control modes per
joint in over-ground displacement while the apparatus provides feedback in order to
correct the child’s posture. These functions enabled the definition of tailored therapies
for each patient.
Although preliminary outcomes are quite promising, the population size of the exposed
pilot trials, the reduced time of intervention and the short-term follow up are the main
limitations of this research. In the next chapter, CPWalker robot and some of its control
strategies will be evaluated in real pediatric patients with CP following a defined clinical
protocol, which is based on the tests exposed here.

Chapter 4
Gait Training Proposal: Goal
Setting, Clinical Implementation,
Results and Discussion
Although the use of robotic trainers has increased with the aim of improving gait function
in patients with limitations, there is an absence of studies that deeply describe detailed
guidelines of how to correctly implement robot-based treatments for gait rehabilitation.
The aim of this chapter is to propose an accurate robot-based training program for gait
rehabilitation of pediatric population with CP. This will serve to provide resources to
facilitate the implementation of robotic therapies into the clinical practice.
The rehabilitation program was focused on the achievement of some specifications defined
by the International Classification of Functioning, Disability and Health framework, Chil-
dren and Youth version (ICF-CY). It was framed on 16 non-consecutive sessions where
motor control, strength and power exercises of lower limbs were performed in parallel
with a postural control strategy. A clinical evaluation with four pediatric patients with
CP using the CPWalker robotic platform is presented.
The improvements achieved in short-term show the importance of working strength and
power functions meanwhile over-ground training with postural control. This research
could serve as preliminary support for future clinical implementations in any robotic
device.
This study was carried out with the number R-0032/12 from Local Ethical Committee of
the Hospital Infantil Nin˜o Jesu´s [14]. Public trial registration: ISRCTN18254257.
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4.1 Robot-based gait training therapy
As the previous chapters have exposed, gait limitation is one of the main impairments
in children with CP [25]. This mobility deficiency in CP is commonly the consequence
of a damage of the child’s CNS, and an optimal functional training is required in order
to maximize the improvements [166], which will highly contribute to the enhancement
of the independence and, therefore, the quality of life for both the young patient and his
family [6].
The use of robotic trainers for neurorehabilitation applications has increased in the last
decades, both in adulthood and childhood, and in several motor diseases [3, 6, 167].
Robot-based therapies have been developed and improved beyond reducing the clini-
cian’s e↵ort. Currently, a new generation of robotic devices [12, 84, 112] provides means
for encouraging the patients to an active participation in exercises, which are now more
task specific. Both the implemented novel control strategies and the modularity of new
exoskeletons and gait trainers o↵er promising possibilities to enhance the rehabilitation
outcomes by adapting the treatment to the patient’s needs [13, 168]. Nevertheless, so far
there is not enough evidence to ensure that classic robot-based rehabilitation provides
better treatment outcomes by itself than conventional physical strategies in childhood
[8]. The intention of CPWalker platform is to support these common physical therapies,
working in parallel with them and taking advantage from both methods, robotic and
non-robotic. Nevertheless, in this sense new approaches are needed in order to improve
the rehabilitation, making the robotic therapy a key feature of the change.
One of the main drawbacks for the everyday use of robotic technologies into the reha-
bilitation practice, apart from the price of the devices, is the absence of studies that
describe a detailed robotic training program for gait rehabilitation. The wide variety
of changes that could be applied to the parameters of robotic training therapies, makes
unclear how to specify rehabilitation settings with the aim of providing a suitable solu-
tion for a large population size. Additionally, most of current studies are only focused
on lower limbs strategies. However, the upper body (head and trunk movement) also
influences gait function through walking balance [88], so a proper program should not
ignore these features.
This chapter presents a detailed robot-based therapy proposal for the rehabilitation of
gait function in children with CP, which is based on the achievement of some specifica-
tions defined by the International Classification of Functioning, Disability and Health
framework, Children and Youth version (ICF-CY) [16]. It contributes with better an-
swers on how to implement robotic rehabilitation following defined guidance, establishing
the baseline settings and subsequently tailoring the therapy to each patient.
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Figure 4.1: Overview of the training protocol and main gait functions that need to
be covered.
The proposed robotic program was elaborated together with the advice of Dr. Gaebler
at Rehabilitation Institute of Chicago (RIC, United States), and it works around a key
factor: the implementation of strength and power exercises at the same time than over-
ground walking guidance, performing in parallel an active head-trunk control therapy.
As a result, the robot-based program recreates a situation as similar as possible to a real
gait scenario, and encourages the patients to control di↵erent movements associated with
gait: not only individual movements of lower limb joints, but also the synergy between
them while maintaining a proper posture of upper body. The hypothesis is that these
essential components, performed following an appropriate progression of the variables,
will boost the patients’ rehabilitation. Figure 4.1 represents the main functions that
author tried to cover with the proposed treatment. It was based on the possibilities
o↵ered by CPWalker, but the objective was that these guidelines could be used on other
gait rehabilitation platforms.
At the end of the chapter, the proposed robot-based therapy is evaluated in four patients
with CP in order to provide preliminary results of its application. CPWalker training
platform [12] was selected as scenario to test the e↵ectiveness of the approach since
it already provided means for adapting the therapy to the user’s necessities through
di↵erent levels of assistance in multi-joint over-ground training.
4. Gait Training Proposal: Implementation, Results and Discussion 104
4.1.1 Robotic training program
In order to define the objectives of the robot-based treatment, the conceptual framework
of ICF-CY [16] was adopted. The proposal was focused on improving the principal gait-
related functions derived from this international classification. Concretely, the selected
goals of the ICF-CY to be achieved with the treatment and the work methodology
implemented in the robotic device, are presented in Table 4.1.
To achieve the goals presented in Table 4.1, a systematic selection of variables based
on the requirements of the National Strength and Conditioning Association (NSCA)
youth training guidelines was previously performed [169], which suggests that eccentric
and explosive strength exercises should be the beginning of a proper training to ensure
greater muscle power generation and the transference of gains to gait (Table 4.2).
According to the proposed objectives (Table 4.1) and complying with the NSCA youth
training guidelines (Table 4.2), the treatment was conceptualized into two main phases,
where the ROM, PBWS and gait velocity were the principal parameters under varia-
tion. The intention was that the patient maximized the gains acquired in the whole
rehabilitation period (ideally the sum of robot-based exercises and common non-robotic
therapy). A detailed description of each phase follows:
• First phase: the main aim of this phase was to improve motor control, teaching
the patients the correct sequence of motion and increasing strength. The patients
were requested to follow the movements established by the exoskeleton with the
minimal possible resistance during swing period, pushing the ground at each step
and trying to keep the maximum flexion-extension values at the end of each gait
cycle. Instructions were given to ensure the comprehension of normative gait
patterns, and verbal encouragement in addition to direct feedback by graphics in
real-time was delivered throughout the sessions.
• Second phase: the main aim of this phase was to further train motor control
and increase power in order to ensure the transference to the independent gait
pattern. Aware of the sequence of movement of a normal gait pattern, the patient’s
contribution became an important aspect to develop neuroplasticity and preserve
the gained motor control [146]. The active participation was achieved both by
boosting the patient’s motivation and by requiring self-activity [85]. The latter
was implemented through AAN algorithms based on the impedance control modes
presented previously for CPWalker in chapter 3.
Figure 4.2 represents the schematic view of the therapy proposal. The treatment was
composed of a total of 16 sessions (first phase: 8 sessions for strength training and
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Table 4.1: Goal settings of the ICF-CY and the robot-based solutions adopted with
CPWalker platform
ICF-CY
functional domain
[16]
Implementation on CPWalker
Mobility and
stability of joint
functions (b710,
b715)
The di↵erent control modes of the exoskeleton are used to
guide the movement of a single or multiple joints, impro-
ving motor control. The exoskeleton also helps to maintain
stability through the coordinated actions of surrounding
tissues. This domain is exercised along the whole treat-
ment with diverse robotic assistance.
Muscle power
functions (b730)
The second phase of the training requires the patient to
contract a muscle or muscle groups to generate the nece-
ssary force in order to start and maintain the movement
with AAN strategies. The force must be maintained for a
time in the extremes of the gait pattern (maximum flexion
and extension) in order to reach the these maximum values
in the complete ROM.
Muscle endurance
functions (b740)
Muscle endurance is exercised when the patient is requested
to sustain a muscle contraction to finalize the required
movement with AAN strategies, mainly in the extremes
of the gait pattern (maximum flexion and extension).
Control of voluntary
movement functions
(b760)
The voluntary movement is implemented through the con-
trol and coordination of simple and complex movements to
collaborate with AAN strategies. Lower impedance implies
more patient’s control.
Gait pattern
functions (b770)
Motor control and gait pattern functions are trained
through the di↵erent control modes to guide the lower limbs
following prescribed gait patterns at several velocities and
supports.
Maintaining a body
position (d415)
A biofeedback strategy for postural control is used to no-
tify the patients when they lose the correct position of the
upper body. See section “Postural control”.
Walking (d450)
Over-ground walking training is executed in all sessions
with controlled PBWS, at di↵erent velocities and supports.
Proprioceptive
functions (b260)
During random moments of the first training session, the
patients perceive feeling using a mask on the eyes at the
same time than the robot performs the movement for single
or multiple joints with 100% of PBWS.
Formal relationships
(d740)
Creating and maintaining patient-researcher relationship.
See section “Motivation and inclusion of challenges”.
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Table 4.2: National Strength and Conditioning Association (NSCA) youth training
guidelines
ADAPTED YOUTH RESISTANCE TRAINING NSCA GUIDELINES
Variables Strength Power
Muscle actions Eccentric/Concentric Eccentric/Concentric
Exercise Single/Multi-joint Single/Multi-joint
Intensity " Load/# Velocity # Load/" Velocity
Velocity Moderate Moderate/Fast
motor control learning; and second phase: 8 sessions to transfer the gains to gait
through power performance). Exercises were multi-joint and gait-oriented, demanding
concentric-eccentric actions based on the gait phase that was being performed. During
the whole treatment (first and second phases) the position of head and trunk during
walking exercises were monitored, especially because these patients usually walked look-
ing at the ground. For this purpose, the strategy for postural control of CPWalker
encouraged the patients giving an acoustic feedback when their position was inappro-
priate, so they could realize and rectified it by themselves. The program was reinforced
with modifications on AAN levels according to the patient’s evolution, based on per-
formance evaluations related to ROM, PBWS and gait velocity. Furthermore, several
challenges were included to enhance the patients’ motivation.
4.1.1.1 Duration of the study
The robot-aided treatment was proposed for a whole period of 2 monthly cycles (one
month for each phase of the treatment) with the aim of having enough sessions to
generate significant neural changes [170]. The children trained 2 non-consecutive days
per week for 8 weeks (16 sessions, see Figure 4.2). The sessions consisted of a 10-15
minutes warm-up and 60 minutes of over-ground exercise with CPWalker, including 3
minutes of independent gait as a cool-down phase. As Figure 4.2 indicates, the first
8 sessions corresponded with general motor control and strength exercises, where the
robot imposed a gait trajectory tracking. Sessions 9 to 16 were related to muscle power
performance through levels of AAN strategies, where self-activity was required.
4.1.1.2 Training phases
In order to individually define the training progression through the di↵erent sessions and
to comply with the NSCA guidelines, the principal modifications were implemented on
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Figure 4.2: Robot-based training program overview. First phase: sessions S1 to S8
for strength exercises where motor control was primary trained. Second phase: sessions
S9 to S16 for power training where the assistance was progressively decreased with
the patient’s progression. The improvements were assessed at three stages of analysis:
before treatment begins, between both phases and at the end of the program (grey
ellipses in the figure).
ROM, PBWS and gait velocity. The selected parameters for both phases are represented
by Figure 4.3 and Figure 4.4 respectively. This selection was concluded in collaboration
with the clinical partners of the HNJ, based on the evaluation of previous studies carried
out with CPWalker [13, 171]. The robot-based tasks began with high assistance and
PBWS, and they progressed toward greater ROM and smaller PBWS as long as the
patient overcame the di↵erent levels of the sessions. Parameter variations within and
between sessions were performed as long as session goals were attained and when the
clinical sta↵ agreed, based on levels of spasticity, fatigue and motor control presented in
the last day. If the patient was not ready to jump to the next challenge, the session was
repeated with the same last percentages.
Within the first phase (Figure 4.3), the first session was performed with the children
completely suspended (100% of PBWS) in order to adapt the users to the movements
with the robot. Moreover, during random moments of this first session, the patients wore
a mask on their eyes to feel the motion performance (Figure 4.5-b); in other occasions, a
visual feedback of motion performance was represented on a screen in order to integrate
the child into the therapy making easier the understanding of motor control (Figure 4.5-
a). For the rest of the first phase children’s lower limbs were guided through a pure
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Figure 4.3: First phase: strength training progression values along first 8 sessions
of the robot-based therapy. Trajectory tracking motion was imposed by the robot.
Blue line represents the movement amplitude (%ROM), yellow line gives the changes
of %PBWS and the green line is referred to gait velocity percentage for each session.
position control imposed by the CPWalker platform, with a gradual decrease in PBWS
(Figure 4.3 yellow), and a gradual amplification of ROM (Figure 4.3 blue). Gait velocity
during this first phase was maintained around a regular and small value (Figure 4.3
green). Notice that in general, only one variable at each session was varied.
The second phase of the training (sessions 9 to 16 in Figure 4.4) presented an additional
di culty that enhanced the user’s collaboration in the exercises performance through
di↵erent levels of AAN strategies in the exoskeleton. The initial ROM for the second
phase was set at 80% of the total gait pattern and reached 100% by session 13 (Figure 4.4
blue), time at which velocity was highly increased (Figure 4.4 green). Note that gait
velocity for this phase became around double of the one achieved in the first phase,
which is in relation to the requisites exposed in Table 4.2. Furthermore, PBWS declined
up to 30% of weight supported by the platform (Figure 4.4 yellow).
It is important to highlight in Figure 4.3 and Figure 4.4 that the percentage of PBWS was
related to the individual patient’s total weight, and the percentage of ROM was applied
to the total trajectory of the gait pattern programmed in the control of CPWalker
[12]. The estimated changes in gait velocity are represented regarding percentages of
CPWalker platform, where 100% corresponded to 0.6 m/s.
Tailored Assist as Needed strategies: With the aim of enhancing the patient’s
participation in the second phase and consequently improving outcomes of the treatment,
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Figure 4.4: Second phase: power training progression values along sessions 9 to
16 of the robot-based therapy. Six di↵erent levels of assistance were selected on the
exoskeleton (combining hips and knees). Blue line represents the movement amplitude
(%ROM), yellow line gives the changes of %PBWS and the green line is referred to gait
velocity percentage for each session.
Figure 4.5: Representation of several patients working with CPWalker in di↵erent
session performance: (a) Patient in session 1 of first phase (with 100% of PBWS)
receiving motion feedback from a screen located in front of her; (b) Patient in session
1 of first phase (with 100% of PBWS) wearing a mask on his eyes in order to enhance
the motion feeling; and (c) Patient during over-ground walking performing one of the
session of the study.
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Table 4.3: Levels of assistance in first and second training phases: Position (P); High
Impedance (HI); Medium Impedance (MI); Low Impedance (LI). The assistance on knee
joint always went behind the assistance on hip, due to the knee movement during gait is
performed following inertial forces, assigning to the hip movement higher importance.
A higher level is implemented if the session performance (real motion versus desired
pattern) is bigger than 85%
First phase Second phase
Level 0 Level 1 Level 2 Level 3 Level 4 Level 5 Level 6
Hips P HI MI MI MI LI LI
Knees P P P HI MI MI LI
in sessions 9 to 16, position control was substituted by six adapted levels of impedance
control in the joints of the exoskeleton (Table 4.3).
One of the main advantages of CPWalker robot was the possibility of selecting three
di↵erent modes of assistance individualized per joint beyond a pure position control
(high, medium and low impedances). In consonance with this, six situations (levels)
were adopted following the criteria of our clinical partners in order to define the scales
of di culty in the assistance of knees and hips in the second phase (Table 4.3). Thereby,
the patients were considered fit to move to the next level when they achieved a perfor-
mance higher than 85% in the execution of each session, together with its corresponding
parameters (ROM, PBWS and gait velocity) represented by Figure 4.4. This percentage
of performance was calculated comparing the real motion executed by the children and
the desired gait pattern of each session.
4.1.1.3 Postural control
It was important to ensure that throughout all the sessions, patients maintained a proper
posture of head and trunk because it facilitates the performance of any activity of daily
living, and improves the social interaction, the participation and communication [88, 96].
In this sense, the proposal uses the biofeedback strategy of CPWalker in order to provide
biofeedback to the patients each time that they kept an incorrect position of the body
during walking (see section 3.2.3). With this goal, the CPWalker robot used IMUs
(Technaid, Spain) to measure the rotation of head and trunk in real-time, and give
an acoustic feedback when subjects overcame predefined maximum values selected by
clinicians. In response to the acoustic feedback, patients were instructed to correct
their position, time at which the acoustic feedback ceased. This strategy was previously
proved in chapter 3 with promising results in children with spastic diplegia [13].
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4.1.1.4 Motivation and inclusion of challenges
In the field of physical rehabilitation, especially in childhood disability, the F-words
(Function, Family, Fitness, Fun, Friends and Future) defined by Dr. Rosenbaum [172]
become really important. It is essential to maintain a high patients’ motivation because
this concept could a↵ect treatment outcomes [173]. To address this issue, author intro-
duced challenges with goals in each session of the robot-based therapy with the aim of
having a more engaged user. An example of that is a classification board where the chil-
dren could follow their progression along the di↵erent sessions, and they were rewarded
when the goals of each session were correctly fulfilled.
Moreover, with the same objective of enhancing motivation, the data collected with the
robotic platform was explained to the patients through graphics so they could feel part
of the team, and their interest in the treatment increased.
The patient’s motivation was subjectively measured in each session through a scale from
0 to 10 points, with 0 being no motivation and 10 being maximum motivation.
4.1.2 Metrics
In order to objectively measure the patient’s evolution and due to the lack of homogeneity
among children with CP, it was decided to evaluate the progression of the therapy by
comparing each patient to himself, instead of maintaining a control group. Some analyses
and evaluation metrics were carried out in di↵erent occasions of the study (Table 4.4):
during the use of the robot, before the treatment begins (pre), in the middle and after
the whole sessions (post).
The 10 mwt [174], thought as a method to evaluate the patients’ walking velocity, was
assessed for two situations: i) normal comfortable walking speed; and ii) maximum walk-
ing speed. The time is measured for the intermediate 6 meters to allow for acceleration
and deceleration. Three trials were collected for each situation and subsequently, the
average of the three trials was calculated.
Regarding the 6 mwt, it was performed indoors along a flat corridor, where the walking
course had a 30 m length and was marked every 3 m [175]. The turnaround points
were marked with cones. The patients received information about remaining time every
minute, but they were not encouraged during the exercise [176]. The heart rate was also
measured for each patient in two situations: resting and just after finishing the test.
This parameter gives the possibility of calculating the Physiological Cost Index (PCI)
after the exercise, which is used to quantify the energy expended by the patients during
the exercise and their progression, [177].
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3D gait analysis was recorded at 200 Hz using a motion capture system Smart-DX (BTS
Bioengineering, Italy). In order to obtain gait kinetics, a set of reflective markers were
placed over the skin on discrete anatomical sites according to the Helen Hayes Model
[178]. Subjects walked barefoot at a self-selected speed.
Maximum isometric strength was measured in kgf with a hand-held dynamometer, mi-
croFET2 (Hoggan Scientific LLC, USA). Three records were taken and averaged for each
movement bilaterally (dorsiflexion, plantarflexion, knee flexion-extension, hip flexion-
extension, abduction and adduction).
The particularity of the SCALE assessment [128] was that it was evaluated by the same
physiotherapist bilaterally on three occasions (pre, middle and post), with the aim of
reducing the subjective error. This metric was used to quantify the patients’ capacity
to perform selective voluntary motor control.
The changes of GMFM-88 [179] were collected for the 88 items, but the comparison
analyses were implemented only for dimensions D (standing) and E (walking).
The kinesiophobia assessment consisted of a test composed of 10 questions of 1 to 4
points each, were queries about fear and pain where evaluated before treatment begins
and in a post assessment. The responses were given by the patients without parents
influence.
Two FAQ questionnaires were requested [180]: one as initial questionnaire at the begin-
ning, and the other as follow up at the end of the treatment. These surveys presented
several questions for parents and others referred to children, which evaluate their expec-
tations, opinion about the therapy, improvements and general feeling.
During the whole treatment, ROM performance and force interactions were measured
for each session in order to evaluate if the patient was prepared to jump to the next
stage with more di cult parameters and level of assistance.
Finally, the users’ motivation was subjectively evaluated by the practitioner from 0 to
10 points for each session with the robot.
Table 4.4: Evaluation metrics and moment of application
Metric Utility
When
During Pre Middle Post
10-meter walking test
(10 mwt) [174]
Gait-speed measure * * *
(To be continued in the next page)
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Table 4.4: Continuation of Table 4.4
Metric Utility
When
During Pre Middle Post
6-minutes walking test
(6 mwt) [175]
Global responses
involved during exercise.
Walked distance and
endurance
* * *
Physiological Cost
Index (PCI) [177]
Energy expended * *
3D gait analysis
Kinematics,
spatial-temporal
parameters, gait
deviation index (GDI),
gait profile score
(GPS)...
* * *
Maximum isometric
strength with
hand-held
dynamometer
Maximum voluntary
contraction of primary
lower limbs muscles
* * *
Selective Control
Assessment of Lower
Extremity (SCALE)
[128]
Quantify selective
voluntary motor control
and its progression
* * *
Gross Motor Function
Measure (GMFM-88)
dimensions D
(standing) and E
(walking) [179]
Evaluate changes in
gross motor function
according to activities as
walking, running or
jumping
* *
Kinesiophobia
assessment
Psychological influence
of fear and pain
* *
(To be continued in the next page)
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Table 4.4: Continuation of Table 4.4
Metric Utility
When
During Pre Middle Post
Gillette Functional
Assessment
Questionnaire (FAQ)
[180]
Independent activities,
locomotor abilities and
user’s satisfaction
* *
ROM performance
Measure of ROM in
lower limbs during robot
walking
*
Selective force
Evolution of forces
executed by the user
during robot walking
*
Patient’s motivation
Estimation of user’s
motivation in 0 to 10
scale
*
4.2 Validation with pediatric population
4.2.1 Patients’ recruitment
Four children diagnosed with spastic CP a↵ecting muscle strength and motor control
of lower limbs (two male, two female, weight 44.75±6.29 kg, height 1.56±0.29 m and
age 14.50±2.38 years-old) were selected to be participants for testing the robotic train-
ing proposal. The patients of this study are di↵erent from those of the preliminary
validation presented in point 3.4 of chapter 3, therefore, in order to continue with the
numeration, they will be numbered starting from 4 (P4, P5, P6 and P7 in Table 4.5).
The inclusion criteria for patients’ recruitment in this case followed: i) children aged
11 to 18 years su↵ering from spastic diplegia; ii) GMFCS levels I to IV; iii) maximum
weight 75 kg; iv) anthropometric measures of lower limbs according to the exoskeleton
of CPWalker; v) capable of understanding the proposed exercises; and vi) able to signal
pain or discomfort. The exclusion criteria was: i) patients who experimented concomi-
tant treatments 3-months prior study (e.g. orthopedic surgery or botulinum toxin); ii)
children with muscle-skeletal deformities or unhealed skin lesions in the lower limbs that
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Table 4.5: Patients’ description. Two females (F) and two males (M) with spastic
diplegia were selected. No medication 3-months prior the study was taken by the
patients. The type of walking support without the aid of the robot is indicated for
a distance of 50m and 500m: crutches-CT, wheelchair-WC, posterior walker-PW and
cane.
Patient Age GMFCS
Weight Height Walking support
(kg) (m) 50m 500m
P4 (F) 12 III 40 1.56 CT WC
P5 (F) 16 II 42 1.60 Cane Cane
P6 (M) 17 III 54 1.53 PW WC
P7 (M) 13 II 43 1.55 - -
could prevent the use of the exoskeleton; iii) patients with critical alterations of motor
control as dystonia, choreoathetosis or ataxia; iv) aggressive or self-harming behaviors;
and v) severe cognitive impairment. The study was carried out at ”Hospital Infantil
Universitario Nin˜o Jesu´s”, (Spain). The Local Ethical Committee of this hospital gave
approval to the study (R-0032/12) and warranted its accordance with the Declaration
of Helsinki. All participants and families were informed, and parental consents were
obtained prior to participation. The study was publicly registered with the number
ISRCTN18254257 on March 23, 2017.
4.2.2 Results
Due to reasons unrelated to the study, three of the four patients (P4, P5 and P7)
completed 15 of a possible 16 total sessions. Concretely, P4 lost the session number
8, P5 lost the number 7 and P7 the number 11. The rest of training was completed
successfully.
The modifications of parameters (ROM, PBWS and gait velocity) proposed in Figure 4.3
and Figure 4.4, were fulfilled by all children without problems. The progressions of the
levels of assistance provided by Table 4.3, which were tailored for each patient between
sessions 9 to 16 (power training with AAN strategies), are represented in Figure 4.6,
where the maximum reached level was level 5 by P4 in the last two sessions.
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Figure 4.6: Levels of assistance (L1 to L6) depending on the patient (P4 to P7) and
the AAN session (S9 to S16). The patients could jump to the next level if they achieved
at least the 85% of the pattern desired for each session. The level for P7 in S11 is not
represented because P7 lost this session.
4.2.2.1 Gait speed, endurance and global responses
All patients improved the outcomes in D and E dimensions of the GMFM-88 scale [179]
(Figure 4.7 (a)). Results, comparing pre and post studies, show normalized improve-
ments per patient in this scale of 91.58% for P4, 6.31% for P5, 143.52% for P6 and
22.58% for P7 (Figure 4.7 (a))
The SCALE assessment [128], also showed better results at the end of the robot-based
treatment (Figure 4.7 (b)). In this case, although the value for the left leg in P4 was
kept same as at the beginning (Figure 4.7 (b), red bars for P4), the rest of measures
were increased or maintained as maximum (SCALE equal to 10 points).
Finally, both the walked distance in the 6 mwt and the walking speed in the 10 mwt
increased after the training period (Figure 4.7 (c) and (d) respectively). The two sit-
uations evaluated for the 10 mwt are represented: a comfortable speed for each child
(blue bars in Figure 4.7 (d)) and the same exercise at maximum speed (orange bars
in Figure 4.7 (d)). More concretely, the percentage of progressions comparing post and
pre-analysis in these metrics, were: P4 (6mwt: 26.92%; 10mwtcomf : 94.69%; 10mwtmax:
51.84%); P5 (6mwt: 14.86%; 10mwtcomf : 21.85%; 10mwtmax: 5.18%); P6 (6mwt:
75.68%; 10mwtcomf : 52.21%; 10mwtmax: 24.60%) and P7 (6mwt: 7.27%; 10mwtcomf :
18.60%; 10mwtmax: 0.81%).
The Physiological Cost Index was evaluated comparing middle and post assessments dur-
ing the 6mwt (see Figure 4.8). All patients reduced the PCI: P4 obtained 0.75 beats/m
(middle) and 0.55 beats/m (post); P5 0.89 beats/m (middle) and 0.80 beats/m (post);
P6 1.57 beats/m (middle) and 1.26 beats/m (post); and P7 0.33 beats/m (middle) and
0.03 beats/m (post).
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Figure 4.7: (a) Results of GMFM-88 (D and E dimensions), (b) SCALE, (c) 6 mwt,
and (d) 10 mwt in pre, middle and post analysis for all the patients (P4 to P7). The
SCALE was measured bilaterally (left and right). The 10 mwt was performed in two
situations: comfortable speed (Comf) and maximum speed (Max).
Figure 4.8: Comparison between middle and post analysis related to the PCI, calcu-
lated as a parameter to express the energy cost expended by the patients in the walking
distance during the 6 mwt.
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Figure 4.9: Maximum strength measures recorded for all the patients in pre (the
light-pink line), middle (the dark-pink line) and post analysis (the purple line). Both
legs were evaluated, right (R) and left (L).
4.2.2.2 Strength progression
In order to quantify the patient’s maximum strength performing on defined and individ-
ual movements without the robot, three measures were taken for each required motion.
According to that, Figure 4.9 represents the average values (in kgf) of the individual-
ized movements recorded in pre, medium and post analyses. In general, results from
Figure 4.9 show that the purple line (post assessment) covers the light-pink line (pre
measures) for all the patients. In some cases, it even covers the dark-pink line (mea-
sured just after finishing the first 8 strength training sessions). This means that higher
values of strength were reached by the children after the robot-based treatment. Con-
cretely, the general improvements (including all the required movements) per patient
in maximum isometric strength measure, comparing pre and post averages, were: P4:
129.77±58.71%; P5: 61.39±58.55%; P6: 70.54±83.68% and P7: 34.41±30.41%.
4.2.2.3 Kinematics and spatiotemporal variability
The 3D kinematic analysis provided outcomes focused on gait improvements respect to
normality. The GPS and GDI (Figure 4.10) are accepted indexes that represent how
close the patient’s gait is to the desired gait. Related to these metrics and comparing
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Figure 4.10: (a) GPS and (b) GDI for pre, middle and post kinematic analyses of
patients P4 to P7. The results represent means ± standard error bilaterally (left in red
bars and right in green bars). Normality in GPS considers values lower than 7 points
(doted-black line in (a)), and normality in GDI comprehends values higher than 100
points (doted-black line in (b)).
pre and post analyses, all the patients obtained better values for both sides (left and
right) after the robot-based treatment. Nevertheless, they were not clinically significant,
except for the right side of P4 (around 10 points in GDI). It is important to highlight
that the post results in P7 could be a↵ected by personal circumstances non-related to
the study occurred the day of the test.
Table 4.6 shows the values of Figure 4.10 in detail and also includes some of the spatial-
temporal parameters recorded during the studies. The average improvement percentages
(four patients) in spatiotemporal parameters were: 21.46±33.79% for mean velocity,
2.84±13.96% for cadence and 17.95±20.45% for step length.
4.2.2.4 ROM performance
Although all the patients succeeded the changes in the parameters of ROM, velocity and
PBWS for the di↵erent sessions, the progression in AAN levels was individualized for
each subject (Figure 4.6). Thereby, P4 was the most advanced, achieving level 5 as the
maximum. An example of ROM performance di↵erence between trajectory tracking and
AAN strategy is represented by Figure 4.11, which shows the data collected for P4 in
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Figure 4.11: ROM performance of some steps walking with CPWalker in two situa-
tions: (a) Session 3 for patient 4 (first phase of the training with trajectory tracking)
and (b) Session 16 for patient 4 (second phase of the training through AAN strategies
with level 5 of assistance (LI at hips and MI at knees)).
session 3 (Figure 4.11 (a)) and session 16 (Figure 4.11 (b)). The last one was recorded
within level 5 (low impedance at hips and medium impedance at knees).
4.2.2.5 Qualitative variables
The motivation of each patient was subjectively evaluated by the practitioner who was
with the children during the whole period of the study. In each training session, the prac-
titioner assigned a score comprehended in a scale from 0 to 10 points to each child, based
on levels of interaction, patient’s participation and initiative. The averaged motivation
values were: 9.4 for P4, 8.6 for P5, 9.44 for P6 and 8.87 for P7.
Moreover, three of four patients decreased the kinesiophobia score after the 16 sessions.
P4 and P6, who were the most a↵ected cases, reduced the score 5 and 6 points respec-
tively, over 40.
4.2.2.6 Patients’ judgement
Parents and patients filled a FAQ questionnaire at the beginning and a follow-up at the
end of the treatment. Regarding parent questionnaires, results show that all of them
thought that the strength and mobility were better at the end of the study thanks to
the robot-based therapy. Meanwhile half of them also included the endurance as an
improved variable due to the robot. 100% of parents felt satisfied towards the results of
robotic therapy with CPWalker, and they ensured that they would like to do it again.
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Nevertheless, 75% of them indicated that they had preferred a longer treatment in order
to achieve higher changes.
The patients’ opinion was very similar. They were also satisfied and, in general, they de-
scribed the treatment as: “really fun”, “the robot makes you feel light and independent”
and “safe”.
The main limitations founded by patients in CPWalker platform were: i) the harness
for the PBWS, which in some occasions was a bit uncomfortable; and ii) the lack of a
steering wheel to control the turns.
4.3 Discussion and conclusion
The main aim of this chapter was to provide a first approach to the implementation of
a novel and defined robotic rehabilitation method that could cover the most important
clinical aspects of the ICF-CY framework. This proposal was tested with four pediatric
patients with CP, which provided some preliminary outcomes to assess it. Although the
patients’ progression was evaluated without a control group, it was not considered as a
relevant limitation of the study, since the wide variety of di↵erences among each child
with CP makes interesting and even necessary to expose the improvements by comparing
each patient with himself.
According to the results, the greatest benefits due to the robot-based treatment corre-
sponded to P4 and P6, who were the most a↵ected levels of GMFCS (III in both cases).
In general, the higher values of gait speed and improved values of global responses
achieved by all the children in several tests, may be in benefit of the patients’ social
mobility. Visual inspection of the graphics show that changes appeared after a small
number of sessions (middle tests) and they were commonly increased or maintained until
the post studies.
The most challenging part was the second phase of the training, which allowed the
possibility of adapting the level of assistance depending on the patient’s progression.
Thereby, any subject could achieve the last level (level 6), and although the action of
reaching level 4 took P6 longer than the rest of children, this patient could pass through
it in the last three sessions.
It is interesting to highlight that the outcomes from isometric strength measure showed
important peaks of improvement, especially for hip and knee flexion-extension, which
was targeted with the CPWalker robotic platform. These higher values were observed
from the middle to the post analysis. The results of the present study are di cult to
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compare with the scientific literature due to the lack of studies using exoskeletons for
gait resistance training. However, the presented results are in line with previous studies
assessing conventional resistance strength training in CP [181].
In relation to 3D-kinematic analysis, as it was said before, P7 su↵ered a non-grata
personal situation the day of the post study. We believe this a↵ected the results of
this metric. Nevertheless, the whole population improved the values for spatiotemporal
parameters, GDI and GPS, although some of these improvements were not clinically
significant. It is important to highlight that not only the kinematics was improved,
also the physiological expenditure in walking activities decreased, as illustrated by the
reduction of the PCI in all patients, which means that better gait performance implies
lower energy cost.
Finally, the motivation scale for the patients and the parents’ satisfaction with the
robot-based treatment was very high in most aspects.
The greatest achievements of this proposal come from the possibility of exercising di↵er-
ent gait functions in an orderly way, individualized per joint and at the same time than
over-ground walking. The proposed protocol could be applied to any current robotic
device for gait rehabilitation making minimal changes on it: e.g. in treadmill pediatric
platforms as Lokomat [182], despite the impossibility of over-ground walking, it already
has di↵erent controllers, whose operation modes are close to the levels of impedance of
CPWalker, ensuring the progression of the therapy into the sessions. Regarding working
postural control in parallel with lower limbs training, which we considered one of the
key factors of the study, it may be solved through other solutions if the selected robotic
device does not have a similar strategy as described with CPWalker, but it is crucial to
guarantee its compliance to get the best results of the treatment [88].
The principal limitation of this research is that it was followed up only in short-term, so
further research with a higher population size is needed to evaluate if the improvements
will be kept over time. Moreover, although other studies propose interventions on 3 non-
consecutive days per week [181], the patients of the present study performed the robotic
exercises during 2 non-consecutive sessions per week. This enabled them to continue
their conventional therapies in parallel to the robot-based rehabilitation. The conven-
tional therapies had been attended on a regular basis for years, so authors considered
to not abolish them for ethical reasons. The conventional therapies of the patients were
performed 2 days a week and consisted of exercises on balance and strength focusing on
quadriceps and abs. Although the patients were doing conventional and robotic therapy
in parallel, authors consider that the improvements achieved in this proposal are exclu-
sively associated to the use of the CPWalker, since the patients got non-robotic therapies
for years with no significant improvements. In conclusion, the method implemented with
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CPWalker is complementary to the common therapies, providing new possibilities to the
clinical practice through robotic rehabilitation and also reaching better outcomes than
conventional therapy alone.
In a nutshell, this chapter contributed with a defined robotic treatment that could be
implemented in most of the existing rehabilitation robotic devices for lower limbs, and
which was evaluated positively in four patients with CP using CPWalker.
Chapter 5
Conclusion and Future Directions
This final chapter presents the most important contributions and main conclusions of this
dissertation, enhancing their significance. Likewise, the chapter also includes approaches
for future work and exposes some of the principal publications derived from the thesis as
an index of its scientific quality.
5.1 Contributions
This doctoral thesis has been developed with the main aim of providing a new robotic so-
lution to improve gait rehabilitation of children with CP and other patients with related
disorders. In order to achieve this objective, author established a work methodology,
which came from an extended review of the state-of-the-art for robotic rehabilitation
in di↵erent pathologies, apart from the bibliography destined to young people with CP.
In this review, several gaps were identified for the current therapies and rehabilitation
devices, being the beginning for the development of this dissertation:
• The need of improving conventional non-robotic therapies due to the lack of e↵ec-
tiveness and movement accuracy. Therapists’ limitation is the main cause of this
shortcoming, and it is also reflected in the scarce duration of the therapy.
• The absence of versatility and adaptability of the current robotic therapies and
devices to the di↵erent patients’ needs.
• The necessity of robotic devices that may execute rehabilitation exercises not only
focusing on peripheral structures, but also including CNS.
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• The lack of gait trainings that motivate the patients through task specific exer-
cises, using control strategies that require patients’ collaboration to perform the
movements.
• The absence of robot-based gait therapies that incorporate postural control as a
main part of recovery during walking, executing di↵erent gait functions in parallel.
• The lack of studies that provide defined guidelines about the implementation of
robotic therapies in the existing rehabilitation devices.
This dissertation tried to cover all the exhibited limitations. The main contributions of
the thesis are summarized in the next points:
• Exposition of a general and descriptive review of the common therapies imple-
mented in CP and the state-of-the-art in robot-based rehabilitation, comprising
robotic devices for both upper and lower limbs. This review helped to perceive
the main advantages and disadvantages of both non-robotic therapies and current
robotic platform for gait rehabilitation in CP (chapter 1).
• Identification of users’ needs in order to establish the design criteria for a new
robotic device that covered previous requirements, complementing the advantages
of current robotic devices with novel solutions to improve the rehabilitation (chap-
ter 2).
• Developing of a robotic platform (CPWalker) for gait rehabilitation of children
with CP. This encompassed mechanical structure and control architecture of the
device (chapter 2).
• Analysis, definition and technical evaluation of several control strategies for gait
rehabilitation in CPWalker platform. Di↵erent algorithms were proposed, whose
combination in several ways provided novel tailored treatments depending on the
rehabilitation stage of each patient (chapter 3).
• Presentation of a clinician interface to control the robotic platform accordingly.
It allowed quick and intuitive definition of exercises, as well as the assessment of
patients’ progression within the robotic treatment (chapter 3).
• Preliminary evaluation of CPWalker robotic platform in three children with spastic
diplegia. The outcomes obtained in this phase o↵ered promising prospects to use
the device into clinical environments (chapter 3).
• Transfer to other robotic devices the novel concepts and control strategies initially
developed for CPWalker. Particularly, the performance-based adaptive controller
opened new horizons in the research with LOPES II gait trainer (chapter 3).
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• Description and evaluation of a defined therapy protocol for gait rehabilitation
of four children with CP. The study provided notable advances for all children
in short-term, and it contributed with better answers on how to use robot-based
rehabilitation in a orderly way (chapter 4).
• Technological transfer of this project to other research centres as RIC with the aim
of starting a collaboration for future studies with CPWalker platform (chapter 5).
5.2 CPWalker in perspective and future work
5.2.1 CPWalker in perspective
Throughout this doctoral thesis, the author reviewed existing robotic devices for the
rehabilitation of children with neurological disorders. Chapters 1 and 2 presented a
comparison between the main gait trainers, exposing their principal advantages, but
also the expected challenges to improve traditional rehabilitation. This section intends
to provide a new perspective of CPWalker to better know where is its real position
comparing to the rest of robotic rehabilitation devices. In [183], Meuleman contrasted
the recommended use of LOPES II gait trainer with the training coverage according to
the patients’ Functional Ambulation Category (FAC). FAC [184] is a functional walking
scale that evaluates patients’ ambulation ability by 6 levels (from 0 to 5). It is mainly
used with, but not limited to, patients with stroke. In order to replicate this comparison
with CPWalker robotic platform, Figure 5.1 shows the suitability of several types of
RAGT as a function of FAC.
Figure 5.1: Recommended use (training coverage) of CPWalker and other RAGT as
a function of FAC.
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Figure 5.2: Progression of CPWalker in the last years as a function of TRL.
To assess the actual maturity level of CPWalker and its evolution since the beginning of
the project, the Technology Readiness Level (TRL) scale has been used. In this regard,
Figure 5.2 presents how was the progression of CPWalker development from year 2013
to the present. Author expects that the robotic platform may reach a TRL 5 at the end
of 2018.
5.2.2 Future work
The work developed in the framework of this thesis and the obtained results, open future
research lines. Some of them are studies that were ruled out from the dissertation due to
time-restrictions, and others are new projections derived from questions that appeared
during the elaboration of the thesis and results analysis.
5.2.2.1 Improvement of mechanical design
The mechanical design of CPWalker should be improved in di↵erent ways, but the most
important part that the author considers is to increase the number of DOFs in order
to improve the kinematic compatibility of CPWalker with the user. The more DOFs
the more transparency of the exoskeleton to the subject. This includes both actuate
and/or provide free motion to DOFs that are currently constrained. In this regard,
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pelvis motion is really influential in gait function, and therefore the author considers a
priority to provide freedom for pelvis transversal rotation and pelvis frontal rotation.
Moreover, it would be desirable to reduce the complexity of the mechanical assembly
for each actuated joint of CPWalker. The current design is composed by too many
pieces that make really di cult to maintain the alignment after the fabrication process.
Both new and existing DOFs for joints should be assembled easily for a better system
operation and eradication of possible misalignments.
5.2.2.2 Improvement of human-robot interaction
The improvement of human-robot interaction would result in an enrichment of robotic
therapies because it implies more patient’s active participation through CNS. An idea
to do that could be the utilization of EEG not only as a trigger to start the movement,
but also to detect patient’s intention to make turns, stop the robot or go faster. In
this regard, other technologies as electromyography (EMG) could be also used to detect
intention of movement or to control the gait. The author also considers EMG mea-
surement as a good estimator for the assessment of patient’s progression. It would be
interesting to integrate EMG in future treatments with CPWalker.
5.2.2.3 Definition of novel treatment protocols
“Contrary to our initial expectations, the major hindrance to the development and de-
ployment of robots for therapy was not engineering, but the lack of strong evidence sup-
porting many current rehabilitation practices.” (Krebs and Hogan, 2006).
RAGT needs to be innovative and defined with goal-directed task. Robotic devices
provide objective measurement and control of the exercise, but new research to validate
the e↵ectiveness and usability of RAGT to complement traditional therapies is needed.
Some author’s assumptions to improve robotic therapies are:
• The combination of functional electrical stimulation (FES) with intensive robotic
gait training is expected to boost the rehabilitation of children with CP by opti-
mizing cortex activation and generating neural changes. The e↵ects of FES with
locomotor training have been satisfactorily proven in individuals with Spinal Cord
Injury [185], but studies are scarce in pediatric population with CP.
• Activities of daily living require simultaneous tasks. To promote the patient a
sense of body-ownership, the e↵ect of dual-task conditions should be evaluated
meanwhile robotic over-ground walking is performed.
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• Backward walking appeared as an emerging rehabilitation approach to enrich the
traditional physical therapies of forward walking [186–188]. Benefits of backward
walking are classified as: i) neurological; ii) cardiovascular; and iii) gait responses
in forward walking. Although backward walking has been proven in traditional
physical therapy, no studies have been found in robotic rehabilitation.
5.2.2.4 Robotics as assessment
A proposed method for assessing the walking function could be the robotic assistance
required by a patient to perform the di↵erent subtasks of gait [43]. An adaptive algo-
rithm developed in the framework of this dissertation (see sections 3.2.2 and 3.5) can
automatically adjust the assistance provided by the robotic platform based on patient’s
performance. The study of how the robotic assistance progresses along therapy sessions
could be an important aspect to assess the patient’s evolution into the robotic treatment.
5.2.2.5 Maximise impact
A possible limitation of this thesis is that robotic studies with CPWalker were evaluated
with a short population size. Future research should involve larger number of patients
to definitively validate the proposed algorithms and training procedures. Following this
purpose, a new CPWalker platform was assembled last year, and it is being tested at
Shirley & Ryan Ability Lab (former RIC) with 70 patients since February 2018 in order
to develop new robotic treatments with a larger population with CP.
5.3 Scientific dissemination
5.3.1 Publications
This thesis, focused on the development and evaluation of CPWalker rehabilitation plat-
form, has allowed the author to work into several robotics fields. This fact is reflected
by the generated scientific contributions, which represent an indicator of the quality
collected in this book. Points below show the main generated publications depending
on the type of dissemination.
5.3.1.1 Journal articles
• C. Bayo´n, S. Lerma, O. Ramı´rez, J.I. Serrano, M.D. Del Castillo, R. Raya, J.M.
Belda-Lois, I. Mart´ınez, E. Rocon, Locomotor training through a novel robotic
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platform for gait rehabilitation in pediatric population: short report, Journal of
NeuroEngineering and Rehabilitation, 10.1186/s12984-016-0206-x, 13:98, 2016.
• C. Bayo´n, T. Mart´ın-Lorenzo, B. Moral-Saiz, O. Ramı´rez, A. Pe´rez-Somarriba, S.
Lerma, I. Mart´ınez, E. Rocon, A robot-based gait training therapy for pediatric
population with Cerebral Palsy: goal setting, proposal and preliminary clinical
implementation, Journal of NeuroEngineering and Rehabilitation, under review,
2018.
• C. Bayo´n, O. Ramı´rez, J.I. Serrano, M.D. del Castillo, A Pe´rez-Somarriba, J.M.
Belda-Lois, I. Mart´ınez, S. Lerma, C. Cifuentes, A. Frizera, E. Rocon, Development
and evaluation of a novel robotic platform for gait rehabilitation in patients with
Cerebral Palsy: CPWalker, Robotics and Autonomous Systems, 10.1016/j.robot.-
2016.12.015, 91:101-114, 2017.
• C. Bayo´n, R. Raya, S. Lerma, O. Ramı´rez, J.I. Serrano, E. Rocon, Robotic Ther-
apies for Children with Cerebral Palsy: a systematic review, Translational Biome-
dicine, 10.21767/2172-0479.100044, 7-1:14, 2016.
• C. Cifuentes, L.F. Aycardi, M. Munera, C. Bayo´n, O. Ramı´rez, E. Rocon, A.
Frizera, S. Lerma, Evaluation of biomechanical gait parameters of patients with
Cerebral Palsy at three di↵erent levels of gait assistance using CPWalker, Journal
of NeuroEngineering and Rehabilitation, under review, 2018.
• S. Lerma, I. Mart´ınez, C. Bayo´n, M.D. del Castillo, I. Serrano, R. Raya, J.M.
Belda, T. Mart´ın, B. Moral, A. Barraga´n, E. Parra, M. Loma-Ossorio, A. Pe´rez, E.
Rocon, Can robotic-based top-down rehabilitation therapies improve motor control
in children with cerebral palsy? A perspective on the CPWalker project, Biomedical
Research and Clinical Practice, 10.15761/BRCP.1000106, 1:1, 2016.
5.3.1.2 Conference proceedings
• C. Bayo´n, O. Ramı´rez, M.D. del Castillo, J.I. Serrano, R. Raya, J.M. Belda, R.
Poveda, F. Molla`, T. Mart´ın-Lorenzo, I. Mart´ınez, S. Lerma, E. Rocon, CPWalker:
Robotic platform for gait rehabilitation in patients with Cerebral Palsy, IEEE In-
ternational Conference on Robotics and Automation (ICRA), 2016.
• C. Bayo´n, O. Ramı´rez, M.Velasco, J.I. Serrano, S. Lerma, I. Mart´ınez, E. Rocon,
Pilot Study of a Novel Robotic Platform for Gait Rehabilitation in Children with
Cerebral Palsy, 6th IEEE RAS & EMBS International Conference on Biomedical
Robotics and Biomechatronics (BioRob), 2016.
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• C. Bayo´n, S.S. Fricke, E. Rocon, H. van der Kooij, E.H.V. van Asseldonk, Per-
formance-Based Adaptive Assistance for Diverse Subtasks of Walking in a Robotic
Gait Trainer: Description of a New Controller and Preliminary Results, EMBS
International Conference on Biomedical Robotics and Biomechatronics (BioRob),
under review, 2018.
• C. Bayo´n, T. Mart´ın-Lorenzo, O. Ramı´rez, B. Moral-Saiz, A. Pe´rez-Somarriba, S.
Lerma, I. Mart´ınez, E. Rocon, Proposal of a robotic therapy for pediatric population
with Cerebral Palsy, Annual Symposium of the IEEE EMBS Benelux Chapter,
2017.
• C. Bayo´n, S.S. Fricke, E. Rocon, H. van der Kooij, E.H.V. van Asseldonk, Per-
formance-based adaptive assistance for di↵erent subtasks of walking in LOPES II,
Annual Symposium of the IEEE EMBS Benelux Chapter, 2017.
• C. Bayo´n, S. Lerma, O. Ramı´rez, J.I. Serrano, M.D. del Castillo, J.M. Belda,
R. Raya, E. Rocon, Gait Rehabilitation in Pediatric Population through a Novel
Robotic Platform: Pilot Study, XXI International Society of Electrophysiology and
Kinesiology (ISEK), Student award winner, 2016.
• C. Cifuentes, C. Bayo´n, S. Lerma, A. Frizera, E. Rocon, Pilot Study of a Novel
Robotic Platform for Gait Rehabilitation in Children with Cerebral Palsy, 6th IEEE
RAS & EMBS International Conference on Biomedical Robotics and Biomecha-
tronics (BioRob), 2016.
• C. Bayo´n, T. Mart´ın-Lorenzo, O. Ramı´rez, B. Moral-Saiz, A. Pe´rez Somarriba,
S. Lerma-Lara, I. Mart´ınez, E. Rocon, Entrenamiento robo´tico de la marcha en
pacientes con Para´lisis Cerebral: definicio´n de objetivos, propuesta de tratamiento
e implementacio´n cl´ınica preliminar, XXXVIII Jornadas de Automa´tica, 2017.
• C. Bayo´n, S. Lerma, O. Ramı´rez, J.I. Serrano, M.D. del Castillo, J.M. Belda,
I. Mart´ınez, E. Rocon, Gait Rehabilitation in Pediatric Population through CP-
Walker Robotic Platform, XXXVII Jornadas de Automa´tica, 2016.
• C. Bayo´n, C. Cifuentes, O. Ramı´rez, R. Raya, M. Velasco, A. Frizera, E. Rocon,
CPWalker. Interaccio´n humano-robot basada en sensor la´ser para rehabilitacio´n
de la marcha de nin˜os con para´lisis cerebral, VIII Congreso Iberoamericano de
Tecnolog´ıas de Apoyo a la Discapacidad (Iberdiscap), 2015.
• C. Bayo´n, E. Rocon, R. Raya, O. Ramı´rez, M.D. del Castillo, J.I. Serrano, S.
Lerma, CPWalker: plataforma robo´tica para la rehabilitacio´n de la marcha en
nin˜os con Para´lisis Cerebral, VI Congreso Internacional de Disen˜o, Redes de In-
vestigacio´n y Tecnolog´ıa para todos (DRT4all), Best paper award, 2015.
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• C. Cifuentes, L.F. Aycardi, M. Munera, C. Bayo´n, O. Ramı´rez, E. Rocon, A. Friz-
era, S. Lerma, Biomechanical comparison of patients with CP with di↵erent levels
of gait assistance using CPWalker, 20th International Conference on Climbing and
Walking Robots and Support Technologies for Mobile Machines (CLAWAR), 2017.
• J.I. Serrano, M.D. del Castillo, R. Raya, C. Bayo´n, E. Rocon, I. Mart´ınez, S.
Lerma, BCI basado en la facilitacio´n asociativa de la actividad cortical para el
inicio de la marcha en Para´lisis Cerebral, 7o Simposio CEA de Bioingenier´ıa,
2015.
5.3.1.3 Book chapters
• J.I. Serrano, M.D. del Castillo, C. Bayo´n, O. Ramı´rez, S. Lerma, I. Mart´ınez, E.
Rocon, BCI-based Facilitation of Cortical Activity Associated to Gait Onset af-
ter Single Event Multi-Level Surgery in Cerebral Palsy, Brain-Computer Interface
Research: A State-of-the-Art, Springer, 5:99-110, 2017.
• C. Cifuentes, C. Bayo´n, S. Lerma, A. Frizera, L. Rodr´ıguez, E. Rocon, Wear-
able Robotic Walker for Gait Rehabilitation and Assistance in Patients with Cere-
bral Palsy, Covering Clinical and Engineering Research on Neurorehabilitation II,
Springer, 1451-1455, 2017.
• T. Mart´ın, S. Lerma, C. Bayo´n, O. Ramı´rez, E. Rocon, CPWalker for Strength
Training in Children with Spastic Cerebral Palsy: a training program proposal,
Covering Clinical and Engineering Research on Neurorehabilitation II, Springer,
1211-1215, 2017.
5.3.1.4 Other dissemination activities
• C. Bayo´n, S. Lerma Lara, O. Ramı´rez, J.I. Serrano, B. Moral, E. Parra, A. Pe´rez,
J.M. Belda-Lois, I. Mart´ınez, E. Rocon, Gait Rehabilitation in Pediatric Popula-
tion through CPWalker Robotic Platform: Pilot Study, MRS Training day North-
western University, 2016.
• C. Bayo´n, Research Lines of group of Neural and Cognitive Engineering: Novel
Robotic Platform for Gait Rehabilitation and Training in Children with Cerebral
Palsy, RIC Research Seminars, 2016.
• Supervision of graduation project: Desarrollo de un Sistema de Reproduccio´n del
Movimiento en Tiempo Real para el Robot Rehabilitador CPWalker, Mar´ıa Begon˜a
Rojas Lo´pez, Universidad Polite´cnica Madrid, 2016.
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• C. Bayo´n, O. Ramı´rez, CPWalker: Plataforma robo´tica para la rehabilitacio´n y el
entrenamiento de la marcha en pacientes con Para´lisis Cerebral, RoboRave Ibe´rica,
Fundacio´n Primera Fila, 2016.
• C. Bayo´n, E. Rocon, CPWalker: plataforma robo´tica para la rehabilitacio´n y el
entrenamiento de la marcha en pacientes con para´lisis cerebral, 40 Aniversario
Escuela de Ingenier´ıas Industriales Badajoz, 2016.
• Award I+D+i ”Dependencia y Sociedad” Fundacio´n CASER, CASER, 2017.
• C. Bayo´n, O. Ramı´rez, E. Rocon, CPWalker: plataforma robo´tica para rehabil-
itacio´n de la marcha en pacientes con Para´lisis Cerebral, Noche Europea de los
Investigadores, 2015.
• C. Bayo´n, O. Ramı´rez, E. Rocon, Tecnolog´ıa Bio´nica en medicina: demostracio´n
plataforma CPWalker, Universidad CEU San Pablo, 2015.
• C. Bayo´n, O. Ramı´rez, E. Rocon, Utilizacio´n del exoesqueleto CPWalker en la
rehabilitacio´n de nin˜os con para´lisis cerebral, Universidad Francisco de Vitoria,
2014.
• Broadcast O´rbita Laika TV program, TVE2, 2015.
• Broadcast Madrid Contigo, TeleMadrid, 2017.
• Broadcast ”Punto de encuentro”, Canal Orbe21 Movistar+, 2017.
• Broadcast Antena3 News, Ejemplos de campan˜as solidarias que salvan vidas, An-
tena3, 2016.
• Broadcast Cuatro TV, La carrera de la vida, Cuatro TV, 2016.
• Broadcast TVE1 News, Carrera Corre por el Nin˜o, TVE1, 2016.
• Broadcast TeleMadrid News, Carrera Corre por el Nin˜o, TeleMadrid, 2016.
• Broadcast TVE1 News, TVE1, 2015.
• Broadcast TeleMadrid News, TeleMadrid, 2015.
• Radio show news, Una carrera con exoesqueleto, COPE, 2016.
• Radio show ”El Sol sale por el Oeste”, Canal Extremadura, 2016.
• Radio show Mediod´ıa COPE, El exoesqueleto que permitira´ andar a nin˜os con PC,
COPE, 2017.
• CPWalker facilita la rehabilitacio´n de nin˜os con PC, newspaper Tecnobility, 2017.
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• El ”leva´ntate y anda” del nin˜o Jesu´s, newspaper El Mundo, 2015.
• Badajoz acoge una presentacio´n de estudios sobre Parkinson y Para´lisis cerebral,
journal GRADA, Fundacio´n Primera Fila, 2016.
• La UEx sen˜ala que el futuro de la rehabilitacio´n para ictus o apopleg´ıas pasa por
utilizar nuevas te´cnicas robo´ticas, newspaper EuropaPress Extremadura, 2016.
5.3.2 International experience
During this doctoral thesis, the author carried out two research visits awarded by the
Spanish Ministry of Economy and Competitiveness. These research fellowships served
to facilitate the transfer of knowledge between the involved centres. It is important to
highlight that the first research visit concluded with an important collaboration between
Spanish National Research Council and Rehabilitation Institute of Chicago, in which the
American centre funded a new CPWalker platform with the aim of testing this robot in
United States.
• Research fellowship awarded by Spanish Ministry of Economy and Competitive-
ness, EEBB-I-16-10663, Rehabilitation Institute of Chicago (United States), from
May 22 to September 28, 2016.
• Research fellowship awarded by Spanish Ministry of Economy and Competitive-
ness, EEBB-I-17-12035, University of Twente (The Netherlands), from September
22 to December 22, 2017.
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